
<html lang="en"     class="pb-page"  data-request-id="70b5ea63-5767-4af3-ad57-1acd6e4ad476"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2008.51.issue-17;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm800113p;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Potent, Plasmodium-Selective Farnesyltransferase Inhibitors That Arrest the Growth of Malaria Parasites: Structure−Activity Relationships of Ethylenediamine-Analogue Scaffolds and Homology Model Validation" /></meta><meta name="dc.Creator" content="Steven  Fletcher" /></meta><meta name="dc.Creator" content="Christopher G.  Cummings" /></meta><meta name="dc.Creator" content="Kasey  Rivas" /></meta><meta name="dc.Creator" content="William P.  Katt" /></meta><meta name="dc.Creator" content="Carrie  Hornéy" /></meta><meta name="dc.Creator" content="Frederick S.  Buckner" /></meta><meta name="dc.Creator" content="Debopam  Chakrabarti" /></meta><meta name="dc.Creator" content="Saïd M.  Sebti" /></meta><meta name="dc.Creator" content="Michael H.  Gelb" /></meta><meta name="dc.Creator" content="Wesley C.  Van Voorhis" /></meta><meta name="dc.Creator" content="Andrew D.  Hamilton" /></meta><meta name="dc.Description" content="New chemotherapeutics are urgently needed to combat malaria. We previously reported on a novel series of antimalarial, ethylenediamine-based inhibitors of protein farnesyltransferase (PFT). In the ..." /></meta><meta name="Description" content="New chemotherapeutics are urgently needed to combat malaria. We previously reported on a novel series of antimalarial, ethylenediamine-based inhibitors of protein farnesyltransferase (PFT). In the ..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 8, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm800113p" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm800113p" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm800113p" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm800113p" /></link>
        
    
    

<title>Potent, Plasmodium-Selective Farnesyltransferase Inhibitors That Arrest the Growth of Malaria Parasites: Structure−Activity Relationships of Ethylenediamine-Analogue Scaffolds and Homology Model Validation | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm800113p" /></meta><meta property="og:title" content="Potent, Plasmodium-Selective Farnesyltransferase Inhibitors That Arrest the Growth of Malaria Parasites: Structure−Activity Relationships of Ethylenediamine-Analogue Scaffolds and Homology Model Validation" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0001.jpeg" /></meta><meta property="og:description" content=" New chemotherapeutics are urgently needed to combat malaria. We previously reported on a novel series of antimalarial, ethylenediamine-based inhibitors of protein farnesyltransferase (PFT). In the current study, we designed and synthesized a series of second generation inhibitors, wherein the core ethylenediamine scaffold was varied in order to examine both the homology model of Plasmodium falciparum PFT (PfPFT) and our predicted inhibitor binding mode. We identified several PfPFT inhibitors (PfPFTIs) that are selective for PfPFT versus the mammalian isoform of the enzyme (up to 136-fold selectivity), that inhibit the malarial enzyme with IC50 values down to 1 nM, and that block the growth of P. falciparum in infected whole cells (erythrocytes) with ED50 values down to 55 nM. The structure−activity data for these second generation, ethylenediamine-inspired PFT inhibitors were rationalized by consideration of the X-ray crystal structure of mammalian PFT and the homology model of the malarial enzyme." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm800113p"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm800113p">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm800113p&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm800113p&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm800113p&amp;href=/doi/10.1021/jm800113p" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 5176-5197</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm8006867" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm8001907" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Potent, Plasmodium-Selective Farnesyltransferase Inhibitors That Arrest the Growth of Malaria Parasites: Structure−Activity Relationships of Ethylenediamine-Analogue Scaffolds and Homology Model Validation</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven++Fletcher">Steven Fletcher</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+G.++Cummings">Christopher G. Cummings</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kasey++Rivas">Kasey Rivas</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+P.++Katt">William P. Katt</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carrie++Horn%C3%A9y">Carrie Hornéy</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frederick+S.++Buckner">Frederick S. Buckner</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Debopam++Chakrabarti">Debopam Chakrabarti</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sa%C3%AFd+M.++Sebti">Saïd M. Sebti</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+H.++Gelb">Michael H. Gelb</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wesley+C.++Van+Voorhis">Wesley C. Van Voorhis</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+D.++Hamilton">Andrew D. Hamilton</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Department of Chemistry, Yale University, 225 Prospect Street, New Haven, Connecticut 06511, Department of Medicine and Department of Chemistry and Biochemistry, University of Washington, Seattle, Washington 98195, Department of Molecular Biology and Microbiology, University of Central Florida, Orlando, Florida 32826, and Department of Oncology and Department of Biochemistry and Molecular Biology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida 33612</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Phone: (203) 432-5570. Fax: (203) 432-3221. E-mail: <a href="/cdn-cgi/l/email-protection#22434c465047550c4a434f4b4e564d4c625b434e470c474657"><span class="__cf_email__" data-cfemail="0869666c7a6d7f2660696561647c6766487169646d266d6c7d">[email protected]</span></a></div><div class="corresp-fn" id="afn1">†Yale University.</div><div class="corresp-fn" id="afn2">‡Department of Medicine, University of Washington.</div><div class="corresp-fn" id="afn4">#Department of Molecular Biology and Microbiology, University of Central Florida.</div><div class="corresp-fn" id="afn5">∥University of South Florida.</div><div class="corresp-fn" id="afn3">§Department of Chemistry and Biochemistry, University of Washington.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm800113p&amp;href=/doi/10.1021%2Fjm800113p" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 5176–5197</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 8, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 February 2008</li><li><span class="item_label"><b>Published</b> online</span>8 August 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 September 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm800113p" title="DOI URL">https://doi.org/10.1021/jm800113p</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5176%26pageCount%3D22%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSteven%2BFletcher%252C%2BChristopher%2BG.%2BCummings%252C%2BKasey%2BRivas%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D17%26contentID%3Djm800113p%26title%3DPotent%252C%2BPlasmodium-Selective%2BFarnesyltransferase%2BInhibitors%2BThat%2BArrest%2Bthe%2BGrowth%2Bof%2BMalaria%2BParasites%253A%2BStructure%25E2%2588%2592Activity%2BRelationships%2Bof%2BEthylenediamine-Analogue%2BScaffolds%2Band%2BHomology%2BModel%2BValidation%26numPages%3D22%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5197%26publicationDate%3DSeptember%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm800113p"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2051</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">28</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm800113p" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Potent, Plasmodium-Selective Farnesyltransferase Inhibitors That Arrest the Growth of Malaria Parasites: Structure−Activity Relationships of Ethylenediamine-Analogue Scaffolds and Homology Model Validation&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;Fletcher&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;G. Cummings&quot;},{&quot;first_name&quot;:&quot;Kasey&quot;,&quot;last_name&quot;:&quot;Rivas&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;P. Katt&quot;},{&quot;first_name&quot;:&quot;Carrie&quot;,&quot;last_name&quot;:&quot;Hornéy&quot;},{&quot;first_name&quot;:&quot;Frederick&quot;,&quot;last_name&quot;:&quot;S. Buckner&quot;},{&quot;first_name&quot;:&quot;Debopam&quot;,&quot;last_name&quot;:&quot;Chakrabarti&quot;},{&quot;first_name&quot;:&quot;Saïd&quot;,&quot;last_name&quot;:&quot;M. Sebti&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;H. Gelb&quot;},{&quot;first_name&quot;:&quot;Wesley&quot;,&quot;last_name&quot;:&quot;C. Van Voorhis&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;D. Hamilton&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;5176-5197&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm800113p&quot;},&quot;abstract&quot;:&quot;New chemotherapeutics are urgently needed to combat malaria. We previously reported on a novel series of antimalarial, ethylenediamine-based inhibitors of protein farnesyltransferase (PFT). In the current study, we designed and synthesized a series of second generation inhibitors, wherein the core ethylenediamine scaffold was varied in order to examine both the homology model of Plasmodium falciparum PFT (PfPFT) and our predicted inhibitor binding mode. We identified several PfPFT inhibitors (PfPFTIs) that are selective for PfPFT versus the mammalian isoform of the enzyme (up to 136-fold selectivity), that inhibit the malarial enzyme with IC50 values down to 1 nM, and that block the growth of P. falciparum in infected whole cells (erythrocytes) with ED50 values down to 55 nM. The structure−activity data for these second generation, ethylenediamine-inspired PFT inhibitors were rationalized by consideration of the X-ray crystal structure of mammalian PFT and the homology model of the malarial enzyme.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800113p&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800113p" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800113p&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800113p" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800113p&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800113p" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm800113p&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800113p&amp;href=/doi/10.1021/jm800113p" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm800113p" /></input><a href="/doi/pdf/10.1021/jm800113p" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm800113p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm800113p%26sid%3Dliteratum%253Aachs%26pmid%3D18686940%26genre%3Darticle%26aulast%3DFletcher%26date%3D2008%26atitle%3DPotent%252C%2BPlasmodium-Selective%2BFarnesyltransferase%2BInhibitors%2BThat%2BArrest%2Bthe%2BGrowth%2Bof%2BMalaria%2BParasites%253A%2BStructure%25E2%2588%2592Activity%2BRelationships%2Bof%2BEthylenediamine-Analogue%2BScaffolds%2Band%2BHomology%2BModel%2BValidation%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D17%26spage%3D5176%26epage%3D5197%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291528" title="Parasites">Parasites</a>,</li><li><a href="/action/doSearch?ConceptID=292201" title="Scaffolds">Scaffolds</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0001.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">New chemotherapeutics are urgently needed to combat malaria. We previously reported on a novel series of antimalarial, ethylenediamine-based inhibitors of protein farnesyltransferase (PFT). In the current study, we designed and synthesized a series of second generation inhibitors, wherein the core ethylenediamine scaffold was varied in order to examine both the homology model of <i>Plasmodium falciparum</i> PFT (<i>Pf</i>PFT) and our predicted inhibitor binding mode. We identified several <i>Pf</i>PFT inhibitors (<i>Pf</i>PFTIs) that are selective for <i>Pf</i>PFT versus the mammalian isoform of the enzyme (up to 136-fold selectivity), that inhibit the malarial enzyme with IC<sub>50</sub> values down to 1 nM, and that block the growth of <i>P. falciparum</i> in infected whole cells (erythrocytes) with ED<sub>50</sub> values down to 55 nM. The structure−activity data for these second generation, ethylenediamine-inspired PFT inhibitors were rationalized by consideration of the X-ray crystal structure of mammalian PFT and the homology model of the malarial enzyme.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76035" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76035" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Malaria is an infectious disease, prevalent primarily in the tropics and subtropics. With as many as 300−500 million cases reported each year, malaria causes between 1 and 3 million deaths annually, approximately 90% of which occur in Africa.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Unfortunately, malaria mortality is increasing, especially in the highest risk group, African children.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> There are a number of likely reasons for this increase, the most important of which is increased resistance of malaria parasites to existing drugs.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4-6)</a> There is now a general consensus that new antimalarials are urgently needed.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">Transmitted by mosquitoes of the genus <i>Anopheles</i>, four species of the protozoal parasite <i>Plasmodium</i> are known to cause malaria in humans, namely <i>falciparum</i>, <i>vivax</i>, <i>malariae</i>, and <i>ovale.</i> Of these, <i>P. falciparum</i><a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a><div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: PFT, protein farnesyltransferase; <i>P. falciparum</i>, <i>Plasmodium falciparum</i>; <i>Pf</i>PFT, <i>P. falciparum</i> protein farnesyltransferase; FPP, farnesyl pyrophosphate; ED<sub>50</sub>, effective dose that inhibits 50% of <i>P. falciparum</i> proliferation; IC<sub>50</sub>, inhibitor concentration that inhibits 50% of PFT enzyme activity; rt, room temperature.</p></div> is the most virulent, and malaria mortality is almost exclusively attributable to infection by this species.<a onclick="showRef(event, 'ref1 ref7'); return false;" href="javascript:void(0);" class="ref ref1 ref7">(1, 7)</a> Chloroquine, which is believed to disrupt heme polymerization, is one of the cheapest and most widespread drugs for malaria chemotherapy. However, <i>P. falciparum</i> has developed considerable resistance to chloroquine and to other antimalarial drugs, such as mefloquine and sulfadoxime/pyrimethamine,<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> and in those countries that are affected most seriously, existing alternative chemotherapeutics are virtually unaffordable. Of significant concern is the identification of multidrug resistant strains of <i>P. falciparum</i>.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The development of drug resistance is not the only cause of the increasing spread of malaria. Other factors also contribute to this worsening scenario, such as the resistance of the <i>Anopheles</i> mosquito to the pesticide DDT, the migration of refugee populations, and an ever-warming climate.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The associated increase in malaria mortality has accelerated research into new antimalarial drugs, to disrupt not only conventional targets, such as heme polymerization, but also more novel targets, such as the biochemical pathways of fatty acid biosynthesis and mevalonate-independent isoprenoid biosynthesis.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> We believe that exploitation of these alternative targets will fast become essential, owing to the existence of multidrug resistant strains of <i>P. falciparum</i> coupled with the observation that the parasite readily mutates to develop resistance to new drugs (designed for conventional targets).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Since the economic reality of the effective treatment of malaria is beyond the means of Third World countries, where this disease is most prevalent, this raises the need for inexpensive chemotherapeutics. Subsequently, while it is acknowledged that the majority of the cost of a new therapeutic lies in its clinical trials, to minimize the cost at the drug development stage and to expedite access to new antimalarials, there has been considerable research into the possible antimalarial activity of drugs designed for other diseases in a so-called “piggy-back” approach.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12 ref13 ref14">(9-14)</a></div><div class="NLM_p">Mammalian protein farnesyltransferase (PFT) is a key target for the antagonism of oncogenic Ras activity that is found in around 30% of human cancers,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and a number of protein farnesyltransferase inhibitors (PFTIs) have shown antitumor activity, having progressed to phase II/III in clinical trials.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> PFT, a member of the prenyltransferase family, is one of three closely related heterodimeric zinc metalloenzymes (the others being the protein geranylgeranyltransferases I and II, PGGT-I and PGGT-II, respectively) that are important post-translational modification enzymes, catalyzing protein prenylation and subsequent membrane association.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> PFT catalyzes the transfer of a C15 isoprenoid (farnesyl) unit from farnesylpyrophosphate (FPP) to the free thiol of a cysteine residue within a specific CaaX tetrapeptide sequence, located at the C-terminus of the substrate protein (e.g., RasGTPase), where a = an aliphatic amino acid and X (which contributes to substrate specificity) = M, S, A, or Q. Chakrabarti et al. have identified prenylated proteins and associated prenyltransferase activity in <i>P. falciparum</i> and confirmed the viability of <i>P. falciparum</i> protein farnesyltransferase (<i>Pf</i>PFT) as a new antimalarial target.<a onclick="showRef(event, 'ref9 ref18'); return false;" href="javascript:void(0);" class="ref ref9 ref18">(9, 18)</a> Upon administration of mammalian-designed anticancer PFTIs to <i>P. falciparum</i>-infected erythrocytes, a reduction in the cellular levels of farnesylated proteins was observed coupled with lysis of the parasites.<a onclick="showRef(event, 'ref13 ref18'); return false;" href="javascript:void(0);" class="ref ref13 ref18">(13, 18)</a> More recently, Van Voorhis and co-workers have identified two <i>P</i>. <i>falciparum</i> mutants, each with single amino acid substitutions (Y837C<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and G612A<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a>) in <i>Pf</i>PFT that map to the predicted inhibitor binding site, which show resistance to tetrahydroquinoline (THQ)-based <i>Pf</i>PFT inhibitors both in vitro and in whole cells, further supporting <i>Pf</i>PFT as the target for antimalarial activity.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> We<a onclick="showRef(event, 'ref10 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref10 ref21 ref22 ref23">(10, 21-23)</a> and others<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> have successfully adopted this “piggy-back” approach with several series of anticancer PFTIs and observed antimalarial activity in every case.<a onclick="showRef(event, 'ref10 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref10 ref21 ref22 ref23">(10, 21-23)</a> Notably, in animal studies we have cured rats infected with malaria via oral dosing of our PFT-targeted THQ-based inhibitors,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> while Schlitzer et al. have cured mice infected with malaria by intraperitoneal injection of their benzophenone-based PFTIs.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The now-complete genome of <i>P. falciparum</i> indicates an apparent lack of PGGT-I,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> suggesting that no alternative protein prenylation can occur upon <i>Pf</i>PFT inhibition, which may explain the observation that PFTIs have been found to be significantly more toxic to plasmodial cells than to mammalian cells.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Indeed, if PFTIs are to be effective antimalarials, plasmodium selectivity may be required, since the antiproliferative nature of PFTIs may preclude or at least restrict their use in children and pregnant women, the main target groups in malaria therapy.</div><div class="NLM_p">Using the sequence alignment of <i>Pf</i>PFT on the template crystal structure of rat PFT complexed with the nonsubstrate tetrapeptide inhibitor CVFM and the cosubstrate FPP, we have developed a homology model of the active site of <i>Pf</i>PFT.<a onclick="showRef(event, 'ref19 ref26'); return false;" href="javascript:void(0);" class="ref ref19 ref26">(19, 26)</a> This model reveals a large (∼20 × 20 × 20 Å<sup>3</sup>), open, and predominantly hydrophobic cavity, with FPP extending across the cavity base, itself forming part of the binding surface for the enzyme substrate. Further inspection of the active site homology model indicates that there are four subpockets. In the first, the Zn(II) ion is chelated by three residues (Cys661, Asp659, His838), with a water molecule hydrogen-bonded between the terminal phosphate of FPP and Asp659, defining the limit of the Zn binding domain. Second and third are two well-defined, predominantly hydrophobic subpockets (Lys149, Asn317, Ser150, Phe151, where Asn317 and Ser150 form a hydrophilic domain at the deepest point; and Trp456, Trp452, Tyr837). The fourth subpocket is a larger hydrophilic domain formed by Arg564 and three water molecules participating in a hydrogen-bonded network between Ser449 and Gln152. We have previously reported on a series of ethylenediamine-based inhibitors that were predicted to allow simultaneous access to the four subpockets within the <i>Pf</i>PFT active site.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> Lead inhibitors displayed excellent activity in vitro (IC<sub>50</sub> < 1 nM) and toxicity toward cultured parasites in whole cells (ED<sub>50</sub> < 100 nM). Furthermore, these PFTIs represent the first antimalarials to exhibit selectivity for plasmodial over mammalian PFT (up to 145-fold selectivity). With such potent data and plasmodium PFT-isoform selectivity already achieved, the main aim of the present research was to investigate the validity of the <i>Pf</i>PFT active site homology model, as well as the initial docking studies reported in our previous work,<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> by introducing alternative scaffolds with different rigidities/flexibilities and with different nitrogen−nitrogen distances into our ethylenediamine-based inhibitors. In turn, we hoped that our findings would assist in future, potent <i>Pf</i>PFT inhibitor design.</div><div class="NLM_p last">First, we illustrate the scaffold modifications that we chose to investigate and then comment on their abilities to dock in the <i>Pf</i>PFT active site homology model using the computer modeling program GOLD.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> We describe the syntheses of these novel inhibitors and then present in vitro PfPFT inhibition data, as well as two sets of whole cell data of erythrocytes infected with either the 3D7 (chloroquine-sensitive) or the K1 (chloroquine-resistant, pyrimethamine-resistant) strain of <i>P. falciparum</i>. To conclude the manuscript, we utilize our computational and experimental data to present quantitative structure−activity relationship (QSAR) models of <i>Pf</i>PFT and discuss their implications.</div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Design</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63144" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63144" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Previous research identified that our most potent ethylenediamine-based inhibitors were functionalized as in <b>1</b> and where varying the R group proved critical to inhibitor potency. As reference compounds, we selected five derivatives of <b>1</b> with the following R groups: <b>a</b>, R = benzyl; <b>b</b>, R = 2-methylbenzyl; <b>c</b>, R = thiophen-3-ylmethyl; <b>d</b>, R = <i>N</i>-Boc-piperidin-4-ylmethyl; <b>e</b> = <i>N</i>-(2-pyrimidinyl)-piperidin-4-ylmethyl. The ethylenediamine-alternative scaffolds selected to test both our predicted inhibitor binding mode and the <i>Pf</i>PFT active site homology model are illustrated in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. These fall into three categories with respect to their rigidities/flexibilities relative to the ethylenediamine scaffold (<b>1</b>). The first category possesses only 1,3-diaminopropane (<b>2</b>), which is acyclic and, with the additional methylene group, more flexible than ethylenediamine. The second category includes <i>gem</i>-dimethylethylenediamine (<b>3</b>), 2-aminoethanamide (<b>4</b>), and 3-aminopropanamide (<b>5</b>), which are acyclic and more rigid than ethylenediamine. The third category incorporates (±)-<i>cis</i>-1,2-diaminocyclopentane (<b>6</b>) and (±)-<i>trans</i>-1,2-diaminocyclopentane (<b>7</b>), (±)-<i>cis</i>-1,3-diaminocyclopentane (<b>8</b>) and (±)-<i>trans</i>-1,3-diaminocyclopentane (<b>9</b>), and (±)-<i>cis</i>-1,4-diaminocyclohexane (<b>10</b>) and (±)-<i>trans</i>-1,4-diaminocyclohexane (<b>11</b>), all of which are cyclic and more rigid than ethylenediamine and exhibit gradually increasing distances between the scaffold nitrogens. The corresponding rigid (±)-<i>cis</i>- and (±)-<i>trans</i>-1,2-diaminocyclobutanes and the (±)-<i>cis</i>- and (±)-<i>trans</i>-1,2-diaminocyclopropanes were deemed too unstable because of the “push−pull effect” and were not investigated.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. The various scaffolds used in this study as alternatives to the ethylenediamine scaffold in <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Computational docking experiments were performed using the GOLD 3.1 software package.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> First, InsightII<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> was used to draw structures (R = Bn), energy-minimize them and to prepare our homology model of the active site of <i>Pf</i>PFT for use in GOLD. Novel ligands were assumed to maintain a similar binding mode to that hypothesized for <b>1a</b>;<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> the two imidazole rings and the cyanoaniline were loosely constrained to their associated binding pockets for each compound (for full details, see <a class="ref internalNav" href="#sec4" aria-label="Experimental Methods">Experimental Methods</a>). Visualization of GOLD low energy docked poses was performed with InsightII. In all figures presented (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> and <a class="ref internalNav" href="#si1" aria-label="Supporting Information Figures 1−8">Supporting Information Figures 1−8</a>), the binding site of PFT has been surfaced, in which the enzyme cosubstrate farnesylpyrophosphate (FPP) forms part of that binding surface.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Low energy docked conformations (GOLD<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a>) of inhibitors loosely constrained to the predicted binding mode of <b>1a</b>.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> Docked inhibitors are colored by atom type and are overlaid by the predicted docking pose of <b>1a</b> in yellow. Farnesylpyrophosphate (FPP) is shown in red. Hydrophobic surface residues are colored red, hydrophilic residues and structural waters are blue, and the Zn<sup>2+</sup> ion is pink: (A) <b>1a</b> docked alone; (B) (±)-<b>6a</b> overlaid with <b>1a</b>; (C) (±)-<b>9a</b> overlaid with <b>1a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The GOLD docking studies predicted that many of these alternative scaffolds should not be as well tolerated as the parent ethylenediamine scaffold in the active site of <i>Pf</i>PFT (Figure 2 and Supporting Information Figures 1–8. As Supporting Information Figure 1 illustrates, the 1,3-diaminopropyl scaffold (inhibitor <b>2a</b>) is accommodated well in the active site, although the extra methylene appears to require the inhibitor to buckle in order to allow all four N-substituents to reach their predicted subpockets. We anticipated that inhibitors derived from this scaffold may bind <i>Pf</i>PFT well but not as potently as the parent ethylenediamine-based inhibitors. As expected, docking of the <i>gem</i>-dimethylethylenediamine-based inhibitor (<a class="ref internalNav" href="#si1" aria-label="Supporting Information Figure 2">Supporting Information Figure 2</a>, inhibitor <b>3a</b>) illustrates that all four subpockets can be reasonably accessed by the four N-derivatives in much the same way as the parent ethylenediamine scaffold, suggesting that these compounds may be potent inhibitors of <i>Pf</i>PFT. While the amide-based scaffolds (<a class="ref internalNav" href="#si1" aria-label="Supporting Information Figure 3">Supporting Information Figure 3</a>, inhibitor <b>4a</b>) are also predicted to bind well, the constraints we imposed in the GOLD docking experiments have caused the increase in hydrophilicity of the core scaffold to be ignored, which may lead to an erroneous result due to the hydrophobic environment in which the inhibitor scaffold is predicted to bind. The rigid <i>cis</i>-1,2- (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B inhibitor <b>6a</b>), <i>trans</i>-1,2- (<a class="ref internalNav" href="#si1" aria-label="Supporting Information Figure 4">Supporting Information Figure 4</a>, inhibitor <b>7a</b>), and <i>cis</i>-1,3-diaminocyclopentyl scaffolds (<a class="ref internalNav" href="#si1" aria-label="Supporting Information Figure 5">Supporting Information Figure 5</a>, inhibitor <b>8a</b>), and the <i>cis</i>-1,4-diaminocyclohexyl (<a class="ref internalNav" href="#si1" aria-label="Supporting Information Figure 7">Supporting Information Figure 7</a>, inhibitor <b>10a</b>) scaffold do not fit well in the active site because of their constrained structures that prevent simultaneous access by all four N-substituents into the four subpockets. These observations suggest that compounds with these scaffolds may be poor inhibitors of <i>Pf</i>PFT. On the other hand, <i>trans</i>-1,3-diaminocyclopentyl- (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C, inhibitor <b>9a</b>) and <i>trans</i>-1,4-diaminocyclohexyl- (<a class="ref internalNav" href="#si1" aria-label="Supporting Information Figure 6">Supporting Information Figure 6</a>, inhibitor <b>11a</b>) derivatives appear to be reasonably well accommodated, so we predicted these inhibitors may bind well to <i>Pf</i>PFT. However, the increasing scaffold nitrogen−nitrogen distance may prove detrimental with bulkier R groups.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0019.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. 2-Aminoethanamide- (<i>n</i> = 1) and 3-aminopropanamide- (<i>n</i> = 2) based inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We hypothesized that if a structure with a diamino-based scaffold (whose nitrogens have been functionalized with four previously optimized groups) is loosely constrained to our predicted binding mode and subsequently docks well in the active site homology model, then that structure should bind well experimentally. In turn, this should be reflected by potent enzyme inhibition data. Conversely, structures that are predicted to bind less well should be poorer inhibitors. By testing this hypothesis over a range of different scaffolds that modulate the inhibitors’ abilities to simultaneously access all four predicted binding subpockets within the <i>Pf</i>PFT active site, we should be able to garner enough information to develop a quantitative structure−activity relationship (QSAR) model and thereby validate both our predicted inhibitor binding mode and the homology model itself. It is our hope that this information will assist in future <i>Pf</i>PFT inhibitor design.</div></div><div id="sec1_2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12765" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12765" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec1_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> 1,3-Diaminopropane-Based Inhibitors (<b>2a</b>−<b>e</b>)</h3><div class="NLM_p">These inhibitors were prepared as in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. <i>N</i>-Carbobenzyloxy-3-amino-1-propanol (<b>12</b>) was converted to its THP ether derivative (with dihydropyan (DHP) and catalytic pyridinium <i>p</i>-toluenesulfonate (PPTS)), after which the Cbz protecting group was removed under standard hydrogenolytic conditions (H<sub>2</sub> and 10% Pd/C) to furnish primary amine <b>13</b>. Nucleophilic aromatic substitution of <b>13</b> with <i>p</i>-fluorobenzonitrile, followed by N-alkylation of secondary aniline <b>14</b> with 5-chloromethyl-1-methyl-1<i>H</i>-imidazole·HCl (<b>15</b>) under optimized conditions gave tertiary aniline <b>16</b> in a yield of 81% (or 97% based on recovered starting material (brsm)). Acid-catalyzed methanolysis of the THP protecting group furnished primary alcohol <b>17</b>, which was coupled to the secondary sulfonamides <b>19a</b>−<b>e</b> (prepared as described in Schemes <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) under Mitsunobu conditions, employing diisopropyl azodicarboxylate (DIAD)/triphenylphosphine (PPh<sub>3</sub>) as the redox system, to give <i>Pf</i>PFT inhibitors <b>2a</b>−<b>e</b> in excellent yields. Due to the success of the Mitsunobu reaction coupled with its convergent effect on the overall syntheses of these 1,3-diaminopropane-based <i>Pf</i>PFTIs, we designed syntheses of the remaining <i>Pf</i>PFTIs that also incorporated Mitsunobu as the final step.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0004.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) DHP, cat. PPTS, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C → rt, 16 h, 85%; (b) H<sub>2</sub>, 10% Pd/C, MeOH, rt, 1 h, 82%; (c) <i>p</i>-fluorobenzonitrile, DIPEA, DMSO, 120 °C, 24 h, 87%; (d) (1) NaH, DMF, 0 °C, 30 min; (2) <b>15</b>, 0 °C → rt, 3 h, 81% (or 97% brsm); (e) <i>p</i>-TsOH·H<sub>2</sub>O, MeOH, rt, 1 h, 88%; (f) <b>19a</b>−<b>e</b>, DIAD, PPh<sub>3</sub>, THF, rt, 1 h, 61−98%.</p></p></figure></div><div id="sec1_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Sulfonamides for Mitsunobu Reactions (<b>19a</b>−<b>e</b>, <b>21</b>)</h3><div class="NLM_p">The secondary sulfonamides <b>19a</b>−<b>d</b> required for the Mitsunobu reactions (e.g., step f in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) were prepared in simple one-step procedures from 1-methyl-1<i>H</i>-imidazole-4-sulfonyl chloride (<b>18</b>) and the respective primary amines in yields ranging from 81% to 93% (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Due to the unavailability of <i>N</i>-(2-pyrimidinyl)-4-aminomethylpiperidine and the need for the more acidic sulfonamide <b>21</b> in the synthesis of 3-aminoethanamide derivatives <b>5a</b> and <b>5d</b> as well as the <i>trans</i>-1,2-diaminocyclopentyl derivatives <b>7a</b>−<b>e</b>, sulfonamide <b>19e</b> was prepared by a different route (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Accordingly, treatment of <b>19a</b> with Boc<sub>2</sub>O led to the fully derivatized sulfonamide <b>20</b> in quantitative yield. Subsequent hydrogenolysis of <b>20</b> furnished <i>N</i>-<i>tert-</i>butoxycarbonyl-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>21</b>), whose NH was expected to have a lower p<i>K</i><sub>a</sub> than that of simple <i>N</i>-alkyl secondary sulfonamides, such as <b>19a</b>, whose p<i>K</i><sub>a</sub> values are just on the cusp (p<i>K</i><sub>a</sub> ≈ 12) of acidic nucleophiles (NuH) allowed in the Mistunobu reaction. The enhanced acidity of <b>21</b> was subsequently found to resolve troublesome Mitsunobu reactions (see sections on the syntheses of <b>5a</b>,<b>d</b> and <b>7a</b>−<b>e</b>). Additionally, compound <b>21</b> was successfully coupled to <i>N</i>-(2-pyrimidinyl)-4-hydroxymethylpiperidine, giving <b>22</b>, which, after Boc deprotection with TFA, yielded sulfonamide <b>19e</b> in an excellent two-step yield of 92%.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0005.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) RNH<sub>2</sub>, DIPEA, CH<sub>3</sub>CN, 0 °C → rt, 16 h, 81−93%.</p></p></figure><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0006.jpeg" id="gs3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Boc<sub>2</sub>O, cat. DMAP, THF, rt, 16 h, 99%; (b) H<sub>2</sub>, 10% Pd/C, EtOH, rt, 16 h, 100%; (c) <i>N</i>-(2-pyrimidinyl)-4-hydroxymethylpiperidine, PPh<sub>3</sub>, DIAD, THF, rt, 16 h; (d) TFA/CH<sub>2</sub>Cl<sub>2</sub>, 1:1, rt, 3 h, 92% (two steps).</p></p></figure></div><div id="sec1_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> <i>gem</i>-Dimethylethylenediamine-Based Inhibitors (<b>3a</b>−<b>e</b>)</h3><div class="NLM_p">The hindered <i>gem</i>-dimethylethylenediamine derivatives <b>3a</b>−<b>e</b> were furnished as shown in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Nucleophilic aromatic substitution of 2-amino-2-methylpropan-1-ol (<b>23</b>) with <i>p</i>-fluorobenzonitrile in a sealed vessel at 180 °C for 48 h afforded <b>24</b> in 40% yield. Attempted chemoselective benzylation of the primary hydroxyl of <b>24</b> with NaH and BnBr led to a mixture of products. However, alternative protection of the alcohol with <i>tert</i>-butyldiphenylsilylchloride (TBDPSCl), employing imidazole (Im) as base and nucleophilic catalyst, gave the desired compound <b>25</b> in excellent yield. The zinc-binding imidazole group was next installed by treatment of secondary aniline <b>25</b> with NaH at 0 °C followed by addition of 5-chloromethyl-1-methyl-1<i>H</i>-imidazole·HCl (<b>15</b>) as before to furnish tertiary aniline <b>26</b>. Quantitative deprotection of the TBDPS group with tetra-<i>n</i>-butylammonium fluoride (TBAF) was observed, and the resultant primary alcohol was condensed with the five sulfonamides <b>19a</b>−<b>e</b> under Mitsunobu conditions at 45 °C to afford the final <i>Pf</i>PFTIs <b>3a</b>−<b>e</b> in 50−68% yields.</div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0007.jpeg" id="gs4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <i>p</i>-fluorobenzonitrile, DIPEA, DMSO, 180 °C, 48 h, 40%; (b) TBDPSCl, Im, DMF, 45 °C, 18 h, 90%; (c) (1) NaH, DMF, 0 °C, 30 min; (2) <b>15</b>, 0 °C → rt, 3 h, 53% (or 82% brsm); (d) TBAF, THF, 0 °C → rt, 2 h, 95%; (e) <b>19a</b>−<b>e</b>, DIAD, PPh<sub>3</sub>, THF, 45 °C, 18 h, 50−68%.</p></p></figure></div><div id="sec1_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> 2-Aminoethanamide-Based Inhibitors (<b>4a</b>, <b>4d</b>) and 3-Aminopropanamide-Based Inhibitors (<b>5a</b>, <b>5d</b>)</h3><div class="NLM_p">Due to earlier findings that incorporation of an amide bond into the inhibitor scaffold is not tolerated,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> we decided to make just two derivatives of each amide-containing scaffold, with a small (<b>a</b>, R = Bn) and a large (<b>d</b>, R = <i>N</i>-Boc-piperidin-4-ylmethyl) R group. The syntheses of these 2-aminoethanamide- (<b>4a</b>, <b>4d</b>) and 3-aminopropanamide-based <i>Pf</i>PFT inhibitors (<b>5a</b>, <b>5d</b>) are presented in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a> and are described in full in <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a>.</div><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0008.jpeg" id="gs5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (1) 3-Methyl-3<i>H</i>-imidazole-4-carbaldehyde, AcOH, 4 Å molecular sieves, MeOH, rt, 1 h; (2) NaCNBH<sub>3</sub>, rt, 16 h, 63%; (b) benzyloxyacetyl chloride (or 3-benzyloxypropanoyl chloride), pyridine, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h, 87−94%; (c) Zn(CN)<sub>2</sub>, 10 mol % Pd(PPh<sub>3</sub>)<sub>4</sub>, cat. Zn(OAc)<sub>2</sub>, cat. Zn dust, DMF, 120 °C, 2 h, 85−89%; (d) H<sub>2</sub>, 10% Pd/C, 0.5% conc HCl (v/v), EtOH, rt, 90 min, 84−94%; (e) <b>19a</b> or <b>19d</b>, PPh<sub>3</sub>, DIAD, THF, rt, 1 h, 52% for <b>4a</b>, or 20% for <b>4d</b>; or <b>21</b>, PPh<sub>3</sub>, DIAD, THF, rt, 1 h, 56% for <b>34</b>; (f) TFA/CH<sub>2</sub>Cl<sub>2</sub>, 1:1, rt, 3 h, 97%; (g) RBr, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, 16−36 h, 50−96%.</p></p></figure></div><div id="sec1_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> (±)-<i>cis</i>-1,2-Diaminocyclopentane-Based Inhibitors ((±)-<b>6a</b>−<b>e</b>) and (±)-<i>trans</i>-1,2-Diaminocyclopentane-Based Inhibitors ((±)-<b>7a</b>−<b>e</b>)</h3><div class="NLM_p">The (±)-<i>cis</i>-1,2-diaminocyclopentyl-based inhibitors (±)-<b>6a</b>−<b>e</b> were furnished by following the synthetic steps described in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>. Racemic (±)-<i>trans</i>-2-benzyloxycyclopentylamine ((±)-<b>36</b>) was arylated with <i>p</i>-fluorobenzonitrile, using an excess of the aryl fluoride to compensate for reduced reactivity due to steric hindrance. N-Alkylation of the resultant secondary aniline (±)-<b>37</b> with <b>15</b> as before furnished (±)-<b>38</b> in a moderate yield of 56% (or 89% brsm), which was then smoothly debenzylated under optimized conditions (1 atm of H<sub>2</sub>, catalyst 10% Pd/C, 0.5% concentrated HCl in EtOH (v/v), 1 h) to furnish secondary alcohol (±)-<b>39</b>. The proposed final step in this synthesis, Mitsunobu reaction of (±)-<b>39</b> with the secondary sulfonamides <b>19a</b>−<b>e</b>, proved unsuccessful, leading to elimination rather than substitution, presumably due to the sterically encumbering tertiary amine and/or the low acidities of the sulfonamides (p<i>K</i><sub>a</sub> ≈ 12) that places them at the uppermost limit of allowed nucleophiles for the Mitsunobu reaction. However, even with the more acidic sulfonamide <b>21</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>), we again observed only elimination. Likewise, alternative, more powerful Mitsunobu redox systems such as <i>N</i>,<i>N</i>,<i>N′</i>,<i>N′</i>-tetramethylazodicarboxamide (TMAD)/tri-<i>n</i>-butylphosphine (TBP) and cyanomethyl-tri-<i>n</i>-butylphosphorane (CMBP) proved fruitless. We next considered the steric hindrance in the desired transformation and found that Mitsunobu reaction of (±)-<b>39</b> with diphenylphosphorylazide (DPPA), which involves the smaller and linear azide ion as the nucleophile, was more successful. These conditions led to a 3:2 inseparable mixture of the azide (substitution) product (±)-<b>40a</b>, wherein the usual inversion of stereochemistry had occurred, and the alkene (elimination) product (±)-<b>40b</b>. Staudinger reduction of azide (±)-<b>40a</b> in the mixture led to the anticipated increase in polarity, enabling facile separation from alkene (±)-<b>40b</b> and furnishing primary amine (±)-<b>41</b> in a yield of 56% for the two steps. Subsequently, sulfonylation of (±)-<b>41</b> afforded secondary sulfonamide (±)-<b>42</b> in good yield, which was then alkylated with a series of bromides (or iodides) to give the (±)-<i>cis</i>-1,2-diaminocyclopentyl <i>Pf</i>PFT inhibitors (±)-<b>6a</b>−<b>e</b> in poor to good yields. Importantly, for the two benzylic and thiophen-3-ylmethyl bromides, this reaction had to be performed under dilute (0.01 M) conditions to reduce the facile quaternization of the Zn(II)-binding imidazole τ-nitrogen (<i>N</i><sup>τ</sup>-alkylation), a side reaction that competed effectively with the desired sulfonamide alkylation because of considerable steric hindrance around the sulfonamide NH.</div><figure id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0009.jpeg" id="gs6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <i>p</i>-Fluorobenzonitrile, DIPEA, DMSO, 120 °C, 24 h, 87%; (b) (1) NaH, DMF, 0 °C, 30 min; (2) <b>15</b>, 0 °C → rt, 3 h, 56% (or 89% brsm); (c) H<sub>2</sub>, 10% Pd/C, 0.5% conc HCl, EtOH, rt, 1 h, 87%; (d) PPh<sub>3</sub>, DIAD, DPPA, THF, 0 °C → rt, 16 h; (e) (1) PPh<sub>3</sub>, THF, rt, 1 h; (2) H<sub>2</sub>O, 65 °C, 7 h, 56% (combined yield for steps d and e); (f) <b>18</b>, DIPEA, CH<sub>3</sub>CN, 0 °C → rt, 16 h, 75%; (g) RBr (or RI), Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, 16 h to 7 days, 22−81%.</p></p></figure><div class="NLM_p">In order to prepare the corresponding <i>trans</i> analogues, (±)-<b>39</b> was reacted with <i>p</i>-nitrobenzoic acid under Mitsunobu conditions (Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>), which again led to an approximate 3:2 mixture of ester (substitution product) and alkene (elimination product). No attempt at purification was made at this stage, and LiOH·H<sub>2</sub>O was added directly to the reaction mixture. After 3 h, the ester hydrolysis was complete. Purification of the reaction mixture gave the cis product (±)-<b>43</b> in 39% yield for the two steps, whose inverted stereochemistry was evident from the comparison of <sup>1</sup>H NMR spectra of (±)-<b>39</b> and (±)-<b>43</b>. Again, the subsequent Mitsunobu reaction with secondary sulfonamide <b>19a</b> was unfruitful. However, reaction with the alternative sulfonamide <b>21</b> was a success, likely due to a combination of the increased acidity of <b>21</b> relative to the other sulfonamides <b>19a</b>−<b>e</b> and reduced steric hindrance in the substitution step of the Mitsunobu reaction. Silica gel flash column chromatography furnished (±)-<b>44</b> in approximately 90% purity, and subsequent removal of the Boc group with TFA, followed by the usual purification, generated pure secondary sulfonamide (±)-<b>45</b> in a yield of 63% for the two steps. Finally, alkylation of sulfonamide (±)-<b>45</b> with the five bromides as before gave the final (±)-<i>trans</i>-1,2-diaminocyclopentyl <i>Pf</i>PFT inhibitors (±)-<b>7a</b>−<b>e</b> in good yields.</div><figure id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0010.jpeg" id="gs7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <i>p</i>-Nitrobenzoic acid, PPh<sub>3</sub>, DIAD, THF, rt, 16 h; (b) LiOH·H<sub>2</sub>O, THF/MeOH/H<sub>2</sub>O, 3:1:1, rt, 3 h, 39% (two steps); (c) <b>21</b>, PPh<sub>3</sub>, DIAD, THF, 45 °C, 16 h; (d) TFA/CH<sub>2</sub>Cl<sub>2</sub>, 1:1, rt, 3 h, 63% (two steps); (e) RBr, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, 16 h to 7 days, 75−85%.</p></p></figure></div><div id="sec1_2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> (±)-<i>cis</i>-1,3-Diaminocyclopentane-Based Inhibitors ((±)-<b>8a</b>−<b>e</b>) and (±)-<i>trans</i>-1,3-Diaminocyclopentane-Based Inhibitors ((±)-<b>9a</b>−<b>e</b>)</h3><div class="NLM_p">The 1,3-diaminocyclopentyl inhibitors (±)-<b>8a</b>−<b>e</b> and (±)-<b>9a</b>−<b>e</b> were prepared as shown in Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a>. After quantitative O-silylation of hepta-1,6-dien-4-ol (<b>46</b>) with TBDPSCl, the cyclopentane scaffold was constructed by treatment with Grubbs’s catalyst to give <b>48</b>. Subsequent oxidation with <i>m</i>-CPBA in CH<sub>2</sub>Cl<sub>2</sub> gave cis epoxide <b>49</b> and trans epoxide <b>50</b> in an approximate 1:1 ratio, in a combined yield of 84%. Reductive opening of the epoxide ring of <b>49</b> with H<sub>2</sub> and a range of catalysts, including 10% Pd/C, Pd(OH)<sub>2</sub>, or PtO<sub>2</sub>, were all attempted but were very slow even at pressures of up to 70 psi of H<sub>2</sub>. Alternative treatment with LiAlH<sub>4</sub> was successful, furnishing racemic (±)-<b>51</b> in 93% yield. On the other hand, while executing the reductive opening of the epoxide ring of diastereomeric compound <b>50</b>, LiAlH<sub>4</sub> also caused the surprising removal of the TBDPS protecting group to give (±)-<i>trans</i>-cyclopentane-1,3-diol ((±)-<b>56</b>) in 84% yield. Nucleophilic aromatic substitution test reactions of the primary amino analogue of (±)-<b>51</b>, specifically 1-<i>tert</i>-butyldiphenylsilyloxy-2-aminocyclopentane, with <i>p</i>-fluorobenzonitrile, led to removal of the silicon protecting group, presumably by the action of liberated fluoride ion, and subsequent O-arylation. Therefore, single re-silylation of (±)-<b>56</b> was not attempted; monobenzylation of (±)-<b>56</b> under phase transfer conditions was instead effected to give (±)-<b>57</b> in excellent yield.</div><figure id="sch8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0011.jpeg" id="gs8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) TBDPSCl, Im, THF, 45 °C, 16 h, 99%; (b) Grubbs’s first generation catalyst, CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 days, 63%; (c) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C → rt, 16 h, 43% (<b>49</b>), 41% (<b>50</b>); (d) LiAlH<sub>4</sub>, THF, 0 °C, 2 h, 93% ((±)-<b>51</b>) or 84% ((±)-<b>56</b>); (e) BnBr, NaH, DMF, 0 °C → rt, 16 h, 98%; (f) TBAF, THF, 0 °C → rt, 3 h, 97%; (g) PPh<sub>3</sub>, DIAD, DPPA, THF, rt, 16 h, 88% (from (±)-<b>52</b>) or 92% (from (±)-<b>57</b>); (h) (1) PPh<sub>3</sub>, THF, rt, 1 h; (2) H<sub>2</sub>O, 65 °C, 7 h, 94% ((±)-<b>53</b>) or 97% ((±)-<b>58</b>); (i) <i>p</i>-fluorobenzonitrile, DIPEA, DMSO, 120 °C, 2 d, 48 h, 99% (from (±)-<b>53</b>) or 94% (from (±)-<b>58</b>); (j) (1) NaH, DMF, 0 °C, 30 min; (2) <b>15</b>, 0 °C → rt, 3 h, 52% ((±)-<b>54</b>) or 47% ((±)-<b>59</b>); (k) H<sub>2</sub>, 10% Pd/C, 0.5% conc HCl (v/v), EtOH, rt, 1 h, 83% ((±)-<b>55</b>) or 85% ((±)-<b>60</b>); (l) <b>19a</b>−<b>e</b>, PPh<sub>3</sub>, DIAD, THF, rt, 16 h, 32−79%; (m) (1) NaH, THF, 0 °C, 1 h; (2) BnBr, TBAI, 0 °C → rt, 16 h, 95%.</p></p></figure><div class="NLM_p last">In order to keep the two syntheses, which were already being conducted in tandem, as similar as possible, we executed a two-step protecting group exchange on <i>O</i>-TBDPS derivative (±)-<b>51</b> to give <i>O</i>-benzyl compound (±)-<b>52</b> (95%, two steps). Mitusnobu conditions effected conversion of the hydroxyl of (±)-<b>52</b> to the inverted azide whose reduction to primary amine (±)-<b>53</b> was accomplished with PPh<sub>3</sub> and water (Staudinger reaction). Nucleophilic aromatic substitution of (±)-<b>53</b>, followed by N-alkylation as before gave tertiary aniline (±)-<b>54</b>, which was then subjected to optimized hydrogenolytic cleavage conditions to furnish secondary alcohol (±)-<b>55</b> in a yield of 83%. Finally, coupling of (±)-<b>55</b> to the series of secondary sulfonamides <b>19a</b>−<b>d</b> with PPh<sub>3</sub> and DIAD proceeded in poor to good yields to afford the (±)-<i>trans</i>-1,3-diaminocyclopentyl <i>Pf</i>PFT inhibitors (±)-<b>8a</b>−<b>d</b>. Due to the limited solubility of sulfonamide <b>19e</b> and the already low yields for this final Mitsunobu step, compound <b>8e</b> had to be prepared in the same manner as that used to prepare the <i>trans</i>-1,2-diaminocyclopentane-based inhibitors. Specifically, (±)-<b>55</b> was coupled to sulfonamide <b>21</b> under standard Mitsunobu conditions, after which the Boc group was removed by TFA, and then the resultant secondary sulfonamide was alkylated with <i>N</i>-(2-pyrimidinyl)-4-iodomethylpiperidine, furnishing (±)-<b>8e</b>. For the syntheses of the (±)-<i>trans</i>-1,3-diaminocyclopentyl <i>Pf</i>PFT inhibitors (±)-<b>9a</b>−<b>e</b>, the synthetic transformations were identical from (±)-<b>57</b>, as depicted in Scheme 8.</div></div><div id="sec1_2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> (±)-<i>cis</i>-1,4-Diaminocyclohexyane-Based Inhibitors ((±)-<b>10a</b>, (±)-<b>10d</b>) and (±)-<i>trans</i>-1,4-Diaminocyclohexane-Based Inhibitors ((±)-<b>11a</b>, (±)-<b>11d</b>)</h3><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch9" aria-label="9">9</a> illustrates the synthetic steps pursued in order to furnish the (±)-<i>cis</i>-1,4- ((±)-<b>10a</b>, (±)-<b>10d</b>) and the (±)-<i>trans</i>-1,4-diaminocyclohexyl ((±)-<b>11a</b>, (±)-<b>11d</b>) <i>Pf</i>PFT inhibitors, for which only the R = Bn and R = <i>N</i>-Boc-piperidin-4-ylmethyl derivatives were prepared. (±)-<i>cis</i>-1,4-Diaminocyclohexane ((±)-<b>61</b>) was mono-arylated with <i>p</i>-fluorobenzonitrile in 77% yield to give (±)-<b>62</b>, which was then sulfonylated with 1-methyl-1<i>H</i>-imidazole-4-sulfonyl choride (<b>18</b>) to furnish <b>63</b>. Chemoselective alkylation of the sulfonamide NH with benzyl bromide and <i>N</i>-Boc-4-bromomethylpiperidine was accomplished without incident, affording (±)-<b>64a</b> and (±)-<b>64d</b>, respectively. Finally, the secondary anilines were alkylated with <b>15</b> to yield the target <i>Pf</i>PFT inhibitors (±)-<b>10a</b> and (±)-<b>10d</b> in moderate yields, where the mass balance was recovered starting material. Starting from (±)-<i>trans</i>-1-<i>tert</i>-butoxycarbonylamino-4-aminocyclohexane ((±)-<b>65</b>), the trans isomers (±)-<b>11a</b> and (±)-<b>11d</b> were furnished in a similar fashion.</div><figure id="sch9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0012.jpeg" id="gs9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <i>p</i>-fluorobenzonitrile, DIPEA, DMSO, 120 °C, 48 h, 77% (for (±)-<b>62</b>) or 89% (from (±)-<b>65</b>); (b) <b>18</b>, DIPEA, CH<sub>3</sub>CN, rt, 16 h, 76% (for (±)-<b>63</b>) or 86% (for (±)-<b>66</b>); (c) RBr, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, 16 h to 3 days, 82−99%; (d) (1) NaH, DMF, 0 °C, 30 min; (2) <b>15</b>, 0 °C → rt, 12 h, 61−69% (92−95% brsm); (e) TFA/CH<sub>2</sub>Cl<sub>2</sub>, 1:1, rt, 30 min, 100%.</p></p></figure></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43402" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43402" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Ethylenediamine-Based Inhibitors (<b>1a</b>−<b>e</b>)</h3><div class="NLM_p">For comparison with the 10 series of inhibitors in this study, we present a table that includes previously published data on the corresponding ethylenediamine-based inhibitors.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> shows percentage enzyme inhibition of <i>Pf</i>PFT by compounds <b>1a</b>−<b>e</b> at 50 and 5 nM inhibitor concentration. Also shown are ED<sub>50</sub> data, which are the required inhibitor concentration to inhibit 50% of the growth of parasites (two strains of <i>P. falciparum</i>: 3D7 and K1) in whole cells (erythrocytes), as determined through the incorporation of tritium-labeled hypoxanthine (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Methods">Experimental Methods</a> for details). As indicated in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, all inhibitors exhibited potent inhibition of <i>Pf</i>PFT in vitro (≥74% inhibition at 5 nM) and proved highly effective antimalarials in whole cells (several ED<sub>50</sub> values <100 nM).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Enzyme Inhibition and Whole Cell Data for Ethylenediamine-Based Inhibitors <b>1a</b>−<b>e</b><a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0013.gif" alt="" id="gr13" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_bottom"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0014.gif" alt="" id="_i17" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">ED<sub>50</sub> = effective dose of inhibitor required to decrease <i>P. falciparum</i> growth (in infected erythrocytes) by 50%.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 1,3-Diaminopropane-Based Inhibitors (<b>2a</b>−<b>e</b>)</h3><div class="NLM_p">By comparison of the percentage enzyme inhibition data for the 1,3-diaminopropane-based inhibitors (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) with the corresponding data for the ethylenediamine scaffold derivatives (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), compounds <b>2a</b>, <b>2b</b>, and <b>2c</b> were all much poorer inhibitors of <i>Pf</i>PFT. However, with the larger <i>N</i>-Boc-piperidin-4-ylmethyl (<b>2d</b>) and <i>N</i>-(2-pyrimidinyl)-piperidin-4-ylmethyl derivatives (<b>2e</b>), inhibition of the enzyme was almost the same as that for the corresponding ethylenediamine derivatives (e.g., <b>2d</b>, 73% inhibition at 5 nM, vs <b>1d</b>, 81% inhibition at 5 nM), suggesting that the reduction in activity caused by the additional methylene in the scaffold may have been offset by incorporating a large R group. Indeed, compound <b>2d</b> was an especially potent inhibitor of <i>Pf</i>PFT, with an IC<sub>50</sub> of 1 nM (Table 7). ED<sub>50</sub> data reflect the variation in <i>Pf</i>PFT inhibitor potency, supporting inhibition of <i>Pf</i>PFT as the target for antimalarial activity, with <b>2d</b> proving the most effective antimalarial of this series in whole cells (ED<sub>50</sub> = 330 nM (3D7), 190 nM (K1)). A low energy docked conformation of <b>2a</b> overlaid with that of <b>1a</b> (<a class="ref internalNav" href="#si1" aria-label="Supporting Information Figure 1">Supporting Information Figure 1</a>) suggested that the ethylenediamine-based derivative should be a much better fit in the homology model of the <i>Pf</i>PFT active site and that <b>2a</b> with its extra methylene unit in the scaffold should be too long to bind as well as <b>1a</b>, requiring a degree of buckling of the scaffold to enable simultaneous access of the four N-appendages into the four subpockets. This prediction appears to have been confirmed experimentally, particularly in the case of the smaller R group derivatives.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Enzyme Inhibition and Whole Cell Data for 1,3-Diaminopropane-Based Inhibitors <b>2a</b>−<b>e</b><a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0015.gif" alt="" id="gr14" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_bottom"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0016.gif" alt="" id="_i20" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">ND = not determined because of limited stocks of <i>Pf</i>PFT enzyme or <i>Plasmodium</i>-infected whole cell cultures.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> <i>gem</i>-Dimethylethylenediamine-Based Inhibitors (<b>3a</b>−<b>e</b>)</h3><div class="NLM_p">Discounting thiophene <b>3c</b>, the <i>gem</i>-dimethylethylenediamine scaffold derivatives (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) were as potent, if not more so, as the corresponding ethylenediamine compounds (e.g., <b>3a</b>, 88% inhibition, vs <b>1a</b>, 86% inhibition at 5 nM; and <b>3e</b>, 93% inhibition, vs <b>1e</b>, 74% inhibition at 5 nM). Especially potent whole cell activity, such as ED<sub>50</sub> = 160 nM (3D7) and 55 nM (K1) for <b>3a</b>, parallels potent enzyme inhibition data in most cases, again supporting <i>Pf</i>PFT as the relevant target for antimalarial activity. Indeed, <b>3a</b> is one of our most potent, ethylenediamine-inspired antimalarials to date, and the improved whole cell activity relative to <b>1a</b> (ED<sub>50</sub> = 349 nM (3D7) and 375 nM (K1)) may be a consequence of the increased hydrophobicity of the scaffold, facilitating cellular entry. GOLD docking studies (<a class="ref internalNav" href="#si1" aria-label="Supporting Information Figure 2">Supporting Information Figure 2</a>) suggested that these <i>gem</i>-dimethylethylenediamine-based inhibitors should be tolerated in the <i>Pf</i>PFT active site as well as the parent ethylenediamines, and this has been supported experimentally. The reason for the increased potency of the <i>gem</i>-dimethylethylenediamine-based <b>3e</b> in vitro may be due to additional hydrophobic contacts between the extra methyls of the inhibitor and the scaffold-binding region of the active site or to improved contacts of the <i>p</i>-cyanoaniline as a direct consequence of the Thorpe−Ingold effect<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> or to a combination of both effects.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Enzyme Inhibition and Whole Cell Data for <i>gem</i>-Dimethylethylenediamine-Based Inhibitors <b>3a</b>−<b>e</b><a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0017.gif" alt="" id="gr15" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_bottom"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0018.gif" alt="" id="_i23" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">ND = not determined.</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 2-Aminoethanamide- and 3-Aminopropanamide-Based Inhibitors (<b>4a</b>,<b>d</b> and <b>5a</b>,<b>d</b>)</h3><div class="NLM_p last">All the amide derivatives (<b>4a</b>,<b>d</b> and <b>5a</b>,<b>d</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) showed 0% enzyme inhibition at 50 nM and were not studied further. Even though GOLD docking studies suggested that these derivatives would be reasonably well accommodated in the <i>Pf</i>PFT active site (<a class="ref internalNav" href="#si1" aria-label="Supporting Information Figure 3">Supporting Information Figure 3</a>), we invoked several constraints that meant the increase in hydrophilicity of the scaffold would be ignored. The scaffold-binding region of the active site is hydrophobic, so it would be expected that a compound with a polar component in the scaffold, such as an amide bond, would be poorly tolerated. In addition, the rigidity incurred upon inclusion of the planar amide bond, which we hoped to offset by the addition of an extra methylene in the scaffold (<b>4 → 5</b>), and the amide-induced withdrawal of electrons from the <i>p</i>-cyanophenyl group (a moiety that is known to contribute particular potency to our inhibitors<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>) are two possible further reasons as to why these amide derivatives showed no inhibition of <i>Pf</i>PFT at 50 nM.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (±)-<i>cis</i>- and (±)-<i>trans</i>-1,2-Diaminocyclopentane-Based Inhibitors ((±)-<b>6a</b>−<b>e</b> and (±)-<b>7a</b>−<b>e</b>)</h3><div class="NLM_p">As Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> shows, the (±)-<i>cis</i>-1,2-diaminocyclopentyl-based derivatives (±)-<b>6a</b>−<b>e</b> performed very poorly indeed, with little or no inhibition of <i>Pf</i>PFT at 50 nM inhibitor concentration. Similarly, ED<sub>50</sub> values were disappointing; in most cases they were at least an order of magnitude worse than their ethylenediamine-based parent compounds. These results were expected, since docking studies of (±)-<b>6a</b> in the homology model of the enzyme active site indicated that the constraint imposed by the cis 1,2-cyclic scaffold meant that only one of the two functionalized scaffold amines could project its appendages into its two predicted binding subpockets (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Enzyme Inhibition and Whole Cell Data for (±)-<i>cis</i>-1,2-Diaminocyclopentane-Based Inhibitors (±)-<b>6a</b>−<b>e</b> and for (±)-<i>trans</i>-1,2-Diaminocyclopentane-Based Inhibitors (±)-<b>7a</b>−<b>e</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0020.gif" alt="" id="gr16" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_bottom"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0021.gif" alt="" id="_i27" /></img></td></tr></tbody></table></div></div><div class="NLM_p last">On the other hand, although the trans diastereoisomers (±)-<b>7a</b>−<b>e</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) did not perform better than the corresponding ethylenediamine-based inhibitors (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), they were more active than their cis counterparts (±)-<b>6a</b>–<b>e</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) at both 50 and 5 nM inhibitor concentration; the most potent trans compound, (±)-<b>7d</b>, displayed 41% enzyme inhibition at 5 nM (cf. 81% for <b>1d</b> and 3% for <b>6d</b>). This improvement in activity in the enzyme assay was also reflected in superior whole cell activity, with (±)-<b>7d</b> exhibiting an ED<sub>50</sub> of 600 nM for K1 strain (<i>cf</i> ED<sub>50</sub> = 1250 nM for (±)-<b>6d</b> (K1)). These trends in the experimental results (<i>cis</i>-1,2-diaminocyclopentane vs <i>trans</i>-1,2-diaminocyclopentane vs ethylenediamine) appear to be mirrored in the GOLD docking studies. While the <i>trans</i>-1,2-diaminocyclopentyl derivatives were predicted (<a class="ref internalNav" href="#si1" aria-label="Supporting Information Figure 4">Supporting Information Figure 4</a>) to be unable to simultaneously access all four subpockets as effectively as the corresponding ethylenediamine-based inhibitors, the trans derivatives ((±)-<b>7a</b>−<b>e</b>) appeared to exhibit better complementarity to the active site than did their more sterically encumbered cis counterparts ((±)-<b>6a</b>−<b>6e</b>).</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (±)-<i>cis</i>- and (±)-<i>trans</i>-1,3-Diaminocyclopentane-Based Inhibitors ((±)-<b>8a</b>−<b>e</b> and (±)-<b>9a</b>−<b>e</b>)</h3><div class="NLM_p">As Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> shows, the (±)-<i>cis</i>-1,3-diaminocyclopentyl-based derivatives (±)-<b>8a</b>−<b>e</b> were not very active <i>Pf</i>PFT inhibitors relative to the ethylenediamine parent compounds <b>1a</b>−<b>e</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Nonetheless, these inhibitors were more potent than the corresponding <i>cis</i>-1,2-diaminocyclopentyl derivatives (±)-<b>6a</b>−<b>e</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) and approximately as potent as the corresponding <i>trans</i>-1,2-diaminocyclopentyl-based inhibitors (±)-<b>7a</b>−<b>e</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). For example, compound (±)-<b>8a</b> exhibited 40% inhibition at 50 nM inhibitor concentration, compared with 0% for (±)-<b>6a</b> and 42% for (±)-<b>7a</b>. <i>N</i>-Boc-piperidin-4-ylmethyl compound (±)<i>-</i><b>8d</b> was approximately as active as (±)-<b>7d</b> in terms of inhibition of <i>Pf</i>PFT ((±)-<b>8d</b>, 33% inhibition at 5 nM, vs (±)-<b>7d</b>, 41% inhibition at 5 nM) but even more potent in whole cells with ED<sub>50</sub> values of 300 nM (3D7) and 125 nM (K1) for (±)-<b>8d</b> compared with ED<sub>50</sub> values of 2650 nM (3D7) and 600 nM (K1) for (±)-<b>7d</b>. GOLD docking studies correctly predicted that the <i>cis</i>-1,3-diaminocyclopentyl scaffold would not facilitate binding as well as the ethylenediamine scaffold (<a class="ref internalNav" href="#si1" aria-label="Supporting Information Figure 5">Supporting Information Figure 5</a>) and also that simultaneous access to the four subpockets would be more reasonable than with the isomeric but more sterically congested <i>cis</i>-1,2-diaminocyclopentyls (compare Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B and <a class="ref internalNav" href="#si1" aria-label="Supporting Information Figure 5">Supporting Information Figure 5</a>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Enzyme Inhibition and Whole Cell Data for (±)-<i>cis</i>-1,3-Diaminocyclopentane-Based Inhibitors (±)-<b>8a</b>–<b>e</b> and for (±)-<i>trans</i>-1,3-Diaminocyclopentane-Based Inhibitors (±)-<b>9a</b>−<b>e</b><a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0022.gif" alt="" id="gr17" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_bottom"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0023.gif" alt="" id="_i30" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last">ND = not determined.</p></div></div></div><div class="NLM_p last">As was the case with the 1,2-cyclopentyl derivatives, the <i>trans</i>-1,3-diaminocyclopentyl-derived inhibitors (±)-<b>9a</b>−<b>e</b> were more active (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) than their analogous <i>cis</i>-1,3-diaminocyclopentyl diastereomers (±)-<b>8a</b>−<b>e</b>. Especially noteworthy are compounds (±)-<b>9a</b> and (±)-<b>9d</b>, which were approximately as active as the corresponding ethylenediamine inhibitors: <b>a</b>, 93% inhibition at 50 nM for (±)-<b>9a</b> vs 98% for <b>1a</b>; <b>d</b>, 86% inhibition at 5 nM for (±)-<b>9d</b> vs 81% for <b>1d</b>. These potent enzyme inhibition data are reflected in potent whole cell data, such as ED<sub>50</sub> = 80 nM (K1) for (±)-<b>9d</b>, making (±)-<b>9d</b> one of our most effective ethylenediamine-inspired antimalarials to date. These experimental findings confirm the docking studies, which suggested that the <i>trans</i>-1,3-diaminocyclopentyl scaffold would allow access by all four N-substituents to each of the predicted subpockets in a similar manner to the ethylenediamine scaffold and were, therefore, predicted to be good inhibitors of <i>Pf</i>PFT (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C).</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (±)-<i>cis</i> and (±)-<i>trans</i>-1,4-Diaminocyclohexane-Based Inhibitors ((±)-<b>10a</b>, (±)-<b>10d</b>, (±)-<b>11a</b>, and (±)-<b>11d</b>)</h3><div class="NLM_p">For the cyclohexyl scaffold, we made only two derivatives of each diastereoisomer, incorporating either the small benzyl group or the larger <i>N</i>-Boc-piperidin-4-ylmethyl group; the percentage enzyme inhibition data and whole cell ED<sub>50</sub> data are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>. The <i>cis</i>-1,4-diaminocyclohexyl derivative (±)-<b>10a</b> exhibited limited inhibition of <i>Pf</i>PFT (23% inhibition at 50 nM), while the trans isomer (±)-<b>11a</b> was more active (73% inhibition at 50 nM). Both isomers were less potent than the parent ethylenediamine-based inhibitor <b>1a</b>, which was predicted by GOLD docking studies. In the case of (±)-<b>10a</b>, the cis configuration of the scaffold appeared to render it difficult for both the scaffold nitrogens to deliver their appendages into the proposed binding pockets (<a class="ref internalNav" href="#si1" aria-label="Supporting Information Figure 6">Supporting Information Figure 6</a>). Conversely, in the case of (±)-<b>11a</b>, the trans configuration was predicted to facilitate simultaneous access to all four subpockets, although the greater interscaffold nitrogen−nitrogen distance appeared to be less optimal than for the parent inhibitor <b>1a</b> (<a class="ref internalNav" href="#si1" aria-label="Supporting Information Figure 7">Supporting Information Figure 7</a>), possibly accounting for the slightly worse percentage inhibition data. <i>N</i>-Boc-piperdin-4-ylmethyl derivatives (±)-<b>10d</b> and (±)-<b>11d</b> demonstrated no inhibitory activity against <i>Pf</i>PFT, which is likely a consequence of the large scaffold coupled with the bulky R group rendering these inhibitors too big to access the active site.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Enzyme Inhibition and Whole Cell Data for (±)-<i>cis</i>-1,4-Diaminocyclohexane-Based Inhibitors (±)-<b>10a</b> and (±)-<b>10d</b> and (±)-<i>trans</i>-1,4-Diaminocyclohexane-Based Inhibitors (±)-<b>11a</b> and (±)-<b>11d</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0024.gif" alt="" id="gr18" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_bottom"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0025.gif" alt="" id="_i33" /></img></td></tr></tbody></table></div></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Selectivity</h3><div class="NLM_p">Previously reported <i>Pf</i>PFT inhibitors have demonstrated poor selectivity for parasitic PFT over mammalian PFT or are highly selective for the mammalian enzyme.<a onclick="showRef(event, 'ref9 ref10 ref18'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref18">(9, 10, 18)</a> Although PFT inhibitors have demonstrated limited toxicities to mammalian cells at concentrations required to effect a therapeutic response,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> the antiproliferative nature of PFT inhibitors may restrict their use by children and pregnant women, two of the main target groups in malaria therapy. Hence, the selective inhibition of parasitic PFT may prove mandatory in order to realize safe and effective antimalarial PFT inhibitors. We previously reported on the selectivity of our ethylenediamine-based inhibitors for <i>Pf</i>PFT over rat PFT; IC<sub>50</sub> values revealed several inhibitors with greater than 100-fold selectivity for the parasitic PFT.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The amino acid sequences of rat and human PFT are 95% identical with complete sequence and structural conservation around the active site.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> While the aim of this research was not to design ever more <i>Plasmodium</i>-selective PFT inhibitors, it is worth noting that modification to the inhibitor scaffold has had no detrimental effect on PFT selectivity. Specifically, for a series of the <i>N</i>-Boc-piperidin-4-ylmethyl derivatives (selected as representative examples of inhibitors bearing the alternative scaffolds) greater than 100-fold selectivity for parasitic over mammalian PFT was observed (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). In particular, compound <b>3d</b> represents one of our most potent (<i>Pf</i>PFT IC<sub>50</sub> = 1.1 nM) and most selective (136-fold) <i>Pf</i>PFT inhibitors.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Comparative <i>P. falciparum</i> and Rat PFT Inhibition Data for a Series of Inhibitors Where R = <i>N</i>-Boc-piperidin-4-ylmethyl</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0026.gif" alt="" id="gr19" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_bottom"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0027.gif" alt="" id="_i36" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl7-fn1"><div class="footnote" id="tbl7-fn1"><sup>a</sup><p class="last">Inhibitor concentration required to decrease <i>P. falciparum</i> or rat PFT activity by 50%. ND = not determined.</p></div><div class="footnote" id="tbl7-fn2"><sup>b</sup><p class="last">Ratio of rat to <i>P. falciparum</i> PFT IC<sub>50</sub> values.</p></div></div></div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> QSAR Models</h3><div class="NLM_p">Quantitative structure−activity relationship (QSAR) models were generated to help determine the validity of both the proposed binding mode and the <i>Pf</i>PFT active site homology model itself. Experimental data selected were the percentage inhibition of <i>Pf</i>PFT at 5 nM inhibitor concentration. Given the often imprecise nature of percentage inhibition data and the unavailability of multiple assay results for any given compound, care was taken to ignore any model that suggested an accuracy of greater than 90% (i.e., <i>r</i><sup>2</sup> or <i>q</i><sup>2</sup> > 0.9). The corresponding theoretical data for the models were obtained as follows. For the first QSAR model, docked poses of each ligand constrained to our hypothesized binding mode were used for descriptor calculations, and the resultant GOLD-Score values were included as descriptors in the modeling. Nineteen samples were randomly chosen as a training set, leaving nine samples as a test set. Further details can be obtained by consulting the <a class="ref internalNav" href="#sec4" aria-label="Experimental Methods">Experimental Methods</a>. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, the training set has an <i>r</i><sup>2</sup> value of 0.86, suggesting there is very good correlation between the observed inhibition and the predicted inhibition of <i>Pf</i>PFT at 5 nM inhibitor concentration. Indeed, a test set of the QSAR model was found to have a <i>q</i><sup>2</sup> value of 0.81, suggesting that this model may hold strong predictive power.</div><figure id="fig4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0028.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. QSAR model in which descriptors were calculated on the basis of docked poses of ligands constrained to our hypothesized binding mode: (blue diamond) training set, <i>r</i><sup>2</sup> = 0.86; (pink square) test set, <i>q</i><sup>2</sup> = 0.81.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In order to further test our hypothesis regarding the proposed binding mode of these molecules to <i>Pf</i>PFT and of the homology model itself, a second QSAR model was prepared. For this model, descriptors were calculated on the basis of molecules that had been energy minimized rather than docked, with the exception of GOLD-Score derived values, which were still included but left unaltered. Also, the training and testing sets were deliberately chosen to be identical to those in the previous model rather than randomly chosen. Other than this, all operations were identical between the two models. The results of this second model are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>. While similar accuracy was achieved for the training set (<i>r</i><sup>2</sup> = 0.86), very little predictive power was seen with the test set (<i>q</i><sup>2</sup> = 0.37), suggesting that this model simply memorized, rather than learned, data from the training set. Also, it suggests that there is information content in the docked poses and thus that these docked poses are reasonable. Taken together, these QSAR models inform us that our hypothesis of the proposed binding mode is sound and that the homology model is a good approximation of the active site of <i>Pf</i>PFT.</div><figure id="fig5" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0029.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. QSAR model in which descriptors were calculated on the basis of ligands that had been energy-minimized: (blue diamond) training set, <i>r</i><sup>2</sup> = 0.86; (pink square) test set, <i>q</i><sup>2</sup> = 0.37.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54774" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54774" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We have synthesized several series of novel antimalarials incorporating a variety of scaffolds based on our previously reported ethylenediamine-derived inhibitors of <i>Pf</i>PFT. These antimalarials were designed to allow exploration of the <i>Pf</i>PFT active site and therein assess the validity of our predicted inhibitor binding mode and of the active site homology model itself. In turn, it was hoped that this garnered information would, in the near future, facilitate, and thereby accelerate, access to increasingly more-potent <i>Pf</i>PFT inhibitors. Low energy docked conformations (GOLD), which were performed by loosely constraining our inhibitors to the docking pose we predicted in our previous publications,<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> suggested which compounds would inhibit <i>Pf</i>PFT well and which would not. Broadly speaking, biological evaluation of our compounds agreed with the computational docking studies, and from these data we developed two QSAR models that suggested the predicted binding mode for our inhibitors is reasonable and that the homology model we have used to design inhibitors is a good approximation of the <i>Pf</i>PFT active site. In addition, our first QSAR model seems to have considerable predictive power and with suitable biological validation could therefore be used to design new inhibitors. Importantly, as well as proving particularly cytotoxic to cultured parasites (ED<sub>50</sub> < 100 nM), some of our novel antimalarial <i>Pf</i>PFTIs reported herein are among the most potent (IC<sub>50</sub> ≈ 1 nM) and the most selective for parasitic PFT over mammalian PFT (up to 136-fold) currently reported in the literature.</div><div class="NLM_p last">Considering cost involved and speed and ease of synthesis, we conclude that the parent ethylenediamine-based inhibitors reported previously<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> are our best antimalarials of this series thus far, and given the already high degree of selectivity over the mammalian isoform of PFT, future research should now be directed toward three goals. Inhibitor <b>1d</b> is highly potent (IC<sub>50</sub> = 1.2 nM), selective for parasitic over mammalian PFT (117-fold), and exhibits very good whole cell activity (ED<sub>50</sub> = 88 nM (3D7), 54 nM (K1)). Therefore, we first suggest further work is undertaken on this inhibitor to improve these ED<sub>50</sub> values, which may be achieved by substituting the 3-methyl-3<i>H</i>-imidazole-4-sulfonyl group with the less basic and more hydrophobic pyridine-2-sulfonyl group,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> for example. Second, efforts should be made toward improving the limited metabolic stability of <b>1d</b> reported by us previously.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> We showed how our inhibitors were quickly oxidized upon incubation with liver microsomes, probably by cytochrome P450, followed by loss of the aniline functionalized zinc-binding imidazole. It is likely that cytochrome P450-mediated inhibitor oxidation is initiated by loss of one electron of the aniline nitrogen lone pair, followed by abstraction of a hydrogen radical from the activated methylene group between the aniline and imidazole, ultimately leading to N-dealkylation of the imidazolylmethyl moiety. As described in the manuscript by Seto et al.,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> aniline N-dealkylation can only proceed when the aniline lone pair of electrons is oxidizable and when there is at least one hydrogen on the carbon directly attached to the aniline nitrogen. Thus, improved inhibitor metabolic stability may be achieved by (a) reducing electron density on the aniline nitrogen through incorporation of additional electron-withdrawing groups on the cyanophenyl ring and/or (b) replacing the methylene unit between the aniline nitrogen and the zinc-binding imidazole with a <i>gem</i>-dimethyl unit. Finally, our third goal should be the investigation of the activities of our antimalarials in drug-resistant strains of <i>P. falciparum</i> PFT (such as the Y837C strain<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> that shows resistance to BMS-388891 and the G612A strain<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> that shows resistance to BMS-339941). This research is essential not only to evaluate the potencies of our compounds in such strains but also, after preparing similar QSAR models for the mutant active sites as we did for the wild-type, to identify structural modifications that we may undertake to restore inhibitor potency where it may be needed. In this way, new antimalarial <i>Pf</i>PFTIs that are active against drug-resistant strains of <i>P. falciparum</i> may be realized.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39">Experimental Methods</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00670" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00670" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Ligand Docking Studies</h3><div class="NLM_p">Docking experiments were performed using the GOLD version 3.1<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> software package. Ligands were prepared for docking in InsightII.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Each ligand was drawn as a two-dimensional representation and converted to three dimensions. Ligands were subsequently energy minimized with the cvff force field. The homology model was also prepared for use in InsightII, where each residue was protonated on the basis of calculated p<i>K</i><sub>a</sub> values at a pH of 7.4.</div><div class="NLM_p last">Ligands were constrained in the active site of <i>Pf</i>PFT at three points in order to maintain the binding mode hypothesized for lead compound <b>1a</b>. A single atom of each imidazole and the cyanoaniline were chosen and constrained to occupy a region of space within 1 Å of that occupied by the equivalent atoms of docked <b>1a</b>. This was performed using the substructure constraint functionality of GOLD. A small spring constant was used as a penalty function such that molecules could dock in alternative conformations, but these would be discouraged. GOLD was allowed to configure the optimal genetic algorithm settings for each ligand.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> QSAR Modeling</h3><div class="NLM_p last">Descriptors were calculated using the MOE software package.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> RECON TAE and RAD descriptors<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> were calculated in addition to the standard assortment of 2D descriptors in MOE. Additional descriptors included energy measurements with the MMFF94x, Amber-99, and OPLS-AA force fields. Feature selection and modeling were performed using the Analyze software package.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> For further details, see <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Chemistry: General Methods</h3><div class="NLM_p last">Solvents CH<sub>2</sub>Cl<sub>2</sub>, THF, CH<sub>3</sub>CN, and DMF were dried on an Innovative Technology SPS-400 dry solvent system. Anhydrous MeOH and DMSO were purchased from Sigma-Aldrich and used directly from their Sure-Seal bottles. Molecular sieves were activated by heating to 300 °C under vacuum overnight. All reactions were performed under an atmosphere of dry nitrogen in oven-dried glassware and were monitored for completeness by thin-layer chromatography (TLC) using silica gel (visualized by UV light or developed by treatment with KMnO<sub>4</sub> stain or Hanessianʼs stain). <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on Bruker AM 400 MHz and Bruker AM 500 MHz spectrometers in either CDCl<sub>3</sub>, MeOH-<i>d</i><sub>4</sub> or DMSO-<i>d</i><sub>6</sub>. Chemical shifts (δ) are reported in parts per million after calibration to residual isotopic solvent. Coupling constants (<i>J</i>) are reported in Hz. Mass spectrometry (MS) was performed using electrospray ionization on either a Varian MAT-CH-5 (HRMS) or a Waters Micromass ZQ (LRMS) instrument. Before biological testing, target molecules (<b>2a</b>−<b>e</b>, <b>3a</b>−<b>e</b>, <b>4a</b>, <b>4d</b>, <b>5a</b>, <b>5d</b>, <b>6a</b>−<b>e</b>, <b>7a</b>−<b>e</b>, <b>8a</b>−<b>e</b>, <b>9a</b>−<b>e</b>, <b>10a</b>, <b>10d</b>, <b>11a</b>, <b>11d</b>), obtained as glassy films after silica gel flash column chromatographic purification (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1), were subjected to further purification by reversed-phase HPLC (rpHPLC). Analysis and purification by rpHPLC were performed using either Phenonenex Luna 5 μm C18 (2) 250 mm × 21 mm column run at 15 mL/min (preparative) or a Microsorb-MV 300 Å C18 250 mm × 4.6 mm column run at 1 mL/min (analytical), using gradient mixtures of (A) water with 0.1% TFA and (B) 10:1 acetonitrile/water with 0.1% TFA. Appropriate product fractions were pooled and lyophilized to dryness, affording the inhibitors as fluffy white powders as their TFA salts. Inhibitor purity was confirmed by analytical rpHPLC using linear gradients from 100% A to 100% B, with changing solvent composition of either (I) 4.5% or (II) 1.5% per minute after an initial 2 min of 100% A. For reporting HPLC data, percentage purity is given in parentheses after the retention time for each condition.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> General Procedure A (Mitsunobu Reactions). Reaction of Primary and Secondary Alcohols with Secondary Sulfonamides</h3><div class="NLM_p last">To a stirring solution of the alcohol (1 equiv) in THF (0.07 M) (occasionally, sonication and a little warming (40 °C) was required to achieve complete dissolution of the alcohol) was added the secondary sulfonamide (2.5 equiv) and PPh<sub>3</sub> (3 equiv). After the mixture was stirred for 15 min at room temperature, DIAD (2.5 equiv) was added dropwise. For the acyclic, primary alcohols, reactions were typically complete within 1 h; for the less reactive, cyclic secondary alcohols and hindered primary alcohols, mixtures were left stirring overnight (16 h). All solvent was removed in vacuo.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> General Procedure B (Sulfonamide Alkylations). Reaction of Secondary Sulfonamides with Benzylic and Alkyl Bromides</h3><div class="NLM_p last">To a stirred solution of the secondary sulfonamide (1 equiv) in DMF (0.01 M for benzylic bromide or 0.1 M for alkyl bromide) was added Cs<sub>2</sub>CO<sub>3</sub> (3 equiv). After 1 h, at room temperature, the bromide (or iodide) alkylating agent (1.1 equiv) was added dropwise. After 16 h, the reaction mixture was diluted with water and extracted into EtOAc (×3). The EtOAc extractions were combined and washed with 5% NaHCO<sub>3</sub> (×3) and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> General Procedure C (Aniline Alkylation). Reaction of Secondary Anilines with 5-Chloromethyl-1-methyl-1<i>H</i>-imidazole·HCl (<b>15</b>)</h3><div class="NLM_p last">The secondary aniline (1 equiv) was dissolved in DMF (0.07 M). Then the mixture was cooled to 0 °C. After 15 min, NaH (3 equiv) was added in one portion. After a further 15 min, 5-chloromethyl-1-methyl-1<i>H</i>-imidazole·HCl<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> (<b>15</b>) (1.1 equiv) was added to the reaction mixture. The mixture was allowed to stir at 0 °C for 2–3 h, when TLC indicated the reaction was complete or had stalled. Upon quenching the reaction with brine (approximately 1 mL), the mixture was diluted with water and extracted with EtOAc (×3). The EtOAc extractions were combined and washed with 5% NaHCO<sub>3</sub> (×3) and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> [<i>N</i>-Benzyl-<i>N</i>-3-{(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino}propyl]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>2a</b>)</h3><div class="NLM_p last">Primary alcohol <b>17</b> was coupled to secondary sulfonamide <b>19a</b> on a 0.106 mmol scale via general procedure A. The crude residue was dry-loaded onto silica gel, then flash chromatographed (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to furnish <b>2a</b> (51 mg, 96%): δ<sub>H</sub> (400 MHz, MeOH-<i>d</i><sub>4</sub>) 1.71 (quin, <i>J</i> = 7.0 Hz, 2H, CH<sub>2</sub>C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>), 3.30−3.36 (obsc m, 4H, C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>C<u class="uu">H</u><sub>2</sub>), 3.83 (s, 3H, CH<sub>3</sub>(Im)), 3.89 (s, 3H, CH<sub>3</sub>(Im)), 4.34 (s, 2H, C<u class="uu">H</u><sub>2</sub>Ph), 4.62 (s, 2H, C<u class="uu">H</u><sub>2</sub>Im), 6.73 (d, <i>J</i> = 8.8 Hz, 2H, 2 CH (Ar)), 7.14 (s, 1H, CH (Im)), 7.31−7.43 (m, 5H, 5 CH (Ph)), 7.50 (d, <i>J</i> = 8.8 Hz, 2H, 2 CH (Ar)), 7.77 (s, 1H, CH (Im)), 7.84 (s, 1H, CH (Im)), 8.93 (s, 1H, CH (Im)); δ<sub>C</sub> (100 MHz, MeOH-<i>d</i><sub>4</sub>) 27.4, 34.3, 34.4, 45.8, 48.6, 49.3, 54.7, 99.8, 113.8, 118.8, 121.0, 126.6, 128.9, 129.7, 129.9, 133.1, 134.7, 137.7, 138.7, 139.3, 141.4, 151.8; HRMS (ES+) calcd for [C<sub>26</sub>H<sub>29</sub>N<sub>7</sub>O<sub>2</sub>S + H] 504.2182, found 504.2198; HPLC (I) <i>t</i><sub>R</sub> = 15.69 min (100%), (II), <i>t</i><sub>R</sub> = 27.81 min (100%).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> [<i>N</i>-(2-Methylbenzyl)-<i>N</i>-3-{(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino}propyl]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>2b</b>)</h3><div class="NLM_p last">Primary alcohol <b>17</b> was coupled to secondary sulfonamide <b>19b</b> on a 0.137 mmol scale via general procedure A. The crude residue was dry-loaded onto silica gel, then flash chromatographed (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to furnish <b>2b</b> (64 mg, 90%): δ<sub>H</sub> (400 MHz, MeOH-<i>d</i><sub>4</sub>) 1.57 (quin, <i>J</i> = 7.3 Hz, 2H, CH<sub>2</sub>C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>), 2.42 (s, 3H, C<u class="uu">H</u><sub>3</sub>Ph), 3.21−3.27 (m, 4H, C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>C<u class="uu">H</u><sub>2</sub>), 3.85 (s, 3H, CH<sub>3</sub>(Im)), 3.88 (s, 3H, CH<sub>3</sub>(Im)), 4.33 (s, 2H, C<u class="uu">H</u><sub>2</sub>Ph), 4.60 (s, 2H, C<u class="uu">H</u><sub>2</sub>Im), 6.70 (d, <i>J</i> = 8.8 Hz, 2H, 2 CH (Ar)), 7.11 (s, 1H, CH (Im)), 7.14−7.26 (m, 3H, 3 CH (Ph)), 7.31 (br d, <i>J</i> = 7.6 Hz, 1H, CH (Ph)), 7.49 (d, <i>J</i> = 8.8 Hz, 2H, 2 CH (Ar)), 7.78 (s, 1H, CH (Im)), 7.86 (s, 1H, CH (Im)), 8.93 (s, 1H, CH (Im)); δ<sub>C</sub> (100 MHz, MeOH-<i>d</i><sub>4</sub>) 19.5, 27.8, 34.3, 34.4, 45.3, 48.0, 49.2, 53.5, 99.8, 113.8, 118.8, 121.0, 126.7, 127.1, 129.3, 131.2, 131.7, 133.0, 134.7, 135.6, 137.7, 138.7, 138.8, 141.4, 151.7; HRMS (ES+) calcd for [C<sub>27</sub>H<sub>31</sub>N<sub>7</sub>O<sub>2</sub>S + H] 518.2338, found 518.2346; HPLC (I) <i>t</i><sub>R</sub> = 15.98 min (100%), (II) <i>t</i><sub>R</sub> = 28.75 min (100%).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> [<i>N</i>-(Thiophen-3-ylmethyl)-<i>N</i>-3-{(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino}propyl]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>2c</b>)</h3><div class="NLM_p last">Primary alcohol <b>17</b> was coupled to secondary sulfonamide <b>19c</b> on a 0.16 mmol scale via general procedure A. The crude residue was dry-loaded onto silica gel, then flash chromatographed (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to give <b>2c</b> (80 mg, 98%): δ<sub>H</sub> (400 MHz, MeOH-<i>d</i><sub>4</sub>) 1.78 (quin, <i>J</i> = 7.2 Hz, 2H, CH<sub>2</sub>C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>), 3.32−3.36 (obsc m, 2H, CH<sub>2</sub>CH<sub>2</sub>C<u class="uu">H</u><sub>2</sub>NSO<sub>2</sub>), 3.37−3.41 (m, 2H, C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NSO<sub>2</sub>), 3.83 (s, 3H, CH<sub>3</sub>(Im)), 3.91 (s, 3H, CH<sub>3</sub>(Im)), 4.36 (s, 2H, C<u class="uu">H</u><sub>2</sub>thiophene), 4.68 (s, 2H, C<u class="uu">H</u><sub>2</sub>Im), 6.79 (d, <i>J</i> = 8.8 Hz, 2H, 2 CH (Ar)), 7.13 (dd, <i>J</i> = 5.0, 1.2 Hz, 1H, CH (thiophene)), 7.18 (s, 1H, CH (Im)), 7.32−7.35 (m, 1H, CH (thiophene)), 7.41 (dd, <i>J</i> = 5.0, 2.8 Hz, 1H, CH (thiophene)), 7.53 (d, <i>J</i> = 8.8 Hz, 2H, 2 CH (Ar)), 7.74 (s, 1H, CH (Im)), 7.83 (s, 1H, CH (Im)), 8.93 (s, 1H, CH (Im)); δ<sub>C</sub> (100 MHz, MeOH-<i>d</i><sub>4</sub>) 27.3, 34.3, 34.4, 45.4, 48.2, 49.3, 49.4, 99.8, 113.8, 118.9, 121.0, 125.1, 126.5, 127.5, 129.2, 133.1, 134.7, 137.7, 139.4, 139.4, 141.3, 151.8; HRMS (ES+) calcd for [C<sub>24</sub>H<sub>27</sub>N<sub>7</sub>O<sub>2</sub>S<sub>2</sub> + H] 510.1746, found 510.1761; HPLC (I) <i>t</i><sub>R</sub> = 15.12 min (100%), (II) <i>t</i><sub>R</sub> = 26.20 min (100%).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> [<i>N</i>-(<i>N</i>-<i>tert</i>-Butoxycarbonylpiperidin-4-ylmethyl)-<i>N</i>-3-{(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino}propyl]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>2d</b>)</h3><div class="NLM_p last">Primary alcohol <b>17</b> was coupled to secondary sulfonamide <b>19d</b> on a 0.24 mmol scale via general procedure A. The crude residue was dry-loaded onto silica gel, then flash chromatographed (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to afford <b>2d</b> (132 mg, 90%): δ<sub>H</sub> (400 MHz, MeOH-<i>d</i><sub>4</sub>) 1.07 (qd, <i>J</i> = 12.3, 4.0 Hz, 2H, 2 CH (piperidinylmethyl)), 1.49 (s, 9H, C(CH<sub>3</sub>)<sub>3</sub>), 1.68−1.76 (m, 2H, 2 CH (piperidinylmethyl)), 1.79−1.90 (m, 1H, CH (piperidinylmethyl)), 1.99 (quin, <i>J</i> = 7.4 Hz, 2H, CH<sub>2</sub>C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>), 2.64−2.80 (m, 2H, 2 CH (piperidinylmethyl)), 3.01 (d, <i>J</i> = 7.6 Hz, 2H, 2 CH (piperidinylmethyl)), 3.29 (t, <i>J</i> = 7.2 Hz, 2H, CH<sub>2</sub>CH<sub>2</sub>C<u class="uu">H</u><sub>2</sub>NSO<sub>2</sub>), 3.61 (t, <i>J</i> = 7.2 Hz, 2H, C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NSO<sub>2</sub>), 3.81 (s, 3H, CH<sub>3</sub>(Im)), 3.95 (s, 3H, CH<sub>3</sub>(Im)), 4.03−4.10 (m, 2H, 2 CH (piperidinylmethyl)), 4.87 (s, 2H, C<u class="uu">H</u><sub>2</sub>Im), 6.96 (d, <i>J</i> = 8.8 Hz, 2H, 2 CH (Ar)), 7.30 (s, 1H, CH (Im)), 7.58 (d, <i>J</i> = 8.8 Hz, 2H, 2 CH (Ar)), 7.73 (s, 1H, CH (Im)), 7.79 (s, 1H, CH (Im)), 8.94 (s, 1H, CH (Im)); δ<sub>C</sub> (100 MHz, MeOH-<i>d</i><sub>4</sub>) 27.9, 28.7, 30.9, 34.2, 34.3, 36.5, 44.7 (br), 45.6, 48.9, 49.0, 56.3, 81.0, 100.0, 114.1, 119.0, 120.9, 126.5, 133.2, 134.8, 137.8, 139.3, 141.3, 151.9, 156.5; HRMS (ES+) calcd for [C<sub>30</sub>H<sub>42</sub>N<sub>8</sub>O<sub>4</sub>S + H] 611.3128, found 611.3129; HPLC (I) <i>t</i><sub>R</sub> = 12.56 min (100%), (II) <i>t</i><sub>R</sub> = 18.92 min (100%).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> [<i>N</i>-{<i>N</i>-(2-Pyrimidinyl)-piperidin-4-ylmethyl}-<i>N</i>-3-{(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino}propyl]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>2e</b>)</h3><div class="NLM_p last">Primary alcohol <b>17</b> was coupled to secondary sulfonamide <b>19e</b> on a 0.106 mmol scale via general procedure A. The crude residue was dry-loaded onto silica gel, then flash chromatographed (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to yield <b>2e</b> (38 mg, 61%): δ<sub>H</sub> (400 MHz, MeOH-<i>d</i><sub>4</sub>) 1.17 (qd, <i>J</i> = 12.2, 4.0 Hz, 2H, 2 CH (piperidinylmethyl)), 1.78−1.86 (m, 2H, 2 CH (piperidinylmethyl)), 1.94−2.04 (m, 3H, CH<sub>2</sub>C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>, CH (piperidinylmethyl)), 2.90−2.98 (m, 2H, 2 CH (piperidinylmethyl)), 3.04 (d, <i>J</i> = 7.6 Hz, 2H, 2 CH (piperidinylmethyl)), 3.26−3.31 (m, 2H, CH<sub>2</sub>CH<sub>2</sub>C<u class="uu">H</u><sub>2</sub>NSO<sub>2</sub>), 3.59−3.66 (m, 2H, C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NSO<sub>2</sub>), 3.81 (s, 3H, CH<sub>3</sub>(Im)), 3.96 (s, 3H, CH<sub>3</sub>(Im)), 4.64−4.71 (m, 2H, 2 CH (piperidinylmethyl)), 4.88 (s, 2H, C<u class="uu">H</u><sub>2</sub>Im), 6.66 (t, <i>J</i> = 5.1 Hz, 1H, CH (pyrimidine)), 6.97 (d, <i>J</i> = 9.2 Hz, 2H, 2 CH (Ar)), 7.31 (s, 1H, CH (Im)), 7.59 (d, <i>J</i> = 9.2 Hz, 2H, 2 CH (Ar)), 7.73 (s, 1H, CH (Im)), 7.80 (s, 1H, CH (Im)), 8.38 (d, <i>J</i> = 5.1 Hz, 2H, 2 CH (pyrimidine)), 8.95 (s, 1H, CH (Im)); δ<sub>C</sub> (100 MHz, MeOH-<i>d</i><sub>4</sub>) 27.9, 30.9, 34.2, 34.3, 36.6, 45.2, 45.6, 49.1, 49.3, 56.3, 100.1, 110.6, 114.1, 119.0, 120.9, 126.5, 133.2, 134.8, 137.8, 139.3, 141.3, 151.9, 158.7, 160.7; HRMS (ES+) calcd for [C<sub>29</sub>H<sub>31</sub>N<sub>10</sub>O<sub>2</sub>S + H] 589.2822, found 589.2831; HPLC (I) <i>t</i><sub>R</sub> = 13.00 min (100%), (II) <i>t</i><sub>R</sub> = 20.28 min (99.69%).</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> [<i>N</i>-Benzyl-<i>N</i>-{(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino}-2,2-dimethylethyl]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>3a</b>)</h3><div class="NLM_p last">The synthesis was as per general procedure A with alcohol <b>27</b> on a 0.037 mmol scale and secondary sulfonamide <b>19a</b>. The mixture was heated to 45 °C for 18 h, reduced, and then dry-loaded onto silica gel and purified by flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to give <b>3a</b> (12 mg, 65%): δ<sub>H</sub> (400 MHz, CDCl<sub>3</sub>) 1.40 (s, 6H, C(CH<sub>3</sub>)<sub>2</sub>), 3.46 (s, 3H, CH<sub>3</sub>(Im)), 3.72 (s, 3H, CH<sub>3</sub>(Im)), 3.87 (s, 2H, C<u class="uu">H</u><sub>2</sub>C(CH<sub>3</sub>)<sub>2</sub>), 4.47 (s, 2H, C<u class="uu">H</u><sub>2</sub>Ph), 4.70 (s, 2H, C<u class="uu">H</u><sub>2</sub>Im), 6.58 (s, 1H, CH(Im)), 6.60 (d, <i>J</i> = 8.3 Hz, 2H, 2 CH (Ar)), 7.27−7.38 (m, 7H, 2 CH (Im), 5 CH (Ph)), 7.45 (d, <i>J</i> = 8.3 Hz, 2H, 2 CH (Ar)), 7.47 (s, 1H, CH (Im)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 26.9, 31.8, 33.9, 47.1, 50.8, 59.3, 65.6, 99.3, 113.7, 120.0, 123.5, 126.7, 127.4, 127.7, 128.6, 129.0, 133.2, 138.4, 138.6, 139.4, 143.1, 151.6; HRMS (ES+) calcd for [C<sub>28</sub>H<sub>31</sub>N<sub>6</sub>O<sub>2</sub>S + H] 518.2343, found 518.2338; HPLC (I) <i>t</i><sub>R</sub> = 12.25 min (99.66%), (II) <i>t</i><sub>R</sub> = 17.75 min (99.34%).</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> [<i>N</i>-(2-Methylbenzyl)-<i>N</i>-{(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino}-2,2-dimethylethyl]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>3b</b>)</h3><div class="NLM_p last">The synthesis was as per general procedure A with alcohol <b>27</b> on a 0.035 mmol scale and secondary sulfonamide <b>19b</b>. The mixture was heated to 45 °C for 18 h, then reduced, and dry-loaded onto silica gel and purified by flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to give <b>3b</b> (11 mg, 60%): δ<sub>H</sub> (400 MHz, CDCl<sub>3</sub>) 1.40 (s, 6H, C(CH<sub>3</sub>)<sub>2</sub>), 2.23 (s, 3H, C<u class="uu">H</u><sub>3</sub>Ph), 3.51 (s, 3H, CH<sub>3</sub>(Im)), 3.70 (s, 3H, CH<sub>3</sub>(Im)), 4.02 (s, 2H, C<u class="uu">H</u><sub>2</sub>C(CH<sub>3</sub>)<sub>2</sub>), 4.56 (s, 2H, C<u class="uu">H</u><sub>2</sub>Ph), 4.62 (s, 2H, C<u class="uu">H</u><sub>2</sub>Im), 6.65 (s, 1H, CH (Im)), 6.72 (d, <i>J</i> = 9.0 Hz, 2H, 2 CH (Ar)), 7.10−7.39 (m, 6H, 2 CH (Im), 4 CH (Ar)), 7.45 (s, 1H, CH (Im)), 7.60 (d, <i>J</i> = 9.0 Hz, 2H, 2 CH (Ar)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 18.9, 26.5, 31.6, 33.6, 47.0, 47.3, 58.9, 65.2, 99.2, 113.6, 119.7, 123.6, 125.8, 126.5, 126.6, 127.0, 128.8, 130.0, 133.0, 133.6, 136.8, 138.2, 138.7, 142.5, 151.4; HRMS (ES+) calcd for [C<sub>28</sub>H<sub>33</sub>N<sub>7</sub>O<sub>2</sub>S + H] 532.2416, found 532.2452; HPLC (I) <i>t</i><sub>R</sub> = 12.80 min (95.01%), (II) <i>t</i><sub>R</sub> = 19.70 min (95.06%).</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> [<i>N</i>-(Thiophen-3-ylmethyl)-<i>N</i>-{(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino}-2,2-dimethylethyl]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>3c</b>)</h3><div class="NLM_p last">The synthesis was as per general procedure A with alcohol <b>27</b> on a 0.088 mmol scale and secondary sulfonamide <b>19c</b>. The mixture was heated to 45 °C for 18 h, reduced, and then dry-loaded onto silica gel and purified by flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to give <b>3c</b> (25 mg, 55%): δ<sub>H</sub> (400 MHz, CDCl<sub>3</sub>) 1.45 (s, 6H, C(CH<sub>3</sub>)<sub>2</sub>), 3.48 (s, 3H, CH<sub>3</sub>(Im)), 3.72 (s, 3H, CH<sub>3</sub>(Im)), 3.82 (s, 2H, CH<sub>2</sub>C(CH<sub>3</sub>)<sub>2</sub>), 4.46 (s, 2H, C<u class="uu">H</u><sub>2</sub>thiophene), 4.67 (s, 2H, C<u class="uu">H</u><sub>2</sub>Im), 6.61 (d, <i>J</i> = 8.5 Hz, 2H, Ar), 6.64 (s, 1H, CH (Im)), 7.22−7.37 (m, 7H, 2 CH (Im), 2 CH (Ar), 3 CH (thiophene)), 7.45 (s, 1H, CH (Im)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 26.9, 31.8, 33.9, 46.0, 46.9, 59.2, 65.3, 99.3, 113.7, 120.0, 122.9, 123.4, 126.0, 126.8, 128.1, 128.8, 133.2, 138.4, 138.5, 140.7, 143.2, 151.6; HRMS (ES+) calcd for [C<sub>25</sub>H<sub>29</sub>N<sub>7</sub>O<sub>2</sub>S<sub>2</sub> + H] 524.1904, found 524.1902; HPLC (I) <i>t</i><sub>R</sub> = 12.56 min (100%), (II) <i>t</i><sub>R</sub> = 18.70 min (100%).</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> [<i>N</i>-(<i>N</i>-<i>tert</i>-Butoxycarbonylpiperidin-4-ylmethyl)-<i>N</i>-{(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino}-2,2-dimethylethyl]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>3d</b>)</h3><div class="NLM_p last">The synthesis was as per general procedure A with alcohol <b>27</b> on a 0.217 mmol scale and secondary sulfonamide <b>19d</b>. The mixture was heated to 45 °C for 18 h, reduced, and then dry-loaded onto silica gel and purified by flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to give <b>3d</b> (68 mg, 50%): δ<sub>H</sub> (400 MHz, CDCl<sub>3</sub>) 1.10 (qd, <i>J</i> = 12.3, 4.0 Hz, 2H, 2 CH (piperidinylmethyl)), 1.39 (s, 6H, C(CH<sub>3</sub>)<sub>2</sub>), 1.44 (s, 9H, C(CH<sub>3</sub>)<sub>3</sub>), 1.67−1.79 (m, 3H, 3 CH (piperidinylmethyl)), 2.58−2.67 (m, 2H, 2 CH (piperidinylmethyl)), 3.28−3.36 (m, 2H, 2 CH (piperidinylmethyl)), 3.53 (s, 3H, CH<sub>3</sub>(Im)), 3.72 (s, 3H, CH<sub>3</sub>(Im)), 3.85 (s, 2H, C<u class="uu">H</u><sub>2</sub>(CH<sub>3</sub>)<sub>2</sub>), 4.05−4.15 (m, 2H, 2 CH (piperidinylmethyl)), 4.66 (s, 2H, C<u class="uu">H</u><sub>2</sub>Im), 6.70 (s, 1H, CH (Im)), 6.92 (d, <i>J</i> = 9.0 Hz, 2H, 2 CH (Ar)), 7.35 (s, 1H, CH (Im)), 7.39 (s, 1H CH (Im)), 7.41 (s, 1H CH (Im)), 7.45 (d, <i>J</i> = 9.0 Hz, 2H, 2 CH (Ar)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 14.4, 27.3, 28.7, 29.9, 30.4, 32.1, 34.2, 38.3, 47.1, 52.5, 58.1, 64.8, 79.6, 100.0, 114.1, 120.1, 123.4, 129.4, 133.7, 138.5, 144.0, 152.1, 155.0, 171.4; HRMS (ES+) calcd for [C<sub>31</sub>H<sub>44</sub>N<sub>8</sub>O<sub>4</sub>S + H] 625.2765, found 625.2720; HPLC (I) <i>t</i><sub>R</sub> = 13.61 min (100%), (II) <i>t</i><sub>R</sub> = 21.80 (100%).</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> [<i>N</i>-{<i>N</i>-(2-Pyrimidinyl)-piperidin-4-ylmethyl}-<i>N</i>-{(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino}-2,2-dimethylethyl]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>3e</b>)</h3><div class="NLM_p last">The synthesis was as per general procedure A with alcohol <b>27</b> on a 0.037 mmol scale and secondary sulfonamide <b>19e</b>. The mixture was heated to 45 °C for 18 h, then dry-loaded onto silica gel and purified by flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 92:7:1) to give <b>3e</b> (15 mg, 68% yield): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 1.17 (qd, <i>J</i> = 12.2, 4.0 Hz, 2H, 2 CH (piperidinylmethyl)), 1.41 (s, 6H, C(CH<sub>3</sub>)<sub>2</sub>), 1.81−2.02 (m, 3H, 3 CH (piperidinylmethyl)), 2.79 (m, 2H, 2 CH (piperidinylmethyl)), 3.33 (d, <i>J</i> = 7.0 Hz, 2H, 2 CH (piperidinylmethyl)), 3.54 (s, 3H, CH<sub>3</sub>(Im)), 3.71 (s, 3H, CH<sub>3</sub>(Im)), 3.87 (m, 2H, C<u class="uu">H</u><sub>2</sub>C(CH<sub>3</sub>)<sub>2</sub>), 4.68 (s, 2H, C<u class="uu">H</u><sub>2</sub>Im), 4.73−4.79 (m, 2H, 2 CH (piperidinylmethyl)), 6.42 (t, <i>J</i> = 4.9 Hz, 1H, CH (pyrimidine)), 6.69 (s, 1H, CH (Im)), 6.91 (d, <i>J</i> = 9.0 Hz, 2H, 2 CH (Ar)), 7.35 (s, 1H, CH (Im)), 7.39 (s, 1H, CH (Im)), 7.42 (s, 1H, CH (Im)), 7.44 (d, <i>J</i> = 9.0 Hz, 2H, 2 CH (Ar)), 8.27 (d, <i>J</i> = 4.9 Hz, 2H, 2 CH (pyrimidine)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 27.4, 30.3, 32.1, 34.2, 38.6, 44.2, 47.1, 52.6, 58.3, 64.8, 99.9, 109.6, 114.1, 120.2, 123.5, 129.1, 133.7, 138.5, 139.0, 143.9, 152.1, 157.9, 161.8, 162.7; HRMS (ES+) calcd for [C<sub>30</sub>H<sub>38</sub>N<sub>10</sub>O<sub>2</sub>S + H] 603.2969, found 603.2978; HPLC (I) <i>t</i><sub>R</sub> = 13.62 min (100%), (II) <i>t</i><sub>R</sub> = 19.16 min (100%).</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 2-[Benzyl(1-methyl-1<i>H</i>-imidazole-4-sulfonyl)amino]-<i>N</i>-(4-cyanophenyl)-<i>N</i>-(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)acetamide (<b>4a</b>)</h3><div class="NLM_p last">Compound <b>32</b> was coupled to secondary sulfonamide <b>19a</b> as per general procedure A on a 0.164 mmol scale. After workup, the crude residue was purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to furnish <b>4a</b> (43 mg, 52%): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 3.60 (s, 3H, CH<sub>3</sub>(Im)), 3.70 (s, 2H, CH<sub>2</sub>CO), 3.76 (s, 3H, CH<sub>3</sub>(Im)), 4.60 (s, 2H, C<u class="uu">H</u><sub>2</sub>Ph), 4.85 (s, 2H, C<u class="uu">H</u><sub>2</sub>Im), 6.59 (br s, 1H, CH (Im)), 6.95 (d, <i>J</i> = 8.5 Hz, 2H, 2 CH (Ar)), 7.19−7.24 (m, 2H, 2 CH (Ph)), 7.27−7.31 (m, 3H, 3 CH (Ph)), 7.43 (br s, 1H, CH (Im)), 7.45 (s, 1H, CH (Im)), 7.46 (s, 1H, CH (Im)), 7.58 (d, <i>J</i> = 8.5 Hz, 2H, 2 CH (Ar)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 31.7, 33.9, 41.5, 47.6, 51.6, 112.6, 117.6, 123.9, 126.1, 127.9, 128.5, 128.6, 129.3, 130.4, 133.6, 135.2, 138.9, 139.1, 140.1, 143.6, 167.1; HRMS (ES+) calcd for [C<sub>25</sub>H<sub>25</sub>N<sub>7</sub>O<sub>3</sub>S + H] 504.1818, found 504.1830; HPLC (I) <i>t</i><sub>R</sub> = 11.48 min (100%), (II) <i>t</i><sub>R</sub> = 15.67 min (100%).</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 2-[(<i>N</i>-<i>tert</i>-Butoxycarbonylpiperidin-4-ylmethyl)(1-methyl-1<i>H</i>-imidazole-4-sulfonyl)amino]-<i>N</i>-(4-cyanophenyl)-<i>N</i>-(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)acetamide (<b>4d</b>)</h3><div class="NLM_p last">Compound <b>32</b> was coupled to secondary sulfonamide <b>19d</b> as per general procedure A on a 0.164 mmol scale. After workup, the crude residue was purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to furnish <b>4b</b> (20 mg, 20%): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 0.99 (m, 2H, 2 CH (piperidinylmethyl)), 1.44 (s, 9H, C(CH<sub>3</sub>)<sub>3</sub>), 1.59−1.75 (m, 3H, 3 CH (piperidinylmethyl)), 2.54−2.68 (m, 2H, 2 CH (piperidinylmethyl)), 3.07−3.19 (m, 2H, 2 CH (piperidinylmethyl)), 3.61 (s, 3H, CH<sub>3</sub>(Im)), 3.71 (s, 3H, CH<sub>3</sub>(Im)), 3.73−3.81 (m, 2H, CH<sub>2</sub>CO), 3.95−4.08 (m, 2H, CHC<u class="uu">H</u><sub>2</sub>N (piperidinylmethyl)), 4.81−4.94 (m, 2H, C<u class="uu">H</u><sub>2</sub>Im), 6.59 (s, 1H, CH (Im)), 7.22 (d, <i>J</i> = 8.5 Hz, 2H, 2 CH (Ar)), 7.33 (app s, 2H, 2 CH (Im)), 7.43 (s, 1H, CH (Im)), 7.69 (d, <i>J</i> = 8.5 Hz, 2H, 2 CH (Ar)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 28.4, 29.6, 31.9, 34.0, 35.3, 41.7, 43.5 (br), 50.2, 55.1, 79.5, 112.8, 117.6, 123.6, 126.1, 129.7, 130.4, 133.9, 138.8, 139.1, 140.0, 143.8, 154.6, 167.5; HRMS (ES+) calcd for [C<sub>29</sub>H<sub>38</sub>N<sub>8</sub>O<sub>5</sub>S + H] 611.2764, found 611.2769; HPLC (I) <i>t</i><sub>R</sub> = 12.44 min (99.53%), (II) <i>t</i><sub>R</sub> = 17.97 min (98.67%).</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 3-[Benzyl-(1-methyl-1<i>H</i>-imidazole-4-sulfonyl)amino]-<i>N</i>-(4-cyanophenyl)-<i>N</i>-(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)propanamide (<b>5a</b>)</h3><div class="NLM_p last"><b>5a</b> was prepared as per general procedure B with <b>35</b> and benzyl bromide on a 0.0845 mmol scale. The crude residue was purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to give <b>5a</b> (42 mg, 96%): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 2.12 (m, 2H, C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>CO), 3.47 (t, <i>J</i> = 7.3 Hz, 2H, CH<sub>2</sub>C<u class="uu">H</u><sub>2</sub>CO), 3.53 (s, 3H, CH<sub>3</sub>(Im)), 3.72 (s, 3H, CH<sub>3</sub>(Im)), 4.31 (s, 2H, C<u class="uu">H</u><sub>2</sub>Ph), 4.78 (s, 2H, C<u class="uu">H</u><sub>2</sub>Im), 6.53 (s, 1H, CH (Im)), 6.68 (d, <i>J</i> = 8.3 Hz, 2H, 2 CH (Ar)), 7.19−7.25 (m, 5H, 5 CH (Ph)), 7.37 (s, 1H, CH (Im)), 7.38 (br s, 1H, CH (Im)), 7.41 (s, 1H, CH (Im)), 7.58 (d, <i>J</i> = 8.3 Hz, 2H, 2 CH (Ar)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 31.7, 34.9, 35.2, 40.9, 45.3, 53.8, 112.3, 117.7, 124.2, 126.5, 127.7, 128.3, 128.4, 129.3, 129.7, 130.2, 133.6, 136.8, 138.9, 139.7, 144.5, 169.7; HRMS (ES+) calcd for [C<sub>26</sub>H<sub>27</sub>N<sub>7</sub>O<sub>3</sub>S + H] 518.1974, found 518.1994; HPLC (I) <i>t</i><sub>R</sub> = 11.82 min (98.91%), (II) <i>t</i><sub>R</sub> = 16.38 min (99.01%).</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 3-[(<i>N</i>-<i>tert</i>-Butoxycarbonylpiperidin-4-ylmethyl)(1-methyl-1<i>H</i>-imidazole-4-sulfonyl)amino]-<i>N</i>-(4-cyanophenyl)-<i>N</i>-(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)propanamide (<b>5d</b>)</h3><div class="NLM_p last"><b>5d</b> was prepared as per general procedure B with <b>35</b> and <i>N</i>-<i>tert</i>-butoxycarbonylpiperidin-4-ylmethyl bromide (1.5 equiv) in DMF (0.1 M) on a 0.0986 mmol scale. After the mixture was stirred at room temperature for 36 h, byproduct began to form. So the reaction mixture was worked up and then the crude residue was purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to give <b>5d</b> (30 mg, 50% (73% brsm)): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 1.03 (qd, <i>J</i> = 12.2, 4.0 Hz, 2H, 2 CH (piperidinylmethyl)), 1.43 (s, 9H, C(CH<sub>3</sub>)<sub>3</sub>), 1.59 (br app d, <i>J</i> = 12.2 Hz, 2H, 2 CH (piperidinylmethyl)), 1.77 (m, 1H, CH (piperidinylmethyl)), 2.46 (m, 2H, C<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>CO), 2.63 (m, 2H, 2 CH (piperidinylmethyl)), 2.92 (m, 2H, 2 CH (piperidinylmethyl)), 3.50 (m, 2H, 2 CH (piperidinylmethyl)), 3.59 (s, 3H, CH<sub>3</sub>(Im)), 3.71 (s, 3H, CH<sub>3</sub>(Im)), 4.05 (m, 2H, CHC<u class="uu">H</u><sub>2</sub>N (piperidinylmethyl)), 4.90 (s, 2H, C<u class="uu">H</u><sub>2</sub>Im), 6.61 (s, 1H, CH (Im)), 7.13 (d, <i>J</i> = 8.0 Hz, 2H, 2 CH (Ar)), 7.32 (s, 1H, CH (Im)), 7.33 (s, 1H, CH (Im)), 7.42 (s, 1H, CH (Im)), 7.68 (d, <i>J</i> = 8.3 Hz, 2H, 2 CH (Ar)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 28.4, 29.7, 31.8, 33.9, 34.9, 35.1, 41.2, 43.4 (br), 46.0, 55.3, 79.4, 112.5, 117.7, 124.2, 126.5, 129.5, 130.3, 133.7, 138.7, 139.0, 139.5, 144.6, 154.7, 170.0; HRMS (ES+) calcd for [C<sub>30</sub>H<sub>40</sub>N<sub>8</sub>O<sub>5</sub>S + H] 625.2921, found 625.2923; HPLC (I) <i>t</i><sub>R</sub> = 12.74 min (98.83%), (II) <i>t</i><sub>R</sub> = 19.28 min (99.47%).</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> (±)-[<i>N</i>-Benzyl-<i>N</i>-{<i>cis</i>-2-[(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclopentyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>6a</b>)</h3><div class="NLM_p last">The synthesis was as per general procedure B with <b>42</b> and benzyl bromide on a 0.0273 mmol scale. The crude residue was purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to afford <b>6a</b> (8 mg, 55%): δ<sub>H</sub> (400 MHz, CDCl<sub>3</sub>) 1.37−1.50 (m, 1H, CH (cyclopentyl)), 1.84−1.96 (m, 2H, 2 CH (cyclopentyl)), 2.04−2.19 (m, 2H, 2 CH (cyclopentyl)), 2.49−2.56 (m, 1H, CH (cyclopentyl)), 3.55 (s, 3H, CH<sub>3</sub>(Im)), 3.67 (s, 3H, CH<sub>3</sub>(Im)), 3.88 (d, <i>J</i> = 16.4 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>a</i></sub></u>Ph), 4.14 (m, 1H, CHN (cyclopentyl)), 4.20 (d, <i>J</i> = 18.0 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>a</i></sub></u>Im), 4.25 (m, 1H, CHN (cyclopentyl)), 4.52 (d, <i>J</i> = 16.4 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>b</i></sub></u>Ph), 4.75 (d, <i>J</i> = 18.0 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>b</i></sub></u>Im), 6.52 (s, 1H, CH (Im)), 6.68 (d, <i>J</i> = 9.2 Hz, 2H, 2 CH (Ar)), 6.97−7.01 (m, 2H, 2 CH (Ph)), 7.15−7.20 (m, 3H, 3 CH (Ph)), 7.25 (s, 1H, CH (Im)), 7.37 (s, 1H, CH (Im)), 7.43 (d, <i>J</i> = 9.2 Hz, 2H, 2 CH (Ar)), 7.47 (s, 1H, CH (Im)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 21.1, 28.4, 28.6, 31.6, 33.9, 41.6, 52.3, 61.2, 61.8, 98.8, 113.2, 120.3, 124.7, 127.0, 127.4, 127.9, 128.3, 128.4, 133.2, 136.7, 137.8, 138.9, 140.6, 151.4; HRMS (ES+) calcd for [C<sub>28</sub>H<sub>31</sub>N<sub>7</sub>O<sub>2</sub>S + H] 530.2338, found 530.2350; HPLC (I) <i>t</i><sub>R</sub> = 12.73 min (100%), (II) <i>t</i><sub>R</sub> = 18.89 min (99.35%).</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> (±)-[<i>N</i>-(2-Methylbenzyl)-<i>N</i>-{<i>cis</i>-2-[(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclopentyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>6b</b>)</h3><div class="NLM_p last">The synthesis was as per general procedure B with <b>42</b> and 2-methylbenzyl bromide on a 0.116 mmol scale. The crude residue was purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to afford <b>6b</b> (14 mg, 22%): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 1.38−1.48 (m, 1H, CH (cyclopentyl)), 1.86−1.99 (m, 5H, C<u class="uu">H</u><sub>3</sub>Ph, 2 CH (cyclopentyl)), 2.14−2.26 (m, 2H, 2 CH (cyclopentyl)), 2.67−2.76 (m, 1H, CH (cyclopentyl)), 3.59 (s, 3H, CH<sub>3</sub>(Im)), 3.62 (s, 3H, CH<sub>3</sub>(Im)), 4.05 (d, <i>J</i> = 17.5 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>a</i></sub></u>Ph), 4.09−4.15 (m, 1H, CHN (cyclopentyl)), 4.26 (m, 1H, CHN (cyclopentyl)), 4.31 (d, <i>J</i> = 18.0 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>a</i></sub></u>Im), 4.42 (d, <i>J</i> = 17.5 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>b</i></sub></u>Ph), 4.90 (d, <i>J</i> = 18.0 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>b</i></sub></u>Im), 6.55 (s, 1H, CH (Im)), 6.69 (d, <i>J</i> = 9.0 Hz, 2H, 2 CH (Ar)), 6.95−7.01 (m, 3H, 3 CH (Ph)), 7.07 (td, <i>J</i> = 7.3, 1.5 Hz, 1H, CH (Ph)), 7.16 (s, 1H, CH (Im)), 7.25 (s, 1H, CH (Im)), 7.43 (d, <i>J</i> = 9.0 Hz, 2H, 2 CH (Ar)), 7.45 (s, 1H, CH (Im)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 18.8, 21.2, 28.6, 28.7, 31.6, 33.8, 41.7, 50.6, 61.5, 62.2, 98.8, 112.9, 120.3, 124.5, 125.5, 126.9, 127.1, 127.3, 128.4, 130.2, 133.4, 134.2, 135.7, 137.8, 138.7, 140.8, 151.5; HRMS (ES+) calcd for [C<sub>29</sub>H<sub>33</sub>N<sub>7</sub>O<sub>2</sub>S + H] 544.2495, found 544.2509; HPLC (I) <i>t</i><sub>R</sub> = 12.77 min (100%), (II) <i>t</i><sub>R</sub> = 19.02 min (100%).</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> (±)-[<i>N</i>-(Thiophen-3-ylmethyl)-<i>N</i>-{<i>cis</i>-2-[(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclopentyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>6c</b>)</h3><div class="NLM_p last">The synthesis was as per general procedure B with <b>42</b> and thiophen-3-ylmethyl bromide (prepared by employing a standard bromination procedure of thiophen-3-ylmethanol with PPh<sub>3</sub>Br<sub>2</sub>; the bromide darkened on standing at room temperature, but <sup>1</sup>H NMR of the material after 1 month suggested no decomposition had occurred) on a 0.121 mmol scale. The crude residue was purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to afford <b>6c</b> (35 mg, 54%): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 1.43−1.53 (m, 1H, CH (cyclopentyl)), 1.85−1.96 (m, 2H, 2 CH (cyclopentyl)), 2.04−2.13 (m, 2H, 2 CH (cyclopentyl)), 2.41−2.50 (m, 1H, CH (cyclopentyl)), 3.57 (s, 3H, CH<sub>3</sub>(Im)), 3.66 (s, 3H, CH<sub>3</sub>(Im)), 3.96 (d, <i>J</i> = 16.5 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>a</i></sub></u>thiophene), 4.18 (m, 1H, CHN (cyclopentyl)), 4.27−4.34 (m, 2H, C<u class="uu">H</u><u class="uu"><sub><i>a</i></sub></u>Im, CHN (cyclopentyl)), 4.43 (d, <i>J</i> = 16.5 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>b</i></sub></u>thiophene), 4.74 (d, <i>J</i> = 18.0 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>b</i></sub></u>Im), 6.53 (s, 1H, CH (Im)), 6.70 (dd, <i>J</i> = 5.0, 1.5 Hz, 1H, CH (thiophene)), 6.72 (d, <i>J</i> = 9.0 Hz, 2H, 2 CH (Ar)), 6.90−6.93 (m, 1H, CH (thiophene)), 7.11−7.13 (dd, <i>J</i> = 5.0, 2.8 Hz, 1H, CH (thiophene)), 7.22 (s, 1H, CH (Im)), 7.39 (s, 1H, CH (Im)), 7.43 (d, <i>J</i> = 9.0 Hz, 2H, 2 CH (Ar)), 7.44 (s, 1H, CH (Im)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 21.0, 28.2, 28.3, 31.5, 33.9, 41.8, 47.4, 60.7, 61.8, 98.8, 113.2, 120.4, 123.0, 124.5, 125.7, 127.5, 127.7, 128.2, 133.2, 137.9, 138.0, 138.8, 140.8, 151.5; HRMS (ES+) calcd for [C<sub>26</sub>H<sub>29</sub>N<sub>7</sub>O<sub>2</sub>S<sub>2</sub> + H] 536.1902, found 536.1915; HPLC (I) <i>t</i><sub>R</sub> = 11.08 min (100%), (II) <i>t</i><sub>R</sub> = 18.85 min (98.38%).</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> (±)-[<i>N</i>-(<i>N</i>-<i>tert</i>-Butoxycarbonylpiperidin-4-ylmethyl)-<i>N</i>-{<i>cis</i>-2-[(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclopentyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>6d</b>)</h3><div class="NLM_p last">The synthesis was as per general procedure B with <b>42</b> and <i>N</i>-<i>tert</i>-butoxycarbonylpiperidin-4-ylmethyl iodide (prepared by Finkelstein transformation on <i>N</i>-<i>tert</i>-butoxycarbonylpiperidin-4-ylmethyl bromide with sodium iodide in acetone) (1.5 equiv) on a 0.116 mmol scale in DMF (0.1 M), and the mixture was stirred for 7 days at room temperature. After the usual workup, the crude residue was purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to yield <b>6d</b> (60 mg, 81%): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 0.62−0.72 (m, 1H, CH (piperidinylmethyl)), 0.81−0.89 (m, 1H, CH (piperidinylmethyl)), 1.24−1.31 (m, 2H, 2 CH (piperidinylmethyl)), 1.41 (s, 9H, C(CH<sub>3</sub>)<sub>3</sub>), 1.42−1.61 (m, 3H, 2 CH (piperidinylmethyl), CH (cyclopentyl)), 1.85−1.95 (m, 2H, 2 CH (cyclopentyl)), 2.06−2.23 (m, 2H, 2 CH (cyclopentyl)), 2.25−2.35 (m, 1H, CH (piperidinylmethyl)), 2.38−2.49 (m, 1H, CH (cyclopentyl)), 2.73−2.81 (m, 1H, CH (piperidinylmethyl)), 2.86−2.99 (m, 1H, CH (piperidinylmethyl)), 3.64 (s, 3H, CH<sub>3</sub>(Im)), 3.73 (s, 3H, CH<sub>3</sub>(Im)), 3.81−3.97 (m, 2H, CHC<u class="uu">H</u><sub>2</sub>N (piperidinylmethyl)), 4.13 (m, 1H, CHN (cyclopentyl)), 4.24 (m, 1H, CHN (cyclopentyl)), 4.57 (d, <i>J</i> = 18.0 Hz, 1H, C<u class="uu">H</u><sub><i>a</i></sub>Im), 5.06 (br d, <i>J</i> = 18.0 Hz, 1H, C<u class="uu">H</u><sub><i>b</i></sub>Im), 6.56 (s, 1H, CH (Im)), 6.81 (d, <i>J</i> = 9.0 Hz, 2H, 2 CH (Ar)), 7.38 (s, 1H, CH (Im)), 7.41−7.46 (m, 4H, 2 CH (Im), 2 CH (Ar)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 20.9, 28.0, 28.2, 28.4, 29.9, 31.6, 34.0, 35.1, 42.3, 43.4 (br), 55.9, 61.8, 62.1, 79.4, 99.1, 113.3, 120.1, 124.1, 127.5, 128.0, 133.3, 138.0, 138.8, 141.4, 151.5, 154.6; HRMS (ES+) calcd for [C<sub>32</sub>H<sub>44</sub>N<sub>8</sub>O<sub>4</sub>S + H] 637.3284, found 637.3288; HPLC (I) <i>t</i><sub>R</sub> = 13.28 min (100%), (II) <i>t</i><sub>R</sub> = 20.60 min (100%).</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> (±)-[<i>N</i>-{<i>N</i>-(2-Pyrimidinyl)-piperidin-4-ylmethyl}-<i>N</i>-{<i>cis</i>-2-[(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclopentyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>6e</b>)</h3><div class="NLM_p last">The synthesis was as per general procedure B with <b>42</b> and <i>N</i>-(2-pyrimidinyl)-piperidin-4-ylmethyl iodide (prepared by the reaction of PPh<sub>3</sub>Br<sub>2</sub> on <i>N</i>-(2-pyrimidinyl)-piperidin-4-ylmethanol to give <i>N</i>-(2-pyrimidinyl)-piperidin-4-ylmethyl bromide, followed by Finkesltein halide exchange with NaI) (1.5 equiv) on a 0.118 mmol scale in DMF (0.1 M), and the mixture was stirred for 7 days at room temperature. The crude residue was purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to furnish <b>6e</b> (57 mg, 79%): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 0.76 (qd, <i>J</i> = 12.5, 4.0 Hz, 1H, CH (piperidinylmethyl)), 0.94 (qd, <i>J</i> = 12.5, 4.0 Hz, 1H, CH (piperidinylmethyl)), 1.35−1.41 (m, 1H, 1 CH (cyclopentyl)), 1.48−1.57 (m, 2H, 2 CH (piperidinylmethyl)), 1.68−1.77 (m, 1H, CH (piperidinylmethyl)), 1.87−1.97 (m, 2H, 2 CH (cyclopentyl)), 2.09−2.20 (m, 2H, 2 CH (cyclopentyl)), 2.39 (td, <i>J</i> = 12.5, 2.5 Hz, 1H, CH (piperidinylmethyl)), 2.44−2.52 (m, 2H, CH (cyclopentyl), CH (piperidinylmethyl)), 2.80 (dd, <i>J</i> = 14.5, 7.0 Hz, 1H, CH (piperidinylmethyl)), 2.97 (dd, <i>J</i> = 14.5, 7.5 Hz, 1H, CH (piperidinylmethyl)), 3.66 (s, 3H, CH<sub>3</sub>(Im)), 3.73 (s, 3H, CH<sub>3</sub>(Im)), 4.17 (m, 1H, CHN (cyclopentyl)), 4.26 (m, 1H, CHN (cyclopentyl)), 4.53−4.63 (m, 3H, C<u class="uu">H</u><sub><i>a</i></sub>Im, CHC<u class="uu">H</u><sub>2</sub>N (piperidinylmethyl)), 5.02 (br d, <i>J</i> = 17.5 Hz, 1H, C<u class="uu">H</u><sub><i>b</i></sub>Im), 6.42 (t, <i>J</i> = 4.9 Hz, 1H, CH (pyrimidine), 6.59 (s, 1H, CH (Im)), 6.82 (d, <i>J</i> = 9.5 Hz, 2H, 2 CH (Ar)), 7.38 (s, 1H, CH (Im)), 7.44−7.47 (m, 3H, CH (Im), 2 CH (Ar)), 7.49 (s, 1H, CH (Im)), 8.25 (d, <i>J</i> = 4.9 Hz, 2H, 2 CH (pyrimidine)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 21.0, 28.1, 28.4, 29.8, 31.7, 34.0, 35.4, 42.3, 43.5, 55.7, 61.9, 62.7, 99.2, 109.4, 113.3, 120.1, 124.0, 127.0, 128.2, 133.4, 137.9, 138.7, 141.6, 151.5, 157.7, 161.4; HRMS (ES+) calcd for [C<sub>31</sub>H<sub>38</sub>N<sub>10</sub>O<sub>2</sub>S + H] 615.2978, found 615.2999; HPLC (I) <i>t</i><sub>R</sub> = 13.12 min (99.94%), (II) <i>t</i><sub>R</sub> = 19.98 min (99.39%).</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> (±)-[<i>N</i>-Benzyl-<i>N</i>-{<i>trans</i>-2-[(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclopentyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>7a</b>)</h3><div class="NLM_p last">The synthesis was as per general procedure B with <b>45</b> and benzyl bromide on a 0.0228 mmol scale. The crude residue was purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to afford <b>7a</b> (10 mg, 85%): δ<sub>H</sub> (400 MHz, CDCl<sub>3</sub>) 1.19−1.29 (m, 1H, CH (cyclopentyl)), 1.54−1.64 (m, 2H, 2 CH (cyclopentyl)), 1.65−1.79 (m, 2H, 2 CH (cyclopentyl)), 1.83−1.91 (m, 1H, CH (cyclopentyl)), 3.60 (s, 3H, CH<sub>3</sub>(Im)), 3.73 (s, 3H, CH<sub>3</sub>(Im)), 3.87 (m, 1H, CHN (cyclopentyl)), 4.04 (d, <i>J</i> = 16.4 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>a</i></sub></u>Ph), 4.41 (d, <i>J</i> = 17.8 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>a</i></sub></u>Im), 4.61−4.72 (m, 2H, C<u class="uu">H</u><u class="uu"><sub><i>b</i></sub></u>Ph, CHN (cyclopentyl)), 4.80 (d, <i>J</i> = 17.8 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>b</i></sub></u>Im), 6.33 (d, <i>J</i> = 8.8 Hz, 2H, 2 CH (Ar)), 6.60 (s, 1H, CH (Im)), 6.94−7.02 (m, 3H, 3 CH (Ph)), 7.20−7.25 (m, 4H, 2 CH (Ph), 2 CH (Ar)), 7.39 (s, 1H, CH (Im)), 7.47 (s, 1H, CH (Im)), 7.45 (s, 1H, CH (Im)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 19.3, 24.1, 26.2, 32.1, 34.0, 39.6, 48.1, 60.0, 61.1, 98.6, 113.1, 120.3, 124.2, 127.0, 127.3 (2), 128.2, 128.6, 133.0, 137.1, 137.9, 139.0, 140.2, 151.2; HRMS (ES+) calcd for [C<sub>28</sub>H<sub>31</sub>N<sub>7</sub>O<sub>2</sub>S + H] 530.2338, found 530.2353; HPLC (I) <i>t</i><sub>R</sub> = 12.98 min (98.35%), (II) <i>t</i><sub>R</sub> = 19.76 min (98.05%).</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> (±)-[<i>N</i>-(2-Methylbenzyl)-<i>N</i>-{<i>trans</i>-2-[(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclopentyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>7b</b>)</h3><div class="NLM_p last">The synthesis was as per general procedure B with <b>45</b> and 2-methylbenzyl bromide on a 0.082 mmol scale. The crude residue was purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to afford <b>7b</b> (37 mg, 83%): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 1.20−1.29 (m, 1H, CH (cyclopentyl)), 1.55−1.66 (m, 2H, 2 CH (cyclopentyl)), 1.76−1.89 (m, 3H, 3 CH (cyclopentyl)), 2.21 (s, 3H, C<u class="uu">H</u><sub>3</sub>Ph), 3.58 (s, 3H, CH<sub>3</sub>(Im)), 3.76 (s, 3H, CH<sub>3</sub>(Im)), 3.90 (m, 1H, CHN (cyclopentyl)), 4.23 (d, <i>J</i> = 16.0 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>a</i></sub></u>Ph), 4.35 (d, <i>J</i> = 18.0 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>a</i></sub></u>Im), 4.57 (d, <i>J</i> = 16.0 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>b</i></sub></u>Ph), 4.62 (m, 1H, CHN (cyclopentyl)), 4.75 (d, <i>J</i> = 18.0 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>b</i></sub></u>Im), 6.40 (d, <i>J</i> = 9.0 Hz, 2H, 2 CH (Ar)), 6.61 (s, 1H, CH (Im)), 6.83−6.97 (m, 3H, 3 CH (Ph)), 7.25−7.30 (m, 3H, 2 CH (Ar), CH (Ph)), 7.41 (s, 1H, CH (Im)), 7.43 (s, 1H, CH (Im)), 7.50 (s, 1H, CH (Im)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 19.2, 19.6, 24.2, 26.4, 31.9, 34.0, 39.5, 46.3, 59.1, 61.2, 98.6, 113.2, 120.4, 124.3, 125.7, 127.3, 128.0, 128.3, 128.4, 130.4, 133.1, 134.6, 135.5, 138.2, 139.0, 140.4, 151.4; HRMS (ES+) calcd for [C<sub>29</sub>H<sub>33</sub>N<sub>7</sub>O<sub>2</sub>S + H] 544.2495, found 544.2501; HPLC (I) <i>t</i><sub>R</sub> = 12.91 min (100%), (II) <i>t</i><sub>R</sub> = 19.69 min (99.61%).</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> (±)-[<i>N</i>-(Thiophen-3-ylmethyl)-<i>N</i>-{<i>trans</i>-2-[(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclopentyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>7c</b>)</h3><div class="NLM_p last">The synthesis was as per general procedure B with <b>45</b> and thiophen-3-ylmethyl bromide on a 0.0888 mmol scale. The crude residue was purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to afford <b>7c</b> (36 mg, 75%): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 1.27−1.35 (m, 1H, CH (cyclopentyl)), 1.57−1.69 (m, 3H, 3 CH (cyclopentyl)), 1.75−1.82 (m, 1H, CH (cyclopentyl)), 1.88−1.95 (m, 1H, CH (cyclopentyl)), 3.56 (s, 3H, CH<sub>3</sub>(Im)), 3.71 (s, 3H, CH<sub>3</sub>(Im)), 4.02 (m, 1H, CHN (cyclopentyl)), 4.14 (d, <i>J</i> = 16.0 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>a</i></sub></u>thiophene), 4.44 (d, <i>J</i> = 18.0 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>a</i></sub></u>Im), 4.55 (d, <i>J</i> = 16.0 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>b</i></sub></u>thiophene), 4.63 (m, 1H, CHN (cyclopentyl)), 4.76 (d, <i>J</i> = 18.0 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>b</i></sub></u>Im), 6.57 (d, <i>J</i> = 9.0 Hz, 2H, 2 CH (Ar)), 6.60 (s, 1H, CH (Im)), 6.92 (dd, <i>J</i> = 5.3, 1.5 Hz, 1H, CH (thiophene)), 6.97 (dd, <i>J</i> = 5.3, 3.0 Hz, 1H, CH (thiophene)), 7.00−7.02 (m, 1H, CH (thiophene)), 7.30 (d, <i>J</i> = 9.0 Hz, 2H, 2 CH (Ar)), 7.34 (s, 1H, CH (Im)), 7.41 (s, 1H, CH (Im)), 7.44 (s, 1H, CH (Im)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 19.4, 24.7, 26.3, 31.8, 33.9, 39.8, 43.5, 60.0, 61.3, 98.8, 113.3, 120.3, 122.4, 124.1, 126.0, 127.2, 128.0, 128.2, 133.1, 138.2, 138.5, 138.9, 140.4, 151.4; HRMS (ES+) calcd for [C<sub>26</sub>H<sub>29</sub>N<sub>7</sub>O<sub>2</sub>S<sub>2</sub> + H] 536.1902, found 536.1912; HPLC (I) <i>t</i><sub>R</sub> = 12.93 min (100%), (II) <i>t</i><sub>R</sub> = 19.55 min (100%).</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> (±)-[<i>N</i>-(<i>N</i>-<i>tert</i>-Butoxycarbonylpiperidin-4-ylmethyl)-<i>N</i>-{<i>trans</i>-2-[(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclopentyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>7d</b>)</h3><div class="NLM_p last">The synthesis was as per general procedure B with <b>45</b> and <i>N</i>-<i>tert</i>-butoxycarbonylpiperidin-4-ylmethyl bromide (1.5 equiv) on a 0.0774 mmol scale in DMF (0.1 M), and the mixture was stirred for 7 days at room temperature. The crude residue was purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to afford <b>7d</b> (41 mg, 83%): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 1.00−1.09 (m, 1H, CH (piperidinylmethyl)), 1.24−1.35 (m, 2H, CH (cyclopentyl), CH (piperidinylmethyl)), 1.37−1.46 (m, 11H, C(CH<sub>3</sub>)<sub>3</sub>, and 2 CH (piperidinylmethyl)), 1.51−1.65 (m, 5H, 3 CH (cyclopentyl), 2 CH (piperidinylmethyl)), 2.00−2.08 (m, 2H, 2 CH (cyclopentyl)), 2.17−2.26 (m, 1H, CH (piperidinylmethyl)), 2.68−2.80 (m, 1H, CH (piperidinylmethyl)), 3.23 (dd, <i>J</i> = 15.0, 9.0 Hz, 1H, CH (piperidinylmethyl)), 3.65 (s, 3H, CH<sub>3</sub>(Im)), 3.75 (s, 3H, CH<sub>3</sub>(Im)), 3.89−4.00 (m, 3H, CHC<u class="uu">H</u><sub>2</sub>N (piperidinylmethyl), CHN (cyclopentyl)), 4.63 (m, 1H, CHN (cyclopentyl)), 4.72 (d, <i>J</i> = 18.0 Hz, 1H, C<u class="uu">H</u><sub><i>a</i></sub>Im), 5.06 (d, <i>J</i> = 18.0 Hz, 1H, C<u class="uu">H</u><sub><i>b</i></sub>Im), 6.71 (s, 1H, CH (Im)), 6.78 (d, <i>J</i> = 9.0 Hz, 2H, 2 CH (Ar)), 7.42 (s, 1H, CH (Im)), 7.46 (s, 1H, CH (Im)), 7.48 (d, <i>J</i> = 9.0 Hz, 2H, 2 CH (Ar)), 7.60 (s, 1H, CH (Im)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 18.5, 23.0, 25.8, 28.4, 30.2, 32.0, 34.0, 36.8, 39.5, 43.7 (br), 49.6, 60.0, 61.5, 79.3, 99.5, 113.1, 119.9, 124.1, 127.7, 128.2, 133.6, 138.2, 139.0, 140.1, 151.6, 154.5; HRMS (ES+) calcd for [C<sub>32</sub>H<sub>44</sub>N<sub>8</sub>O<sub>4</sub>S + H] 637.3284, found 637.3292; HPLC (I) <i>t</i><sub>R</sub> = 13.45 min (100%), (II) <i>t</i><sub>R</sub> = 21.09 min (100%).</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> (±)-[<i>N</i>-{<i>N</i>-(2-Pyrimidinyl)-piperidin-4-ylmethyl}-<i>N</i>-{<i>trans</i>-2-[(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclopentyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>7e</b>)</h3><div class="NLM_p last">The synthesis was as per general procedure B with <b>45</b> and <i>N</i>-(2-pyrimidinyl)-piperidin-4-ylmethyl bromide (1.5 equiv) on a 0.0799 mmol scale in DMF (0.1 M), and the mixture was stirred for 7 days at room temperature. The crude residue was purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to afford <b>7e</b> (38 mg, 78%): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 0.88 (qd, <i>J</i> = 12.2, 4.0 Hz, 1H, CH (piperidinylmethyl)), 1.01 (qd, <i>J</i> = 12.3, 4.0 Hz, 1H, CH (piperidinylmethyl)), 1.25−1.34 (m, 1H, 1 CH (cyclopentyl)), 1.38−1.48 (m, 2H, 2 CH (piperidinylmethyl)), 1.52−1.78 (m, 4H, 3 CH (cyclopentyl), CH (piperidinylmethyl)), 1.98−2.09 (m, 2H, 2 CH (cyclopentyl)), 2.28 (br t, <i>J</i> = 12.0, 1H, CH (piperidinylmethyl)), 2.40 (br t, <i>J</i> = 12.0 Hz, 1H, CH (piperidinylmethyl)), 2.74 (dd, <i>J</i> = 14.8, 6.0 Hz, 1H, CH (piperidinylmethyl)), 3.24 (dd, <i>J</i> = 14.8, 8.5 Hz, 1H, CH (piperidinylmethyl)), 3.61 (s, 3H, CH<sub>3</sub>(Im)), 3.74 (s, 3H, CH<sub>3</sub>(Im)), 3.97 (m, 1H, CHN (cyclopentyl)), 4.47−4.54 (m, 2H, CHC<u class="uu">H</u><sub>2</sub>N (piperidinylmethyl)), 4.63 (m, 1H, CHN (cyclopentyl)), 4.73 (d, <i>J</i> = 17.5 Hz, 1H, C<u class="uu">H</u><sub><i>a</i></sub>Im), 5.05 (d, <i>J</i> = 17.5 Hz, 1H, C<u class="uu">H</u><sub><i>b</i></sub>Im), 6.41 (t, <i>J</i> = 4.9 Hz, 1H, CH (pyrimidine), 6.59 (s, 1H, CH (Im)), 6.78 (d, <i>J</i> = 8.5 Hz, 2H, 2 CH (Ar)), 7.41 (s, 1H, CH (Im)), 7.43−7.49 (m, 4H, 2 CH (Im), 2 CH (Ar)), 8.25 (d, <i>J</i> = 4.9 Hz, 2H, 2 CH (pyrimidine)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 18.6, 23.1, 25.8, 29.9, 31.8, 33.9, 37.0, 39.5, 43.5, 49.7, 60.1, 61.6, 99.4, 109.3, 113.2, 119.9, 124.1, 128.2, 128.4, 133.6, 138.4, 138.9, 140.1, 151.8, 157.6, 161.3; HRMS (ES+) calcd for [C<sub>31</sub>H<sub>38</sub>N<sub>10</sub>O<sub>2</sub>S + H] 615.2978, found 615.2990; HPLC (I) <i>t</i><sub>R</sub> = 12.91 min (99.70%), (II) <i>t</i><sub>R</sub> = 19.32 min (99.65%).</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> (±)-[<i>N</i>-Benzyl-<i>N</i>-{<i>cis</i>-3-[(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclopentyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>8a</b>)</h3><div class="NLM_p last">The synthesis was as per general procedure A with alcohol <b>55</b> and sulfonamide <b>19a</b> on a 0.102 mmol scale. The crude residue was purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to furnish <b>8a</b> (38 mg, 71%): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 1.45−1.55 (m, 1H, CH (cyclopentyl)), 1.62−1.86 (m, 4H, 4 CH (cyclopentyl)), 1.92−1.98 (m, 1H, CH (cyclopentyl)), 3.42 (s, 3H, CH<sub>3</sub>(Im)), 3.65 (s, 3H, CH<sub>3</sub>(Im)), 4.02−4.17 (m, 4H, C<u class="uu">H</u><sub>2</sub>Ph, 2 CHN (cyclopentyl)), 4.30 (d, <i>J</i> = 16.5 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>a</i></sub></u>Im), 4.41 (d, <i>J</i> = 16.5 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>b</i></sub></u>Im), 6.52−6.58 (m, 3H, 2 CH (Ar), CH (Im)), 7.14−7.27 (m, 6H, 5 CH (Ph), CH (Im)), 7.30 (d, <i>J</i> = 8.5 Hz, 2H, 2 CH (Ar)), 7.33 (s, 1H, CH (Im)), 7.39 (s, 1H, CH (Im)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 26.8, 28.0, 31.5, 33.6, 33.9, 41.6, 49.5, 56.4, 57.3, 99.2, 113.5, 120.0, 123.8, 127.1, 127.2, 127.3, 128.0, 128.4, 133.3, 138.2, 138.4, 138.9, 140.7, 151.9; HRMS (ES+) calcd for [C<sub>28</sub>H<sub>31</sub>N<sub>7</sub>O<sub>2</sub>S + H] 530.2338, found 530.2357; HPLC (I) <i>t</i><sub>R</sub> = 12.28 min (100%), (II) <i>t</i><sub>R</sub> = 18.26 min (100%).</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> (±)-[<i>N</i>-(2-Methylbenzyl)-<i>N</i>-{<i>cis</i>-3-[(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclopentyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>8b</b>)</h3><div class="NLM_p last">The synthesis was as per general procedure A with alcohol <b>55</b> and sulfonamide <b>19b</b> on a 0.102 mmol scale. The crude residue was purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to yield <b>8b</b> (36 mg, 65%): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 1.51−1.58 (m, 1H, CH (cyclopentyl)), 1.66−1.75 (m, 1H, CH (cyclopentyl)), 1.75−1.93 (m, 3H, 3 CH (cyclopentyl)), 2.03−2.08 (m, 1H, CH (cyclopentyl)), 2.26 (s, 3H, C<u class="uu">H</u><sub>3</sub>Ph), 3.46 (s, 3H, CH<sub>3</sub>(Im)), 3.73 (s, 3H, CH<sub>3</sub>(Im)), 4.13 (m, 1H, CHN (cyclopentyl)), 4.17−4.24 (m, 3H, C<u class="uu">H</u><sub>2</sub>Ph, CHN (cyclopentyl)), 4.34 (d, <i>J</i> = 16.5 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>a</i></sub></u>Im), 4.46 (d, <i>J</i> = 16.5 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>b</i></sub></u>Im), 6.60−6.64 (m, 3H, CH (Im), 2 CH (Ar)), 7.08−7.11 (m, 1H, CH (Ph)), 7.13−7.17 (m, 2H, 2 CH (Ph)), 7.28 (s, 1H, CH (Im)), 7.36−7.40 (m, 3H, 2 CH (Ar), CH (Im)), 7.41−7.44 (m, 1H, CH (Ph)), 7.45 (s, 1H, CH (Im)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 19.2, 26.9, 27.8, 31.5, 33.5, 34.0, 41.7, 47.4, 56.4, 57.2, 99.3, 113.5, 120.1, 123.9, 126.0, 127.2, 127.7, 128.0, 128.1, 130.2, 133.4, 135.2, 135.8, 138.3, 138.9, 140.7, 151.9; HRMS (ES+) calcd for [C<sub>29</sub>H<sub>33</sub>N<sub>7</sub>O<sub>2</sub>S + H] 544.2495, found 544.2495; HPLC (I) <i>t</i><sub>R</sub> = 12.41 min (98.55%), (II) <i>t</i><sub>R</sub> = 17.99 min (98.89%).</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> (±)-[<i>N</i>-(Thiophen-3-ylmethyl)-<i>N</i>-{<i>cis</i>-3-[(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclopentyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>8c</b>)</h3><div class="NLM_p last">The synthesis was as per general procedure A with alcohol <b>55</b> and sulfonamide <b>19c</b> on a 0.102 mmol scale. The crude residue was purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to afford <b>8c</b> (43 mg, 79%): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 1.53−1.62 (m, 1H, CH (cyclopentyl)), 1.74−1.86 (m, 3H, 3 CH (cyclopentyl)), 1.87−1.93 (m, 1H, CH (cyclopentyl)), 2.01−2.06 (m, 1H, CH (cyclopentyl)), 3.54 (s, 3H, CH<sub>3</sub>(Im)), 3.71 (s, 3H, CH<sub>3</sub>(Im)), 4.11−4.19 (m, 2H, 2 CHN (cyclopentyl)), 4.25 (AB quartet, <i>J</i> = 17.8 Hz, 2H, C<u class="uu">H</u><sub>2</sub>Ph), 4.37 (d, <i>J</i> = 16.4 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>a</i></sub></u>Im), 4.45 (d, <i>J</i> = 16.4 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>b</i></sub></u>Im), 6.61−6.61 (m, 3H, 2 CH (Ar), CH (Im)), 7.04 (dd, <i>J</i> = 5.0, 1.2 Hz, 1H, CH (thiophene)), 7.05−7.07 (m, 1H, CH (thiophene)), 7.22 (dd, <i>J</i> = 5.0, 3.0 Hz, 1H, CH (thiophene)), 7.25 (s, 1H, CH (Im)), 7.38 (d, <i>J</i> = 9.0 Hz, 2H, 2 CH (Ar)), 7.41 (s, 1H, CH (Im)), 7.42 (s, 1H, CH (Im)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 26.9, 28.1, 31.5, 33.6, 33.9, 41.8, 45.2, 56.5, 57.2, 99.3, 113.5, 120.0, 122.0, 123.7, 126.0, 127.2, 127.4, 128.1, 133.4, 138.3, 138.8, 139.7, 141.0, 152.0; HRMS (ES+) calcd for [C<sub>26</sub>H<sub>29</sub>N<sub>7</sub>O<sub>2</sub>S<sub>2</sub> + H] 536.1902, found 536.1910; HPLC (I) <i>t</i><sub>R</sub> = 12.09 min (100%), (II) <i>t</i><sub>R</sub> = 17.62 min (100%).</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> (±)-[<i>N</i>-(<i>N</i>-<i>tert</i>-Butoxycarbonylpiperidin-4-ylmethyl)-<i>N</i>-{<i>cis</i>-3-[(4-cyanophenyl)-(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclopentyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>8d</b>)</h3><div class="NLM_p last">The synthesis was as per general procedure A with alcohol <b>55</b> and sulfonamide <b>19d</b> on a 0.102 mmol scale. The crude residue was purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to furnish <b>8d</b> (40 mg, 62%): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 0.92−0.98 (m, 1H, CH (piperidinylmethyl)), 1.04 (qd, <i>J</i> = 12.5, 4.0 Hz, 1 H, CH (piperidinylmethyl)), 1.45 (s, 9H, C(CH<sub>3</sub>)<sub>3</sub>), 1.65−1.77 (m, 3H, 2 CH (piperidinylmethyl), CH (cyclopentyl)), 1.79−1.91 (m, 4H, 3 CH (cyclopentyl), CH (piperidinylmethyl)), 1.94−2.06 (m, 2H, 2 CH (cyclopentyl)), 2.58−2.69 (m, 2H, 2 CH (piperidinylmethyl)), 2.87−2.98 (m, 1H, CH (piperidinylmethyl)), 2.99−3.10 (m, 1H, CH (piperidinylmethyl)), 3.62 (s, 3H, CH<sub>3</sub>(Im)), 3.72 (s, 3H, CH<sub>3</sub>(Im)), 3.98 (m, 1H, CHN (cyclopentyl)), 4.03−4.14 (m, 2H, CHC<u class="uu">H</u><sub>2</sub>N (piperidinylmethyl)), 4.18 (m, 1H, CHN (cyclopentyl)), 4.42 (AB quartet, <i>J</i> = 17.5 Hz, 2H, C<u class="uu">H</u><sub>2</sub>Im), 6.67 (s, 1H, CH (Im)), 6.69 (d, <i>J</i> = 9.0 Hz, 2H, 2 CH (Ar)), 7.20 (s, 1H, CH (Im)), 7.39 (s, 1H, CH (Im)), 7.41 (d, <i>J</i> = 9.0 Hz, 2 CH (Ar)), 7.44 (s, 1H, CH (Im)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 26.9, 28.2, 28.4, 29.9, 31.6, 33.5, 33.9, 36.7, 41.9, 43.6 (br), 52.5, 56.3, 58.3, 79.3, 99.4, 113.6, 120.0, 123.7, 128.1, 128.3, 133.4, 138.3, 138.7, 140.7, 152.0, 154.7; HRMS (ES+) calcd for [C<sub>32</sub>H<sub>44</sub>N<sub>8</sub>O<sub>4</sub>S + H] 637.3284, found 637.3283; HPLC (I) <i>t</i><sub>R</sub> = 12.89 min (99.52%), (II) <i>t</i><sub>R</sub> = 20.14 min (99.30%).</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> (±)-[<i>N</i>-{<i>N</i>-(2-Pyrimidinyl)-piperidin-4-ylmethyl}-<i>N</i>-{<i>cis</i>-3-[(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclopentyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>8e</b>)</h3><div class="NLM_p last">The synthesis was as per general procedure A with alcohol <b>55</b> (0.203 mmol, 1 equiv) and sulfonamide <b>21</b> (1.5 equiv), with 2 equiv of PPh<sub>3</sub> and 1.5 equiv of DIAD. The crude residue was purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to furnish (±)-[<i>N</i>-<i>tert</i>-butoxycarbonyl-<i>N</i>-{<i>cis</i>-3-[(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclopentyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide as a white powder (108 mg, 99%): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 1.37 (s, 9H, C(CH<sub>3</sub>)<sub>3</sub>), 1.90−1.96 (m, 1H, CH (cyclopentyl)), 1.98−2.06 (m, 1H, CH (cyclopentyl)), 2.09−2.17 (m, 1H, CH (cyclopentyl)), 2.25−2.41 (m, 3H, 3 CH (cyclopentyl)), 3.66 (s, 3H, CH<sub>3</sub>(Im)), 3.76 (s, 3H, CH<sub>3</sub>(Im)), 4.28 (m, 1H, CHN (cyclopentyl)), 4.50 (AB quartet, <i>J</i> = 17.5 Hz, 2H, C<u class="uu">H</u><sub>2</sub>Im), 4.95 (m, 1H, CHN (cyclopentyl)), 6.72−6.79 (m, 3H, CH (Im) 2 CH (Ar)), 7.41−7.50 (m, 4H, 2 CH (Im), 2 CH (Ar)), 7.59 (s, 1H, CH (Im)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 27.5, 27.7, 28.1, 31.3, 32.7, 33.9, 41.1, 56.1, 57.5, 83.8, 98.5, 113.1, 120.1, 124.9, 127.6, 128.3, 133.2, 138.0, 138.4, 140.0, 150.6, 152.0; HRMS (ES+) calcd for [C<sub>26</sub>H<sub>33</sub>N<sub>7</sub>O<sub>4</sub>S + H] 540.2393, found 540.2391. The material (108 mg, 0.201 mmol) was redissolved in a 1:1 mixture of CH<sub>2</sub>Cl<sub>2</sub>/TFA (7 mL). After the mixture was stirred for 3 h at room temperature, TLC indicated the reaction was complete, and so all solvent was removed in vacuo. The residue was dry-loaded onto silica gel and purified by flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 92:7:1) to give (±)-[<i>N</i>-{<i>cis</i>-3-[(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclopentyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide as a glassy film (88 mg, 96%): δ<sub>H</sub> (500 MHz, MeOH-<i>d</i><sub>4</sub>) 1.55−1.61 (m, 1H, CH (cyclopentyl)), 1.64−1.72 (m, 2H, 2 CH (cyclopentyl)), 1.81−1.89 (m, 1H, CH (cyclopentyl)), 1.93−1.99 (m, 1H, CH (cyclopentyl)), 2.08−2.13 (m, 1H, CH (cyclopentyl)), 3.56 (m, 1H, C<u class="uu">H</u>NHSO<sub>2</sub>), 3.69 (s, 3H, CH<sub>3</sub>(Im)), 3.75 (s, 3H, CH<sub>3</sub>(Im)), 4.26 (m, 1H, CHN (cyclopentyl)), 4.46 (AB quartet, <i>J</i> = 18.0 Hz, 2H, C<u class="uu">H</u><sub>2</sub>Im), 6.57 (s, 1H, CH (Im)), 6.68 (d, <i>J</i> = 9.3 Hz, 2H, 2 CH (Ar)), 7.41 (d, <i>J</i> = 9.3 Hz, 2H, 2 CH (Ar)), 7.47 (s, 1H, CH (Im)), 7.50 (s, 1H, CH (Im)), 7.52 (s, 1H, CH (Im)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 26.3, 30.3, 30.5, 32.9, 35.7, 40.6, 51.7, 56.8, 97.5, 112.7, 119.5, 123.9, 125.7, 128.5, 132.7, 137.5, 138.9, 139.2, 151.7; HRMS (ES+) calcd for [C<sub>21</sub>H<sub>25</sub>N<sub>7</sub>O<sub>2</sub>S + H] 440.1869, found 440.1881. Finally, (±)-[<i>N</i>-{<i>cis</i>-3-[(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclopentyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (0.096 mmol) and <i>N</i>-(2-pyrimidinyl)-4-iodomethylpiperidine (1.5 equiv) were reacted together as per general procedure B in DMF (0.1 M), and the mixture was stirred for 3 days at room temperature. After the usual workup, the crude residue was purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 92:7:1) to yield the title compound <b>8e</b> (50 mg, 85%): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 1.04 (qd, <i>J</i> = 12.3, 4.0 Hz, 1H, CH (piperidinylmethyl)), 1.11 (qd, <i>J</i> = 12.3, 4.0 Hz, 1H, CH (piperidinylmethyl)), 1.65−1.72 (m, 1H, 1 CH (cyclopentyl)), 1.78−2.09 (m, 8H, 5 CH (cyclopentyl), 3 CH (piperidinylmethyl)), 2.77−2.85 (m, 2H, 2 CH (piperidinylmethyl)), 2.95 (dd, <i>J</i> = 14.5, 7.0 Hz, 1H, CH (piperidinylmethyl)), 3.07 (dd, <i>J</i> = 14.5, 7.5 Hz, 1H, CH (piperidinylmethyl)), 3.59 (s, 3H, CH<sub>3</sub>(Im)), 3.72 (s, 3H, CH<sub>3</sub>(Im)), 4.04 (m, 1H, CHN (cyclopentyl)), 4.18 (m, 1H, CHN (cyclopentyl)), 4.43 (AB quartet, <i>J</i> = 17.5 Hz, 2H, C<u class="uu">H</u><sub>2</sub>Im), 4.73−4.80 (m, 2H, CHC<u class="uu">H</u><sub>2</sub>N (piperidinylmethyl)), 6.44 (t, <i>J</i> = 4.8 Hz, 1H, CH (pyrimidine), 6.67 (s, 1H, CH (Im)), 6.69 (d, <i>J</i> = 9.0 Hz, 2H, 2 CH (Ar)), 7.20 (s, 1H, CH (Im)), 7.39 (s, 1H, CH (Im)), 7.40−7.44 (m, 3H, CH (Im), 2 CH (Ar)) 8.28 (d, <i>J</i> = 4.8 Hz, 2H, 2 CH (pyrimidine)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 26.9, 28.3, 29.9, 31.6, 33.5, 33.9, 37.1, 41.9, 43.7, 52.6, 56.3, 58.3, 99.6, 109.4, 113.6, 120.0, 123.7, 128.2, 128.3, 133.5, 138.4, 138.7, 140.9, 152.1, 157.7, 161.5; HRMS (ES+) calcd for [C<sub>31</sub>H<sub>38</sub>N<sub>10</sub>O<sub>2</sub>S + H] 615.2978, found 615.3008; HPLC (I) <i>t</i><sub>R</sub> = 12.56 min (99.21%), (II) <i>t</i><sub>R</sub> = 19.15 min (99.37%).</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> (±)-[<i>N</i>-Benzyl-<i>N</i>-{<i>trans</i>-3-[(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclopentyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>9a</b>)</h3><div class="NLM_p last">The synthesis was as per general procedure A with alcohol <b>60</b> and sulfonamide <b>19a</b> on a 0.102 mmol scale. The crude residue was purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to furnish <b>9a</b> (29 mg, 54%): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 1.31−1.39 (m, 1H, CH (cyclopentyl)), 1.46−1.54 (m, 1H, CH (cyclopentyl)), 1.69−1.76 (m, 1H, CH (cyclopentyl)), 1.76−1.84 (m, 2H, 2 CH (cyclopentyl)), 1.91−1.97 (m, 1H, CH (cyclopentyl)), 3.56 (s, 3H, CH<sub>3</sub>(Im)), 3.63 (s, 3H, CH<sub>3</sub>(Im)), 4.14 (m, 1H, CHN (cyclopentyl)), 4.24 (s, 2H, C<u class="uu">H</u><sub>2</sub>Ph), 4.26 (d, <i>J</i> = 16.8 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>a</i></sub></u>Im), 4.43 (d, <i>J</i> = 16.8 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>b</i></sub></u>Im), 4.49 (m, 1H, CHN (cyclopentyl)), 6.48 (d, <i>J</i> = 9.0 Hz, 2H, 2 CH (Ar)), 6.54 (s, 1H, CH (Im)), 7.20−7.23 (m, 2H, CH (Ph), CH (Im)), 7.25−7.31 (m, 5H, 2 CH (Ar), 2 CH (Ph), CH (Im)), 7.32−7.36 (m, 2H, CH (Im), CH (Ph)), 7.38 (s, 1H, CH (Im)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 29.0, 29.1, 30.9, 31.6, 33.9, 41.7, 48.1, 56.9, 57.9, 99.1, 113.3, 120.1, 123.7, 127.1, 127.3, 127.9, 128.2, 128.5, 133.3, 138.2, 138.3, 138.9, 140.5, 151.8; HRMS (ES+) calcd for [C<sub>28</sub>H<sub>31</sub>N<sub>7</sub>O<sub>2</sub>S + H] 530.2338, found 530.2349; HPLC (I) <i>t</i><sub>R</sub> = 12.21 min (100%), (II) <i>t</i><sub>R</sub> = 18.09 min (99.84%).</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> (±)-[<i>N</i>-(2-Methylbenzyl)-<i>N</i>-{<i>trans</i>-3-[(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclopentyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>9b</b>)</h3><div class="NLM_p last">The synthesis was as per general procedure A with alcohol <b>60</b> and sulfonamide <b>19b</b> on a 0.136 mmol scale. The crude residue was purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to give <b>9b</b> (36 mg, 49%): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 1.37−1.53 (m, 2H, 2 CH (cyclopentyl)), 1.78−1.85 (m, 1H, CH (cyclopentyl)), 1.86−1.92 (m, 2H, 2 CH (cyclopentyl)), 1.97−2.02 (m, 1H, CH (cyclopentyl)), 2.32 (s, 3H, C<u class="uu">H</u><sub>3</sub>Ph), 3.63 (s, 3H, CH<sub>3</sub>(Im)), 3.69 (s, 3H, CH<sub>3</sub>(Im)), 4.17 (m, 1H, CHN (cyclopentyl)), 4.27−4.31 (m, 3H, C<u class="uu">H</u><sub>2</sub>Ph, C<u class="uu">H</u><u class="uu"><sub><i>a</i></sub></u>Im), 4.44 (d, <i>J</i> = 16.5 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>b</i></sub></u>Im), 4.58 (m, 1H, CHN (cyclopentyl)), 6.53 (d, <i>J</i> = 9.0 Hz, 2H, 2 CH (Ar)), 6.61 (s, 1H, CH (Im)), 7.12−7.15 (m, 1H, CH (Ph)), 7.16−7.22 (m, 2H, 2 CH (Ph)), 7.28 (s, 1H, CH (Im)), 7.34−7.37 (m, 3H, 2 CH (Ar), CH (Im)), 7.44 (s, 1H, CH (Im)), 7.48−7.51 (m, 1H, CH (Ph)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 19.3, 28.9, 29.0, 31.5, 31.6, 33.9, 41.8, 45.9, 57.0, 57.9, 99.2, 113.3, 120.1, 123.8, 126.1, 127.1, 127.4, 128.0, 128.2, 130.1, 133.4, 134.9, 135.8, 138.3, 138.9, 140.4, 151.8; HRMS (ES+) calcd for [C<sub>29</sub>H<sub>33</sub>N<sub>7</sub>O<sub>2</sub>S + H] 544.2495, found 544.2503; HPLC (I) <i>t</i><sub>R</sub> = 12.34 min (98.09%), (II) <i>t</i><sub>R</sub> = 18.02 min (98.07%).</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> (±)-[<i>N</i>-(Thiophen-3-ylmethyl)-<i>N</i>-{<i>trans</i>-3-[(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclopentyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>9c</b>)</h3><div class="NLM_p last">The synthesis was as per general procedure A with alcohol <b>60</b> and sulfonamide <b>19c</b> on a 0.136 mmol scale. The crude residue was purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to furnish <b>9c</b> (47 mg, 65%): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 1.40−1.48 (m, 1H, CH (cyclopentyl)), 1.58−1.67 (m, 1H, CH (cyclopentyl)), 1.77−1.83 (m, 1H, CH (cyclopentyl)), 1.86−1.92 (m, 2H, 2 CH (cyclopentyl)), 2.00−2.06 (m, 1H, CH (cyclopentyl)), 3.62 (s, 3H, CH<sub>3</sub>(Im)), 3.68 (s, 3H, CH<sub>3</sub>(Im)), 4.25 (m, 1H, CHN (cyclopentyl)), 4.31 (s, 2H, C<u class="uu">H</u><sub>2</sub>thiophene), 4.32 (d, <i>J</i> = 16.5 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>a</i></sub></u>Im), 4.46 (d, <i>J</i> = 16.5 Hz, 1H, C<u class="uu">H</u><u class="uu"><sub><i>b</i></sub></u>Im), 4.52 (m, 1H, CHN (cyclopentyl)), 6.58 (d, <i>J</i> = 9.1 Hz, 2H, 2 CH (Ar)), 6.61 (s, 1H, CH (Im)), 7.09 (dd, <i>J</i> = 5.0, 1.2 Hz, 1H, CH (thiophene)), 7.12−7.14 (m, 1H, CH (thiophene)), 7.26 (s, 1H, CH (Im)), 7.28 (dd, <i>J</i> = 5.0, 3.0 Hz, 1H, CH (thiophene)), 7.35 (s, 1H, CH (Im)), 7.37 (d, <i>J</i> = 9.1 Hz, 2H, 2 CH (Ar)), 7.43 (s, 1H, CH (Im)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 29.0, 29.1, 31.6, 31.8, 33.9, 41.8, 43.9, 57.0, 57.9, 99.2, 113.3, 120.1, 122.1, 123.7, 126.0, 127.2, 128.0, 128.1, 133.4, 138.3, 138.8, 139.6, 140.6, 151.8; HRMS (ES+) calcd for [C<sub>26</sub>H<sub>29</sub>N<sub>7</sub>O<sub>2</sub>S<sub>2</sub> + H] 536.1902, found 536.1911; HPLC (I) <i>t</i><sub>R</sub> = 12.05 min (98.16%), (II) <i>t</i><sub>R</sub> = 17.43 min (98.44%).</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> (±)-[<i>N</i>-(<i>N</i>-<i>tert</i>-Butoxycarbonylpiperidin-4-ylmethyl)-<i>N</i>-{<i>trans</i>-3-[(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclopentyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>9d</b>)</h3><div class="NLM_p last">The synthesis was as per general procedure A with alcohol <b>60</b> and sulfonamide <b>19d</b> on a 0.136 mmol scale. The crude residue was purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to afford <b>9d</b> (27 mg, 32%): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 1.00−1.13 (m, 2H, 2 CH (piperidinylmethyl)), 1.40−1.52 (s, 11H, C(CH<sub>3</sub>)<sub>3</sub>, CH (piperidinylmethyl), CH (cyclopentyl)), 1.56−1.65 (m, 1H, CH (cyclopentyl)), 1.70−1.84 (m, 3H, 2 CH (piperidinylmethyl), CH (cyclopentyl)), 1.87−2.01 (m, 2H, 2 CH (cyclopentyl)), 2.12−2.19 (m, 1H, CH (cyclopentyl)), 2.61−2.75 (m, 3H, 3 CH (piperidinylmethyl)), 3.02−3.11 (m, 1H, CH (piperidinylmethyl)), 3.67 (s, 3H, CH<sub>3</sub>(Im)), 3.68 (s, 3H, CH<sub>3</sub>(Im)), 4.04−4.19 (m, 2H, CHC<u class="uu">H</u><sub>2</sub>N (piperidinylmethyl)), 4.31−4.37 (m, 3H, C<u class="uu">H</u><sub>2</sub>Im, CHN (cyclopentyl)), 4.42 (m, 1H, CHN (cyclopentyl)), 6.62 (s, 1H, CH (Im)), 6.66 (d, <i>J</i> = 9.3 Hz, 2H, 2 CH (Ar)), 7.24 (s, 1H, CH (Im)), 7.25 (s, 1H, CH (Im)), 7.41 (d, <i>J</i> = 9.3 Hz, 2H, 2 CH (Ar)), 7.47 (s, 1H, CH (Im)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 28.4, 29.0, 29.8, 30.2, 31.4, 33.9, 34.1, 36.9, 41.1, 43.7 (br), 49.9, 56.2, 58.7, 79.7, 100.7, 113.2, 118.6, 119.5, 124.7, 132.4, 133.8, 136.0, 138.1, 139.2, 150.9, 154.9; HRMS (ES+) calcd for [C<sub>32</sub>H<sub>44</sub>N<sub>8</sub>O<sub>4</sub>S + H] 637.3284, found 637.3293; HPLC (I) <i>t</i><sub>R</sub> = 12.97 min (98.72%), (II) <i>t</i><sub>R</sub> = 20.52 min (99.01%).</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> (±)-[<i>N</i>-{<i>N</i>-(2-Pyrimidinyl)-piperidin-4-ylmethyl}-<i>N</i>-{<i>trans</i>-3-[(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclopentyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>9e</b>)</h3><div class="NLM_p last">The synthesis was as per general procedure A with alcohol <b>60</b> (0.203 mmol, 1 equiv) and sulfonamide <b>21</b> (1.5 equiv), with 2 equiv of PPh<sub>3</sub> and 1.5 equiv of DIAD. The crude residue was purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to furnish (±)-[<i>N</i>-<i>tert</i>-butoxycarbonyl-<i>N</i>-{2-<i>trans</i>-[(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclopentyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide as a white powder (90 mg, 83%): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 1.42 (s, 9H, C(CH<sub>3</sub>)<sub>3</sub>), 1.51−1.61 (m, 1H, CH (cyclopentyl)), 1.92−1.99 (m, 1H, CH (cyclopentyl)), 2.09−2.18 (m, 2H, 2 CH (cyclopentyl)), 2.20−2.28 (m, 1H, CH (cyclopentyl)), 2.43−2.49 (m, 1H, 1 CH (cyclopentyl)), 3.65 (s, 3H, CH<sub>3</sub>(Im)), 3.76 (s, 3H, CH<sub>3</sub>(Im)), 4.38 (AB quartet, <i>J</i> = 17.0 Hz, 2H, C<u class="uu">H</u><sub>2</sub>Im), 4.72 (m, 1H, CHN (cyclopentyl)), 5.03 (m, 1H, CHN (cyclopentyl)), 6.72−6.77 (m, 3H, CH (Im), 2 CH (Ar)), 7.41 (d, <i>J</i> = 9.0 Hz, 2H, 2 CH (Ar)), 7.45 (s, 1H, CH (Im)), 7.51 (s, 1H, CH (Im)), 7.52 (s, 1H, CH (Im)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 28.1, 30.0, 30.8, 31.6, 32.2, 34.0, 41.4, 56.4, 57.7, 84.3, 98.8, 113.3, 120.2, 125.0, 127.6, 128.0, 133.3, 138.5, 139.1, 140.1, 150.5, 152.2; HRMS (ES+) calcd for [C<sub>26</sub>H<sub>33</sub>N<sub>7</sub>O<sub>4</sub>S + H] 540.2393, found 540.2396. The material (85 mg, 0.158 mmol) was redissolved in a 1:1 mixture of CH<sub>2</sub>Cl<sub>2</sub>/TFA (5 mL). After the mixture was stirred for 3 h at room temperature, TLC indicated the reaction was complete, and so all solvent was removed in vacuo. The residue was dry-loaded onto silica gel and purified by flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 92:7:1) to give (±)-[<i>N</i>-{2-<i>trans</i>-[(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclopentyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide as a glassy film (68 mg, 99%): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 1.39−1.47 (m, 1H, CH (cyclopentyl)), 1.57−1.70 (m, 2H, 2 CH (cyclopentyl)), 1.90−2.06 (m, 3H, 3 CH (cyclopentyl)), 3.58 (s, 3H, CH<sub>3</sub>(Im)), 3.68 (s, 3H, CH<sub>3</sub>(Im)), 3.78 (m, 1H, C<u class="uu">H</u>NHSO<sub>2</sub>), 4.27 (s, 2H, C<u class="uu">H</u><sub>2</sub>Im), 4.40 (m, 1H, CHN (cyclopentyl)), 6.56 (s, 1H, CH (Im)), 6.61 (d, <i>J</i> = 9.0 Hz, 2H, 2 CH (Ar)), 7.20 (s, 1H, CH (Im)), 7.28 (d, <i>J</i> = 9.0 Hz, 2H, 2 CH (Ar)), 7.40 (s, 1H, CH (Im)), 7.43 (s, 1H, CH (Im)), 7.47 (s, 1H, CH (Im)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 27.9, 31.6, 32.7, 34.0, 35.7, 42.6, 53.0, 57.2, 98.6, 113.4, 120.2, 123.9, 127.6, 128.2, 133.2, 138.3, 139.0, 140.5, 151.9; HRMS (ES+) calcd for [C<sub>21</sub>H<sub>25</sub>N<sub>7</sub>O<sub>2</sub>S + H] 440.1869, found 440.1882. Finally, (±)-[<i>N</i>-{<i>trans</i>-3-[(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclopentyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (0.095 mmol) and <i>N</i>-(2-pyrimidinyl)-piperidin-4-ylmethyl iodide (1.5 equiv) were reacted together as per general procedure B in DMF (0.1 M), and the mixture was stirred for 3 days at room temperature. After the usual workup, the crude residue was purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 92:7:1) to yield the title compound <b>9e</b> (49 mg, 85%): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 1.08−1.19 (m, 2H, 2 CH (piperidinylmethyl)), 1.41−1.51 (m, 1H, 1 CH (cyclopentyl)), 1.57−1.65 (m, 1H, CH (cyclopentyl)), 1.69−1.93 (m, 3H, 2 CH (piperidinylmethyl), CH (cyclopentyl)), 1.97−2.02 (m, 1H, CH (cyclopentyl)), 2.04−2.15 (m, 2H, 2 CH (cyclopentyl)), 2.74 (dd, <i>J</i> = 14.8, 8.1 Hz, 1H, CH (piperidinylmethyl)), 2.80−2.87 (m, 2H, 2 CH (piperidinylmethyl)), 2.97 (dd, <i>J</i> = 14.5, 7.5 Hz, 1H, CH (piperidinylmethyl)), 3.08 (dd, <i>J</i> = 14.8, 6.8 Hz, 1H, CH (piperidinylmethyl)), 3.67 (s, 3H, CH<sub>3</sub>), 3.68 (s, 3H, CH<sub>3</sub>), 4.29−4.39 (m, 3H, CHN (cyclopentyl), C<u class="uu">H</u><sub>2</sub>Im), 4.45 (m, 1H, CHN (cyclopentyl)), 4.76−4.81 (m, 2H, CHC<u class="uu">H</u><sub>2</sub>N (piperidinylmethyl)), 6.43 (t, <i>J</i> = 4.8 Hz, 1H, CH (pyrimidine), 6.60 (s, 1H, CH (Im)), 6.65 (d, <i>J</i> = 9.0 Hz, 2H, 2 CH (Ar)), 7.26 (m, 2H, 2 CH (Im)), 7.38 (d, <i>J</i> = 8.9 Hz, 2H, 2 CH (Ar)), 7.41 (s, 1H, CH (Im)), 8.28 (d, <i>J</i> = 4.8 Hz, 2H, 2 CH (pyrimidine)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 26.6, 29.5, 29.9, 31.0, 31.7, 33.9, 37.4, 41.8, 43.8, 50.4, 57.7, 58.6, 99.2, 109.4, 113.3, 120.0, 123.8, 127.8, 128.3, 133.1, 138.4, 138.8, 139.8, 151.7, 157.8, 161.5; HRMS (ES+) calcd for [C<sub>31</sub>H<sub>38</sub>N<sub>10</sub>O<sub>2</sub>S + H] 615.2978, found 615.2959; HPLC (I) <i>t</i><sub>R</sub> = 12.59 min (100%), (II) <i>t</i><sub>R</sub> = 19.17 min (100%).</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> (±)-[<i>N</i>-Benzyl-<i>N</i>-{<i>cis</i>-4-[(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclohexyl}] 1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>10a</b>)</h3><div class="NLM_p last">The synthesis was as per general procedure C with <b>64a</b> on a 0.149 mmol scale. After workup, the crude residue was dry-loaded onto silica gel, then purified by flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to afford <b>10a</b> (52 mg, 65% (or 92% brsm)): δ<sub>H</sub> (400 MHz, CDCl<sub>3</sub>) 1.55−1.67 (m, 8H, 2 NCH<sub>2</sub>CH<sub>2</sub>N), 3.35 (s, 3H, CH<sub>3</sub>(Im)), 3.65 (m, 1H, CHN (cyclohexyl)), 3.73 (s, 3H, CH<sub>3</sub>(Im)), 3.77 (m, 1H, CHN (cyclopentyl)), 4.17 (s, 2H, C<u class="uu">H</u><sub>2</sub>Ph), 4.43 (s, 2H, C<u class="uu">H</u><sub>2</sub>Im), 6.58 (s, 1H, CH (Im)), 6.67 (d, <i>J</i> = 9.0 Hz, 2H, CH (Ar)), 7.23−7.44 (m, 10H, CH (Im), 5 CH (Ph), 2 CH (Ar), 2 CH (Im)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 27.0, 27.2, 31.1, 33.7, 42.3, 48.9, 52.1, 56.3, 94.9, 97.5, 101.0, 116.5, 119.5, 123.6, 126.9, 127.2, 128.0, 128.3, 132.9, 138.6, 138.7, 140.9, 151.6; HPLC (I) <i>t</i><sub>R</sub> = 12.59 min (96.06%), (II) <i>t</i><sub>R</sub> = 18.98 min (95.85%); HRMS (ES+) calcd for [C<sub>29</sub>H<sub>33</sub>N<sub>7</sub>O<sub>2</sub>S + H] 544.2507, found 544.2495.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> (±)-[<i>N</i>-(<i>N</i>-<i>tert</i>-Butoxycarbonylpiperidin-4-ylmethyl)-<i>N</i>-{<i>cis</i>-4-[(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclohexyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>10d</b>)</h3><div class="NLM_p last">The synthesis was as per general procedure C with <b>64d</b> on a 0.108 mmol scale. After workup, the crude residue was dry-loaded onto silica gel, then purified by flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to furnish <b>10d</b> (48 mg, 69% (or 94% brsm)): δ<sub>H</sub> (400 MHz, CDCl<sub>3</sub>) 0.94−1.03 (m, 2H, 2 CH (piperidinylmethyl)), 1.46 (s, 9H, C(CH<sub>3</sub>)<sub>3</sub>), 1.56−1.85 (m, 9H, 2 NCH<sub>2</sub>CH<sub>2</sub>N (cyclohexyl), CH (piperidinylmethyl)), 2.00−2.10 (m, 2H, 2 CH (piperidinylmethyl)), 2.58−2.70 (m, 2H, 2 CH (piperidinylmethyl)), 2.87−3.01 (m, 2H, 2 CH (piperidinylmethyl)), 3.49 (s, 3H, CH<sub>3</sub>Im), 3.63 (m, 1H, CHN (cyclohexyl)), 3.72 (s, 3H, CH<sub>3</sub>(Im)), 3.81 (m, 1 H, CHN (cyclohexyl)), 4.03−4.16 (m, 2H, 2 CH (piperidinylmethyl)), 4.48 (s, 2H, C<u class="uu">H</u><sub>2</sub>Im), 6.66 (s, 1H, CH (Im)), 6.78 (d, <i>J</i> = 9.0 Hz, 2H, 2 CH (Ar)), 7.32 (s, 1H, CH (Im)), 7.37 (s, 1H, CH (Im)), 7.39 (s, 1H, CH (Im)), 7.45 (d, <i>J</i> = 9.0 Hz, 2H, CH(Ar)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 27.9, 28.2, 28.7, 29.7, 30.3, 31.7, 34.2, 36.9, 43.6, 51.3, 52.1, 58.3, 79.6, 101.9, 117.5, 119.9, 124.0, 127.8, 129.0, 133.5, 138.6, 139.0, 141.5, 152.4, 155.0; HRMS (ES+) calcd for [C<sub>33</sub>H<sub>46</sub>N<sub>8</sub>O<sub>4</sub>S + H] 651.3420, found 651.3455; HPLC (I) <i>t</i><sub>R</sub> = 13.42 min (100%), (II) <i>t</i><sub>R</sub> = 21.42 min (100%).</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> (±)-[<i>N</i>-Benzyl-<i>N</i>-{<i>trans</i>-4-[(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclohexyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>11a</b>)</h3><div class="NLM_p last">Compound <b>66</b> was benzylated on the sulfonamide NH as per general procedure B on a 0.139 mmol scale with benzyl bromide. The sample was purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 292:7:1 1:2) to furnish (±)-[<i>N</i>-benzyl-<i>N</i>-{<i>trans</i>-4-(4-cyanophenylamino)cyclohexyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide as a colorless film (61 mg, 98%): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 1.17 (qd, <i>J</i> = 12.5, 3.0 Hz, 2H, 2 CH (cyclohexyl)), 1.41 (qd, <i>J</i> = 12.5, 3.0 Hz, 2H, 2 CH (cyclohexyl)), 1.76−1.82 (m, 2H, 2 CH (cyclohexyl)), 1.96−2.02 (m, 2H, 2 CH (cyclohexyl)), 3.02 (tt, <i>J</i> = 11.0, 3.5 Hz, 1H, CHNSO<sub>2</sub>), 3.69 (s, 3H, CH<sub>3</sub>(Im)), 3.91 (tt, <i>J</i> = 12.5 Hz, 3.5 Hz, 1H, C<u class="uu">H</u>NHAr), 4.43 (s, 2H, C<u class="uu">H</u><sub>2</sub>Ph), 6.42 (d, <i>J</i> = 8.0 Hz, 2H, 2 CH (Ar)), 7.21−7.32 (m, 5H, 5 CH (Ph)), 7.33 (s, 1H, CH (Im)), 7.39 (d, <i>J</i> = 8.0 Hz, 2H, 2 CH (Ar)), 7.44 (s, 1H, CH (Im)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 30.0, 32.2, 33.9, 47.8, 50.6, 57.7, 98.3, 112.4, 120.4, 123.8, 127.2, 127.5, 128.3, 133.5, 138.8, 138.9, 141.2, 150.2; HRMS (ES+) calcd for [C<sub>24</sub>H<sub>27</sub>N<sub>5</sub>O<sub>2</sub>S + H] 450.1964, found 450.1972. The secondary aniline NH was then alkylated with imidazole <b>15</b> as per general procedure C on a 0.107 mmol scale, but the mixture was allowed to stir for 12 h, with the temperature gradually warming from 0 °C to room temperature, after which time the reaction appeared to have stalled. After usual workup, the crude residue was purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to give the title compound <b>11a</b> (38 mg, 65% (or 97% brsm)): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 1.41−1.53 (m, 4H, 4 CH (cyclohexyl)), 1.80−1.86 (m, 4H, 4 CH (cyclohexyl)), 3.55 (m, 1H, CHNSO<sub>2</sub>), 3.61 (s, 3H, CH<sub>3</sub>(Im)), 3.71 (s, 3H, CH<sub>3</sub>(Im)), 3.95 (m, 1H, C<u class="uu">H</u>NAr), 4.29 (s, 2H, C<u class="uu">H</u><sub>2</sub>Im), 4.42 (s, 2H, C<u class="uu">H</u><sub>2</sub>Ph), 6.59 (d, <i>J</i> = 9.5 Hz, 2H, 2 CH (Ar)), 6.62 (br s, 1H, CH (Im)), 7.24−7.44 (m, 10H, 5 CH (Ph), 2 CH (Ar), 3 CH (Im)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 29.1, 30.4, 31.6, 33.9, 40.7, 47.6, 56.3, 57.5, 98.9, 112.9, 120.1, 123.7, 127.3, 127.4, 128.1, 127.9, 128.3, 133.4, 138.2, 138.6, 138.8, 141.2, 151.2; HRMS (ES+) calcd for [C<sub>29</sub>H<sub>33</sub>N<sub>7</sub>O<sub>2</sub>S + H] 544.2495, found 544.2502; HPLC (I) <i>t</i><sub>R</sub> = 11.97 (100%), (II) <i>t</i><sub>R</sub> = 17.04 (99.37%).</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> (±)-[<i>N</i>-(<i>N</i>-<i>tert</i>-Butoxycarbonylpiperidin-4-ylmethyl)-<i>N</i>-{<i>trans</i>-4-[(4-cyanophenyl)(3-methyl-3<i>H</i>-imidazol-4-ylmethyl)amino]cyclohexyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide (<b>11d</b>)</h3><div class="NLM_p last">Compound <b>66</b> was alkylated on the sulfonamide NH as per general procedure B on a 0.139 mmol scale and with <i>N</i>-<i>tert</i>-butoxycarbonyl-4-bromomethylpiperidine in DMF (0.1 M). After 4 days, the reaction was worked up, then purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 292:7:1) to furnish the (±)-[<i>N</i>-(<i>N</i>-<i>tert</i>-butoxycarbonylpiperidin-4-ylmethyl)-<i>N</i>-{4-(4-<i>trans</i>-cyanophenylamino)cyclohexyl}]-1-methyl-1<i>H</i>-imidazole-4-sulfonamide as a colorless film (77 mg, 100%): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 1.07 (qd, <i>J</i> = 12.3, 4.3 Hz, 2H, 2 CH (piperidinylmethyl)), 1.25 (qd, <i>J</i> = 12.3, 3.0 Hz, 2H, 2 CH (cyclohexyl)), 1.44 (s, 9H, C(CH<sub>3</sub>)<sub>3</sub>), 1.56 (qd, <i>J</i> = 12.2, 3.0 Hz, 2H, 2 CH (cyclohexyl)), 1.72−1.79 (m, 2H, 2 CH (cyclohexyl)), 1.81−1.92 (m, 3H, 3 CH (piperidinylmethyl)), 2.07−2.13 (m, 2H, 2 CH (cyclohexyl)), 2.61−2.71 (m, 2H, 2 CH (piperidinylmethyl)), 3.01−3.08 (m, 2H, 2 CH (piperidinylmethyl), 3.18 (tt, <i>J</i> = 11.5, 3.5 Hz, 1H, CHNSO<sub>2</sub>), 3.73 (s, 3H, CH<sub>3</sub>(Im)), 3.77 (qd, <i>J</i> = 12.0, 3.5 Hz, 1H, C<u class="uu">H</u>NH), 4.06−4.15 (m, 2H, 2 CH (piperidinylmethyl)), 6.50 (d, <i>J</i> = 8.8 Hz, 2H, 2 CH (Ar)), 7.36 (d, <i>J</i> = 8.8 Hz, 2H, 2 CH (Ar)), 7.39 (s, 1H, CH (Im)), 7.44 (s, 1H, CH (Im)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 28.4, 30.0, 30.2, 32.2, 33.9, 36.9, 43.4 (br), 50.2, 50.7, 57.7, 78.6, 98.3, 112.4, 120.4, 123.6, 134.6, 139.8, 141.0, 150.2, 154.7; HRMS (ES+) calcd for [C<sub>28</sub>H<sub>40</sub>N<sub>6</sub>O<sub>4</sub>S + H] 557.2910, found 557.2931. The secondary aniline NH was then alkylated with imidazole <b>15</b> as per general procedure C on a 0.0937 mmol scale, but the mixture was allowed to stir for 12 h, with the temperature gradually warming from 0 °C to room temperature. After usual workup, the crude residue was purified by silica gel flash column chromatography (eluent CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 192:7:1) to furnish the target molecule <b>11d</b> (37 mg, 61% (or 95% brsm)): δ<sub>H</sub> (500 MHz, CDCl<sub>3</sub>) 1.07 (qd, <i>J</i> = 12.3, 4.3 Hz, 2H, 2 CH (piperidinylmethyl)), 1.44 (s, 9H, C(CH<sub>3</sub>)<sub>3</sub>), 1.51−1.61 (m, 4H, 4 CH (cyclohexyl)), 1.72−1.80 (m, 2H, 2 CH (cyclohexyl)), 1.82−1.95 (m, 5H, 3 CH (piperidinylmethyl), 2 CH (cyclohexyl)), 2.60−2.71 (m, 2H, 2 CH (piperidinylmethyl)), 2.97−3.03 (m, 2H, 2 CH (piperidinylmethyl)), 3.63 (s, 3H, CH<sub>3</sub>(Im)), 3.68 (m, 1H, CHNSO<sub>2</sub>), 3.72 (s, 3H, CH<sub>3</sub>(Im)), 3.80 (m, 1H, C<u class="uu">H</u>NAr), 4.05−4.17 (m, 2H, 2 CH (piperidinylmethyl)), 4.36 (s, 2H, C<u class="uu">H</u><sub>2</sub>Im), 6.63−6.69 (m, 3H, 2 CH (Ar), CH (Im)), 7.37 (s, 1H, Im), 7.40 (d, <i>J</i> = 9.0 Hz, 2H, 2 CH (Ar)), 7.42 (s, 1H, CH (Im)), 7.45 (br s, 1H, CH (Im)); δ<sub>C</sub> (125 MHz, CDCl<sub>3</sub>) 28.2, 29.1, 30.0, 30.5 (br), 31.8, 33.9, 36.8, 40.8, 43.4 (br), 50.0, 56.4, 57.5, 79.5, 99.1, 113.0, 120.1, 123.5, 127.9, 128.2, 133.5, 138.3, 138.9, 140.9, 151.2, 154.7; HRMS (ES+) calcd for [C<sub>33</sub>H<sub>46</sub>N<sub>8</sub>O<sub>4</sub>S + H] 651.3441, found 651.3446; HPLC (I) <i>t</i><sub>R</sub> = 13.18 (100%), (II) <i>t</i><sub>R</sub> = 20.66 (99.92%).</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> Biological Assays</h3><div id="sec4_45_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> Plasmodium Strains</h4><div class="NLM_p last">The <i>P. falciparum</i> strains used in this study were 3D7 (The Netherlands, [airport-associated malaria], chloroquine-sensitive) provided by Dr. Pradipsinh Rathod from the University of Washington and K1 (Thailand, chloroquine-resistant, pyrimethamine-resistant) obtained from the MR4 Unit of the American Type Culture Collection (ATCC, Manassas, VA).</div></div><div id="sec4_45_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> <i>P. falciparum</i> Culture</h4><div class="NLM_p last">Strains of <i>P. falciparum</i> were sustained in vitro on the basis of experimental techniques as described by Trager and Jensen.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Cultures were maintained in RPMI-1640 (Sigma, St. Louis, MO) with 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, 25 mM HEPES, 33 mM NaHCO<sub>3</sub>, 20 μg/mL gentamicin sulfate, and 20% (v/v) heat-inactivated human plasma type A+ (RP-20P). Type A+ erythrocytes were obtained from laboratory donors, washed three times with RPMI, resuspended in 50% RPMI, and stored at 4 °C. Parasites were grown in 10 mL of a 2% hematocrit/RP-20P (v/v) in 50 mL flasks under a 5% CO<sub>2</sub>, 5% O<sub>2</sub>, and 90% N<sub>2</sub> atmosphere.</div></div><div id="sec4_45_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> <i>P. falciparum</i> ED<sub>50</sub> Determination</h4><div class="NLM_p last">An amount of 1 μL of <i>P</i>. <i>falciparum</i> PFT inhibitor (<i>Pf</i>PFTI) dissolved in DMSO was added to each well of a 96-well plate followed by the addition of 200 μL of <i>P. falciparum</i> culture at parasitemia and hematocrit of 0.5%. Plates were flushed with 5% CO<sub>2</sub>, 5% O<sub>2</sub>, and 90% N<sub>2</sub> and then incubated at 37 °C for 48 h. [8-<sup>3</sup>H]Hypoxanthine (0.3 μCi, 20 Ci/mmol, American Radiolabeled Chemicals) in 30 μL of RP-20P was added to cultures and incubated for an additional 24 h. Cells were harvested onto filter mats by a Multiharvester (Skatron, Sunnyvale, CA), and the radioactivity incorporated into the parasites was counted on a β-scintillation counter. The background level detected with uninfected erythrocytes was subtracted from the data. The <sup>3</sup>H<i>-</i>incorporation into infected RBCs with 1 μL of DMSO vehicle alone represents 100% malaria growth. ED<sub>50</sub> values were determined by linear regression analysis of the plots of <sup>3</sup>H<i>-</i>hypoxanthine incorporation versus concentration of compound.</div></div><div id="sec4_45_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> PfPFT and Rat PFT IC<sub>50</sub> Determination</h4><div class="NLM_p last">The PFT assay used to determine the IC<sub>50</sub> values (inhibitor concentration that causes 50% enzyme inhibition) of the compounds is based on a PFT [<sup>3</sup>H] scintillation proximity assay (SPA) (TRKQ7010 Amersham Biosciences Corp., Piscataway, NJ). Assays were carried out in assay buffer (pH 7.5, 50 mM HEPES, 30 mM MgCl<sub>2</sub>, 20 mM KCl, 5 mM DTT, 0.01% Triton X-100), 1 μm human lamin-B carboxy-terminus sequence peptide (biotin-YRASNRSCAIM), and 1 μCi [<sup>3</sup>H]farnesylpyrophosphate (Amersham specific activity 15−20 Ci/mM) in a total volume of 50 μL which included 1 μL of <i>Pf</i>PFT inhibitor solution in DMSO and 5 μL of partially purified <i>Pf</i>PFT.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Assays in the absence of <i>Pf</i>PFT inhibitor and <i>Pf</i>PFT were included as positive and negative controls, respectively. Reaction mixtures were incubated at 37 °C for 60 min and terminated by addition of 70 μL of assay STOP solution and 5 μL of SPA beads. The assay mixture was incubated at room temperature for 30 min. The assay was counted on a plate Chameleon 425-104 multilabel counter (Hidex Oy Turku, Finland). IC<sub>50</sub> values were calculated using linear regression analysis of the plots of the amount of radioprenylation versus the concentration of compound. For ratPFT IC<sub>50</sub> determination, 0.01 μm human lamin-B carboxy-terminus sequence peptide (biotin-YRASNRSCAIM) was used. The assay was incubated at 37 °C for 15 min; otherwise, experimental conditions were the same as for <i>Pf</i>PFT IC<sub>50</sub> determination.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i90"><a href="/doi/suppl/10.1021/jm800113p">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82661" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82661" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">GOLD low energy docked pictures of compounds <b>2a</b>−<b>5a</b>, <b>7a</b>, <b>8a</b>, <b>10a</b>, and <b>11a</b>, experimental procedures and full characterizations of compounds <b>14</b>−<b>64d</b>, and HPLC traces of two independent conditions for all target molecules (<b>2a</b>−<b>9e</b>, <b>10a</b>, <b>10d</b>, <b>11a</b>, <b>11d</b>). This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm800113p/suppl_file/jm800113p-file002.pdf">jm800113p-file002.pdf (3.72 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm800113p" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38143" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38143" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew D. Hamilton</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Yale University, 225 Prospect Street, New Haven, Connecticut 06511, Department of Medicine and Department of Chemistry and Biochemistry, University of Washington, Seattle, Washington 98195, Department of Molecular Biology and Microbiology, University of Central Florida, Orlando, Florida 32826, and Department of Oncology and Department of Biochemistry and Molecular Biology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida 33612</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ea8b848e988f9dc4828b8783869e8584aa938b868fc48f8e9f"><span class="__cf_email__" data-cfemail="94f5faf0e6f1e3bafcf5f9fdf8e0fbfad4edf5f8f1baf1f0e1">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven Fletcher</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Yale University, 225 Prospect Street, New Haven, Connecticut 06511, Department of Medicine and Department of Chemistry and Biochemistry, University of Washington, Seattle, Washington 98195, Department of Molecular Biology and Microbiology, University of Central Florida, Orlando, Florida 32826, and Department of Oncology and Department of Biochemistry and Molecular Biology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida 33612</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher G. Cummings</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Yale University, 225 Prospect Street, New Haven, Connecticut 06511, Department of Medicine and Department of Chemistry and Biochemistry, University of Washington, Seattle, Washington 98195, Department of Molecular Biology and Microbiology, University of Central Florida, Orlando, Florida 32826, and Department of Oncology and Department of Biochemistry and Molecular Biology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida 33612</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kasey Rivas</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Yale University, 225 Prospect Street, New Haven, Connecticut 06511, Department of Medicine and Department of Chemistry and Biochemistry, University of Washington, Seattle, Washington 98195, Department of Molecular Biology and Microbiology, University of Central Florida, Orlando, Florida 32826, and Department of Oncology and Department of Biochemistry and Molecular Biology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida 33612</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William P. Katt</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Yale University, 225 Prospect Street, New Haven, Connecticut 06511, Department of Medicine and Department of Chemistry and Biochemistry, University of Washington, Seattle, Washington 98195, Department of Molecular Biology and Microbiology, University of Central Florida, Orlando, Florida 32826, and Department of Oncology and Department of Biochemistry and Molecular Biology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida 33612</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carrie Hornéy</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Yale University, 225 Prospect Street, New Haven, Connecticut 06511, Department of Medicine and Department of Chemistry and Biochemistry, University of Washington, Seattle, Washington 98195, Department of Molecular Biology and Microbiology, University of Central Florida, Orlando, Florida 32826, and Department of Oncology and Department of Biochemistry and Molecular Biology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida 33612</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frederick S. Buckner</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Yale University, 225 Prospect Street, New Haven, Connecticut 06511, Department of Medicine and Department of Chemistry and Biochemistry, University of Washington, Seattle, Washington 98195, Department of Molecular Biology and Microbiology, University of Central Florida, Orlando, Florida 32826, and Department of Oncology and Department of Biochemistry and Molecular Biology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida 33612</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Debopam Chakrabarti</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Yale University, 225 Prospect Street, New Haven, Connecticut 06511, Department of Medicine and Department of Chemistry and Biochemistry, University of Washington, Seattle, Washington 98195, Department of Molecular Biology and Microbiology, University of Central Florida, Orlando, Florida 32826, and Department of Oncology and Department of Biochemistry and Molecular Biology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida 33612</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Saïd M. Sebti</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Yale University, 225 Prospect Street, New Haven, Connecticut 06511, Department of Medicine and Department of Chemistry and Biochemistry, University of Washington, Seattle, Washington 98195, Department of Molecular Biology and Microbiology, University of Central Florida, Orlando, Florida 32826, and Department of Oncology and Department of Biochemistry and Molecular Biology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida 33612</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael H. Gelb</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Yale University, 225 Prospect Street, New Haven, Connecticut 06511, Department of Medicine and Department of Chemistry and Biochemistry, University of Washington, Seattle, Washington 98195, Department of Molecular Biology and Microbiology, University of Central Florida, Orlando, Florida 32826, and Department of Oncology and Department of Biochemistry and Molecular Biology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida 33612</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wesley C. Van Voorhis</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Yale University, 225 Prospect Street, New Haven, Connecticut 06511, Department of Medicine and Department of Chemistry and Biochemistry, University of Washington, Seattle, Washington 98195, Department of Molecular Biology and Microbiology, University of Central Florida, Orlando, Florida 32826, and Department of Oncology and Department of Biochemistry and Molecular Biology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida 33612</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i89">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24103" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24103" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Financial support for this work was provided by the Medicines for Malaria Venture (MMV) and the National Institutes of Health (Grants CA67771 and AI54384). We thank David Floyd, Lou Lombardo, and David Williams from Bristol-Myers Squibb for helpful suggestions.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i91">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70831" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70831" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 38 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Sachs, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malaney, P.</span><span> </span><span class="NLM_article-title">The economic and social burden of malaria</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">415</span><span class="NLM_x">, </span> <span class="NLM_fpage">680</span><span class="NLM_x">–</span> <span class="NLM_lpage">685</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm800113p&amp;key=10.1038%2F415680a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm800113p&amp;key=11832956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm800113p&amp;key=1%3ACAS%3A528%3ADC%252BD38XhsVCjtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=415&publication_year=2002&pages=680-685&author=J.+Sachsauthor=P.+Malaney&title=The+economic+and+social+burden+of+malaria"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The economic and social burden of malaria</span></div><div class="casAuthors">Sachs, Jeffrey; Malaney, Pia</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">415</span>
        (<span class="NLM_cas:issue">6872</span>),
    <span class="NLM_cas:pages">680-685</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Where malaria prospers most, human societies have prospered least.  The global distribution of per-capita gross domestic product shows a striking correlation between malaria and poverty, and malaria-endemic countries also have lower rates of economic growth.  There are multiple channels by which malaria impedes development, including effects on fertility, population growth, saving and investment, worker productivity, absenteeism, premature mortality and medical costs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJw0oyArOfc7Vg90H21EOLACvtfcHk0lhHyk6iWzYSJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhsVCjtrY%253D&md5=0c755731170660d29535bc48425b494e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2F415680a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F415680a%26sid%3Dliteratum%253Aachs%26aulast%3DSachs%26aufirst%3DJ.%26aulast%3DMalaney%26aufirst%3DP.%26atitle%3DThe%2520economic%2520and%2520social%2520burden%2520of%2520malaria%26jtitle%3DNature%26date%3D2002%26volume%3D415%26spage%3D680%26epage%3D685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><a href="http://www.mmv.org" class="extLink">www.mmv.org</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=www.mmv.org."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Snow, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trape, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K.</span><span> </span><span class="NLM_article-title">The past, present and future of childhood malaria mortality in Africa</span> <span class="citation_source-journal">Trends Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">593</span><span class="NLM_x">–</span> <span class="NLM_lpage">597</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm800113p&amp;key=10.1016%2FS1471-4922%2801%2902031-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm800113p&amp;key=11756044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm800113p&amp;key=1%3ACAS%3A280%3ADC%252BD38%252Fjs1OmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2001&pages=593-597&author=R.+W.+Snowauthor=J.+F.+Trapeauthor=K.+Marsh&title=The+past%2C+present+and+future+of+childhood+malaria+mortality+in+Africa"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The past, present and future of childhood malaria mortality in Africa</span></div><div class="casAuthors">Snow R W; Trape J F; Marsh K</div><div class="citationInfo"><span class="NLM_cas:title">Trends in parasitology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">593-7</span>
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    </div><div class="casAbstract">During the past few years, there has been a historic series of declarations of renewed commitment to malaria control in Africa.  Whether the burden of malaria is increasing in Africa is a moot point.  This article attempts to re-construct the evidence for the trends in childhood mortality as a result of Plasmodium falciparum infection over the last century in Africa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS4Qd7nIUDExhjv2lLSLOxFfW6udTcc2ebJYof8XZs017ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38%252Fjs1OmtA%253D%253D&md5=dafa1e94d9454a0acc3057b88e5f9efb</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS1471-4922%2801%2902031-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1471-4922%252801%252902031-1%26sid%3Dliteratum%253Aachs%26aulast%3DSnow%26aufirst%3DR.%2BW.%26aulast%3DTrape%26aufirst%3DJ.%2BF.%26aulast%3DMarsh%26aufirst%3DK.%26atitle%3DThe%2520past%252C%2520present%2520and%2520future%2520of%2520childhood%2520malaria%2520mortality%2520in%2520Africa%26jtitle%3DTrends%2520Parasitol.%26date%3D2001%26volume%3D17%26spage%3D593%26epage%3D597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Olliaro, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloland, P. B.</span><span> </span><span class="NLM_article-title">Clinical and public health implications of antimalarial drug resistance</span> <span class="citation_source-journal">Antimalar. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm800113p&amp;key=10.1385%2F1-59259-111-6%3A65" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=65-83&author=P.+L.+Olliaroauthor=P.+B.+Bloland&title=Clinical+and+public+health+implications+of+antimalarial+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1385%2F1-59259-111-6%3A65&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252F1-59259-111-6%253A65%26sid%3Dliteratum%253Aachs%26aulast%3DOlliaro%26aufirst%3DP.%2BL.%26aulast%3DBloland%26aufirst%3DP.%2BB.%26atitle%3DClinical%2520and%2520public%2520health%2520implications%2520of%2520antimalarial%2520drug%2520resistance%26jtitle%3DAntimalar.%2520Chemother.%26date%3D2001%26spage%3D65%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Wiesner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jomaa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlitzer, M.</span><span> </span><span class="NLM_article-title">New antimalarial drugs</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5274</span><span class="NLM_x">–</span> <span class="NLM_lpage">5293</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=5274-5293&author=J.+Wiesnerauthor=R.+Ortmannauthor=H.+Jomaaauthor=M.+Schlitzer&title=New+antimalarial+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWiesner%26aufirst%3DJ.%26aulast%3DOrtmann%26aufirst%3DR.%26aulast%3DJomaa%26aufirst%3DH.%26aulast%3DSchlitzer%26aufirst%3DM.%26atitle%3DNew%2520antimalarial%2520drugs%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D5274%26epage%3D5293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">May, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, C. G.</span><span> </span><span class="NLM_article-title">Chemoresistance in falciparum malaria</span> <span class="citation_source-journal">Trends Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">432</span><span class="NLM_x">–</span> <span class="NLM_lpage">435</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm800113p&amp;key=10.1016%2Fj.pt.2003.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm800113p&amp;key=14519577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm800113p&amp;key=1%3ACAS%3A528%3ADC%252BD3sXns1Kmtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2003&pages=432-435&author=J.+Mayauthor=C.+G.+Meyer&title=Chemoresistance+in+falciparum+malaria"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoresistance in falciparum malaria</span></div><div class="casAuthors">May, Jurgen; Meyer, Christian G.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Parasitology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">432-435</span>CODEN:
                <span class="NLM_cas:coden">TPRACT</span>;
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Tropical countries increasingly face the burden of drug resistance in Plasmodium falciparum infections.  Malaria-related mortality of African children rises in contrast to the decline of the overall mortality of children under five years of age in sub-Saharan Africa within the past four decades.  The disaster can largely be attributed to antimalarial drug resistance in most malaria-endemic countries.  The principles and mechanisms of chemoresistance in Plasmodium falciparum infections, in addn. to the development and evaluation of new drugs and drug combinations, are major concerns of current malaria research and control strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWU6fqwkUYzrVg90H21EOLACvtfcHk0libRBFO7mhlTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXns1Kmtbc%253D&md5=489d889d4b6005107d52853be32b5187</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2003.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2003.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DJ.%26aulast%3DMeyer%26aufirst%3DC.%2BG.%26atitle%3DChemoresistance%2520in%2520falciparum%2520malaria%26jtitle%3DTrends%2520Parasitol.%26date%3D2003%26volume%3D19%26spage%3D432%26epage%3D435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Ridley, R. G.</span><span> </span><span class="NLM_article-title">Medical need, scientific opportunity and the drive for antimalarial drugs</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">415</span><span class="NLM_x">, </span> <span class="NLM_fpage">686</span><span class="NLM_x">–</span> <span class="NLM_lpage">693</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm800113p&amp;key=10.1038%2F415686a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm800113p&amp;key=11832957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm800113p&amp;key=1%3ACAS%3A528%3ADC%252BD38XhsVCjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=415&publication_year=2002&pages=686-693&author=R.+G.+Ridley&title=Medical+need%2C+scientific+opportunity+and+the+drive+for+antimalarial+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Medical need, scientific opportunity and the drive for antimalarial drugs</span></div><div class="casAuthors">Ridley, Robert G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">415</span>
        (<span class="NLM_cas:issue">6872</span>),
    <span class="NLM_cas:pages">686-693</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Continued and sustainable improvements in antimalarial medicines through focused research and development are essential for the world's future ability to treat and control malaria.  Unfortunately, malaria is a disease of poverty, and despite a wealth of scientific knowledge there is insufficient market incentive to generate the competitive, business-driven industrial antimalarial drug research and development that is normally needed to deliver new products.  Mechanisms of partnering with industry have been established to overcome this obstacle and to open up and build on scientific opportunities for improved chemotherapy in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5CP8Iq1Vig7Vg90H21EOLACvtfcHk0libRBFO7mhlTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhsVCjtrc%253D&md5=49bc148f43f8cd433d585b2e28e5a739</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F415686a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F415686a%26sid%3Dliteratum%253Aachs%26aulast%3DRidley%26aufirst%3DR.%2BG.%26atitle%3DMedical%2520need%252C%2520scientific%2520opportunity%2520and%2520the%2520drive%2520for%2520antimalarial%2520drugs%26jtitle%3DNature%26date%3D2002%26volume%3D415%26spage%3D686%26epage%3D693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Greenwood, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutabingwa, T.</span><span> </span><span class="NLM_article-title">Malaria in 2002</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">415</span><span class="NLM_x">, </span> <span class="NLM_fpage">670</span><span class="NLM_x">–</span> <span class="NLM_lpage">672</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=415&publication_year=2002&pages=670-672&author=B.+Greenwoodauthor=T.+Mutabingwa&title=Malaria+in+2002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGreenwood%26aufirst%3DB.%26aulast%3DMutabingwa%26aufirst%3DT.%26atitle%3DMalaria%2520in%25202002%26jtitle%3DNature%26date%3D2002%26volume%3D415%26spage%3D670%26epage%3D672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Chakrabarti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azam, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DelVecchio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, Y.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, C. M.</span><span> </span><span class="NLM_article-title">Protein prenyl transferase activities of <i>Plasmodium falciparum</i></span> <span class="citation_source-journal">Mol. Biochem. Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm800113p&amp;key=10.1016%2FS0166-6851%2898%2900065-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm800113p&amp;key=9747968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm800113p&amp;key=1%3ACAS%3A528%3ADyaK1cXkvFOlu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1998&pages=175-184&author=D.+Chakrabartiauthor=T.+Azamauthor=C.+DelVecchioauthor=L.+Qiuauthor=Y.-I.+Parkauthor=C.+M.+Allen&title=Protein+prenyl+transferase+activities+of+Plasmodium+falciparum"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Protein prenyl transferase activities of Plasmodium falciparum</span></div><div class="casAuthors">Chakrabarti, Debopam; Azam, Tania; DelVecchio, Cherie; Qiu, Libo; Park, Yong-il; Allen, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Biochemical Parasitology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">175-184</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Prenylated proteins have been shown to function in important cellular regulatory processes, including signal transduction.  The enzymes involved in protein prenylation, farnesyl transferase and geranylgeranyl transferase, have been recent targets for development of cancer chemotherapeutics.  We have initiated a systematic study of protein prenyl transferases of the malaria parasite, Plasmodium falciparum, to det. whether these enzymes can be developed as targets for antimalarial chemotherapy.  We report here the identification of protein farnesyl transferase and protein geranylgeranyl transferase-I in the malaria parasite, P. falciparum.  The farnesyl transferase has been partially purified from the cytosolic fraction through ammonium sulfate pptn. and Mono-Q chromatog.  Farnesyl and geranylgeranyl transferase-I activities are present at all stages of P. falciparum intraerythrocytic development with max. specific activity in the ring stage.  Geranylgeranyl transferase-I specific activity is two times that of farnesyl transferase in the ring stage.  Peptidomimetics and prenyl analogs of protein farnesyl transferase substrates were tested as in vitro inhibitors of partially purified P. falciparum prenyl transferase and of malaria parasite growth.  The peptidomimetics were significantly more potent inhibitors than lipid substrate analogs of both the activity of Mono-Q purified enzyme and parasite growth in intraerythrocytic cultures.  Exposure of the parasite to the peptidomimetic L-745,631 also showed significant inhibition of morphol. development beyond the trophozoite stage.  These studies suggest the potential of designing or identifying differential inhibitors of P. falciparum and mammalian prenyl transferases as an approach to novel malaria therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNLhRGJJLEGLVg90H21EOLACvtfcHk0lhONCcMfdQZjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvFOlu7o%253D&md5=a68f47f1f5b51cc77c6fb85eb997ccb3</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0166-6851%2898%2900065-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-6851%252898%252900065-6%26sid%3Dliteratum%253Aachs%26aulast%3DChakrabarti%26aufirst%3DD.%26aulast%3DAzam%26aufirst%3DT.%26aulast%3DDelVecchio%26aufirst%3DC.%26aulast%3DQiu%26aufirst%3DL.%26aulast%3DPark%26aufirst%3DY.-I.%26aulast%3DAllen%26aufirst%3DC.%2BM.%26atitle%3DProtein%2520prenyl%2520transferase%2520activities%2520of%2520Plasmodium%2520falciparum%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D1998%26volume%3D94%26spage%3D175%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nallan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bendale, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornéy, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pendyala, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windsor, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrabarti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Voorhis, W. C.</span><span> </span><span class="NLM_article-title">Protein farnesyltransferase inhibitors exhibit potent antimalarial activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3704</span><span class="NLM_x">–</span> <span class="NLM_lpage">3713</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0491039" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3704-3713&author=L.+Nallanauthor=K.+D.+Bauerauthor=P.+Bendaleauthor=K.+Rivasauthor=K.+Yokoyamaauthor=C.+P.+Horn%C3%A9yauthor=P.+R.+Pendyalaauthor=D.+Floydauthor=L.+J.+Lombardoauthor=D.+F.+Williamsauthor=A.+Hamiltonauthor=S.+Sebtiauthor=W.+T.+Windsorauthor=P.+C.+Weberauthor=F.+S.+Bucknerauthor=D.+Chakrabartiauthor=M.+H.+Gelbauthor=W.+C.+van+Voorhis&title=Protein+farnesyltransferase+inhibitors+exhibit+potent+antimalarial+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1021%2Fjm0491039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0491039%26sid%3Dliteratum%253Aachs%26aulast%3DNallan%26aufirst%3DL.%26aulast%3DBauer%26aufirst%3DK.%2BD.%26aulast%3DBendale%26aufirst%3DP.%26aulast%3DRivas%26aufirst%3DK.%26aulast%3DYokoyama%26aufirst%3DK.%26aulast%3DHorn%25C3%25A9y%26aufirst%3DC.%2BP.%26aulast%3DPendyala%26aufirst%3DP.%2BR.%26aulast%3DFloyd%26aufirst%3DD.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DWilliams%26aufirst%3DD.%2BF.%26aulast%3DHamilton%26aufirst%3DA.%26aulast%3DSebti%26aufirst%3DS.%26aulast%3DWindsor%26aufirst%3DW.%2BT.%26aulast%3DWeber%26aufirst%3DP.%2BC.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DChakrabarti%26aufirst%3DD.%26aulast%3DGelb%26aufirst%3DM.%2BH.%26aulast%3Dvan%2BVoorhis%26aufirst%3DW.%2BC.%26atitle%3DProtein%2520farnesyltransferase%2520inhibitors%2520exhibit%2520potent%2520antimalarial%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3704%26epage%3D3713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bendale, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olepu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suryadevara, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulbule, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nallan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smart, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ankala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pendyala, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrabarti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verlinde, C. L. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Voorhis, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gel</span><span class="NLM_x">; </span><span class="NLM_contrib-group">M. H</span><span> </span><span class="NLM_article-title">Second generation tetrahydroquinoline-based protein farnesyltransferase inhibitors as antimalarials</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4585</span><span class="NLM_x">–</span> <span class="NLM_lpage">4605</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0703340" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4585-4605&author=P.+Bendaleauthor=S.+Olepuauthor=P.+K.+Suryadevaraauthor=V.+Bulbuleauthor=K.+Rivasauthor=L.+Nallanauthor=B.+Smartauthor=K.+Yokoyamaauthor=S.+Ankalaauthor=P.+R.+Pendyalaauthor=D.+Floydauthor=L.+J.+Lombardoauthor=D.+K.+Williamsauthor=F.+S.+Bucknerauthor=D.+Chakrabartiauthor=C.+L.+M.+J.+Verlindeauthor=W.+C.+van+Voorhisauthor=+Gelauthor=+M.+H&title=Second+generation+tetrahydroquinoline-based+protein+farnesyltransferase+inhibitors+as+antimalarials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1021%2Fjm0703340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0703340%26sid%3Dliteratum%253Aachs%26aulast%3DBendale%26aufirst%3DP.%26aulast%3DOlepu%26aufirst%3DS.%26aulast%3DSuryadevara%26aufirst%3DP.%2BK.%26aulast%3DBulbule%26aufirst%3DV.%26aulast%3DRivas%26aufirst%3DK.%26aulast%3DNallan%26aufirst%3DL.%26aulast%3DSmart%26aufirst%3DB.%26aulast%3DYokoyama%26aufirst%3DK.%26aulast%3DAnkala%26aufirst%3DS.%26aulast%3DPendyala%26aufirst%3DP.%2BR.%26aulast%3DFloyd%26aufirst%3DD.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DWilliams%26aufirst%3DD.%2BK.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DChakrabarti%26aufirst%3DD.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%2BM.%2BJ.%26aulast%3Dvan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DGel%26aulast%3DM.%2BH%26atitle%3DSecond%2520generation%2520tetrahydroquinoline-based%2520protein%2520farnesyltransferase%2520inhibitors%2520as%2520antimalarials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4585%26epage%3D4605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Clough, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, R. J. M.</span><span> </span><span class="NLM_article-title">Antibiotics and plasmodial plastid organelle</span> <span class="citation_source-journal">Antimalar. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm800113p&amp;key=10.1385%2F1-59259-111-6%3A265" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=265-286&author=N.+Cloughauthor=R.+J.+M.+Wilson&title=Antibiotics+and+plasmodial+plastid+organelle"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1385%2F1-59259-111-6%3A265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252F1-59259-111-6%253A265%26sid%3Dliteratum%253Aachs%26aulast%3DClough%26aufirst%3DN.%26aulast%3DWilson%26aufirst%3DR.%2BJ.%2BM.%26atitle%3DAntibiotics%2520and%2520plasmodial%2520plastid%2520organelle%26jtitle%3DAntimalar.%2520Chemother.%26date%3D2001%26spage%3D265%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Loyevsky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordeuk, V. R.</span><span> </span><span class="NLM_article-title">Iron chelators</span> <span class="citation_source-journal">Antimalar. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm800113p&amp;key=10.1385%2F1-59259-111-6%3A307" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=307-324&author=M.+Loyevskyauthor=V.+R.+Gordeuk&title=Iron+chelators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1385%2F1-59259-111-6%3A307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252F1-59259-111-6%253A307%26sid%3Dliteratum%253Aachs%26aulast%3DLoyevsky%26aufirst%3DM.%26aulast%3DGordeuk%26aufirst%3DV.%2BR.%26atitle%3DIron%2520chelators%26jtitle%3DAntimalar.%2520Chemother.%26date%3D2001%26spage%3D307%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Gelb, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Voorhis, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panethymitaki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. F.</span><span> </span><span class="NLM_article-title">Protein farnesyl and <i>N</i>-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics</span> <span class="citation_source-journal">Mol. Biochem. Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm800113p&amp;key=10.1016%2FS0166-6851%2802%2900282-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm800113p&amp;key=12615314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm800113p&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhs1Kktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2003&pages=155-163&author=M.+H.+Gelbauthor=W.+C.+van+Voorhisauthor=F.+S.+Bucknerauthor=K.+Yokoyamaauthor=R.+Eastmanauthor=E.+P.+Carpenterauthor=C.+Panethymitakiauthor=K.+A.+Brownauthor=D.+F.+Smith&title=Protein+farnesyl+and+N-myristoyl+transferases%3A+piggy-back+medicinal+chemistry+targets+for+the+development+of+antitrypanosomatid+and+antimalarial+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Protein farnesyl and N-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics</span></div><div class="casAuthors">Gelb, Michael H.; Van Voorhis, Wesley C.; Buckner, Frederick S.; Yokoyama, Kohei; Eastman, Richard; Carpenter, Elisabeth P.; Panethymitaki, Chrysoula; Brown, Katherine A.; Smith, Deborah F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-163</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  To accelerate progress in the development of therapeutics for protozoan parasitic diseases, we are studying enzymes active in co- and post-translational protein modification that are already the focus of drug development in other eukaryotic systems.  Inhibitors of the protein farnesyltransferases (PFT) are well-established antitumor agents of low cytotoxicity and known pharmokinetic properties, while inhibitors of N-myristoyl transferase show both selectivity and specificity in the treatment of fungal infections.  Here, we summarize the current evidence that supports the targeting of these ubiquitous eukaryotic enzymes for drug development against trypanosomatid infections and malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotJTH0pFykdLVg90H21EOLACvtfcHk0lh2CK1lYzBS6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhs1Kktro%253D&md5=a3bed65fea78e6b5ca32b3663cea627a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0166-6851%2802%2900282-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-6851%252802%252900282-7%26sid%3Dliteratum%253Aachs%26aulast%3DGelb%26aufirst%3DM.%2BH.%26aulast%3Dvan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DYokoyama%26aufirst%3DK.%26aulast%3DEastman%26aufirst%3DR.%26aulast%3DCarpenter%26aufirst%3DE.%2BP.%26aulast%3DPanethymitaki%26aufirst%3DC.%26aulast%3DBrown%26aufirst%3DK.%2BA.%26aulast%3DSmith%26aufirst%3DD.%2BF.%26atitle%3DProtein%2520farnesyl%2520and%2520N-myristoyl%2520transferases%253A%2520piggy-back%2520medicinal%2520chemistry%2520targets%2520for%2520the%2520development%2520of%2520antitrypanosomatid%2520and%2520antimalarial%2520therapeutics%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D2003%26volume%3D126%26spage%3D155%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wiesner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kettler, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzin, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jomaa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlitzer, M.</span><span> </span><span class="NLM_article-title">Farnesyltransferase inhibitors inhibit the growth of malaria parasites in vitro and in vivo</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=251-254&author=J.+Wiesnerauthor=K.+Kettlerauthor=J.+Sakowskiauthor=R.+Ortmannauthor=A.+M.+Katzinauthor=E.+A.+Kimuraauthor=K.+Silberauthor=G.+Klebeauthor=H.+Jomaaauthor=M.+Schlitzer&title=Farnesyltransferase+inhibitors+inhibit+the+growth+of+malaria+parasites+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWiesner%26aufirst%3DJ.%26aulast%3DKettler%26aufirst%3DK.%26aulast%3DSakowski%26aufirst%3DJ.%26aulast%3DOrtmann%26aufirst%3DR.%26aulast%3DKatzin%26aufirst%3DA.%2BM.%26aulast%3DKimura%26aufirst%3DE.%2BA.%26aulast%3DSilber%26aufirst%3DK.%26aulast%3DKlebe%26aufirst%3DG.%26aulast%3DJomaa%26aufirst%3DH.%26aulast%3DSchlitzer%26aufirst%3DM.%26atitle%3DFarnesyltransferase%2520inhibitors%2520inhibit%2520the%2520growth%2520of%2520malaria%2520parasites%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2004%26volume%3D43%26spage%3D251%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schlitzer, M.</span><span> </span><span class="NLM_article-title">Structure based design of benzophenone-based non-thiol farnesyltransferase inhibitors</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1713</span><span class="NLM_x">–</span> <span class="NLM_lpage">1722</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Fjm800113p&amp;key=10.2174%2F1381612023394061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Fjm800113p&amp;key=12171543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Fjm800113p&amp;key=1%3ACAS%3A528%3ADC%252BD38XlslKhtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=1713-1722&author=M.+Schlitzer&title=Structure+based+design+of+benzophenone-based+non-thiol+farnesyltransferase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Structure based design of benzophenone-based non-thiol farnesyltransferase inhibitors</span></div><div class="casAuthors">Schlitzer, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1713-1722</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  Farnesyltransferase catalyzes the transfer of a farnesyl residue from farnesylpyrophosphate to the thiol of a cysteine side chain of proteins which carry at the C-terminus the so called CAAX-sequence.  Although the exact cellular events affected by farnesyltransferase inhibition remain to be detd., farnesyltransferase has become a major target in the development of potential anti-cancer drugs.  Numerous farnesyltransferase inhibitors have been described from which the majority are CAAX-peptidomimetics possessing a free thiol group which coordinates the enzyme-bound zinc ion.  The development of farnesyltransferase inhibitors is clearly directed towards the so-called non-thiol farnesyltransferase inhibitors because of adverse drug effects connected to free thiols.  This review mainly deals with the efforts of the authors group towards the design of non-thiol-farnesyltransferase inhibitors.  Our first step on the way to non-thiol farnesyltransferase inhibitors was the development of an CAAX-peptidomimetic based on a pharmacophore model.  On the basis of this benzophenone core, bisubstrate analogs were developed as one class of non-thiol farnesyltransferase inhibitors.  In most non-thiol farnesyltransferase inhibitors known in literature nitrogen contg. heterocycles are used as cysteine replacements supposedly coordinating the enzyme bound zinc.  However, we and others have shown that nitrogen heterocycles can be replaced by aryl residues lacking the ability to coordinate metal atoms, an observation which let to the postulation of two hitherto unknown aryl binding sites.  Using flexible docking of model compds. and GRID anal. we were able to locate these postulated aryl binding sites.  Subsequently, we used one of this aryl binding sites for the structure based design of highly active non-thiol farnesyltransferase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowWax3Ap70g7Vg90H21EOLACvtfcHk0lipbHQqz13b8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlslKhtrs%253D&md5=48165f5372f0478027c34284631014c4</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.2174%2F1381612023394061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612023394061%26sid%3Dliteratum%253Aachs%26aulast%3DSchlitzer%26aufirst%3DM.%26atitle%3DStructure%2520based%2520design%2520of%2520benzophenone-based%2520non-thiol%2520farnesyltransferase%2520inhibitors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2002%26volume%3D8%26spage%3D1713%26epage%3D1722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, A. D.</span><span> </span><span class="NLM_article-title">Farnesyltransferase and geranylgeranyltransferase-I inhibitors and cancer therapy: lessons from mechanism and bench-to-bedside translational studies</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6584</span><span class="NLM_x">–</span> <span class="NLM_lpage">6593</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=6584-6593&author=S.+M.+Sebtiauthor=A.+D.+Hamilton&title=Farnesyltransferase+and+geranylgeranyltransferase-I+inhibitors+and+cancer+therapy%3A+lessons+from+mechanism+and+bench-to-bedside+translational+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26atitle%3DFarnesyltransferase%2520and%2520geranylgeranyltransferase-I%2520inhibitors%2520and%2520cancer%2520therapy%253A%2520lessons%2520from%2520mechanism%2520and%2520bench-to-bedside%2520translational%2520studies%26jtitle%3DOncogene%26date%3D2000%26volume%3D19%26spage%3D6584%26epage%3D6593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Bell, I. M.</span><span> </span><span class="NLM_article-title">Inhibitors of farnesyltransferase: a rational approach to cancer chemotherapy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1870</span><span class="NLM_x">–</span> <span class="NLM_lpage">1878</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1870-1878&author=I.+M.+Bell&title=Inhibitors+of+farnesyltransferase%3A+a+rational+approach+to+cancer+chemotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DI.%2BM.%26atitle%3DInhibitors%2520of%2520farnesyltransferase%253A%2520a%2520rational%2520approach%2520to%2520cancer%2520chemotherapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1870%26epage%3D1878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Strickland, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windsor, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bond, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beese, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P. C.</span><span> </span><span class="NLM_article-title">Crystal structure of farnesyl protein transferase complexed with a CaaX peptide and farnesyl diphosphate analog</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">16601</span><span class="NLM_x">–</span> <span class="NLM_lpage">16611</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi981197z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=16601-16611&author=C.+L.+Stricklandauthor=W.+T.+Windsorauthor=R.+Sytoauthor=L.+Wangauthor=R.+Bondauthor=Z.+Wuauthor=J.+Schwartzauthor=H.+V.+Leauthor=L.+S.+Beeseauthor=P.+C.+Weber&title=Crystal+structure+of+farnesyl+protein+transferase+complexed+with+a+CaaX+peptide+and+farnesyl+diphosphate+analog"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fbi981197z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi981197z%26sid%3Dliteratum%253Aachs%26aulast%3DStrickland%26aufirst%3DC.%2BL.%26aulast%3DWindsor%26aufirst%3DW.%2BT.%26aulast%3DSyto%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBond%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DSchwartz%26aufirst%3DJ.%26aulast%3DLe%26aufirst%3DH.%2BV.%26aulast%3DBeese%26aufirst%3DL.%2BS.%26aulast%3DWeber%26aufirst%3DP.%2BC.%26atitle%3DCrystal%2520structure%2520of%2520farnesyl%2520protein%2520transferase%2520complexed%2520with%2520a%2520CaaX%2520peptide%2520and%2520farnesyl%2520diphosphate%2520analog%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26spage%3D16601%26epage%3D16611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Chakrabarti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Silva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquette, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, C. M.</span><span> </span><span class="NLM_article-title">Protein farnesyltransferase and protein prenylation in <i>Plasmodium falciparum</i></span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">42066</span><span class="NLM_x">–</span> <span class="NLM_lpage">42073</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=42066-42073&author=D.+Chakrabartiauthor=T.+Da+Silvaauthor=J.+Bargerauthor=S.+Paquetteauthor=H.+Patelauthor=S.+Pattersonauthor=C.+M.+Allen&title=Protein+farnesyltransferase+and+protein+prenylation+in+Plasmodium+falciparum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChakrabarti%26aufirst%3DD.%26aulast%3DDa%2BSilva%26aufirst%3DT.%26aulast%3DBarger%26aufirst%3DJ.%26aulast%3DPaquette%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DH.%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DAllen%26aufirst%3DC.%2BM.%26atitle%3DProtein%2520farnesyltransferase%2520and%2520protein%2520prenylation%2520in%2520Plasmodium%2520falciparum%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D42066%26epage%3D42073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Eastman, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hucke, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nallan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrabarti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verlinde, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rathod, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Voorhis, W. C.</span><span> </span><span class="NLM_article-title">Resistance to a protein farnesyltransferase inhibitor in <i>Plasmodium falciparum</i></span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">13554</span><span class="NLM_x">–</span> <span class="NLM_lpage">13559</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=13554-13559&author=R.+T.+Eastmanauthor=J.+Whiteauthor=O.+Huckeauthor=K.+Bauerauthor=K.+Yokoyamaauthor=L.+Nallanauthor=D.+Chakrabartiauthor=C.+L.+Verlindeauthor=M.+H.+Gelbauthor=P.+K.+Rathodauthor=W.+C.+van+Voorhis&title=Resistance+to+a+protein+farnesyltransferase+inhibitor+in+Plasmodium+falciparum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEastman%26aufirst%3DR.%2BT.%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DHucke%26aufirst%3DO.%26aulast%3DBauer%26aufirst%3DK.%26aulast%3DYokoyama%26aufirst%3DK.%26aulast%3DNallan%26aufirst%3DL.%26aulast%3DChakrabarti%26aufirst%3DD.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%26aulast%3DGelb%26aufirst%3DM.%2BH.%26aulast%3DRathod%26aufirst%3DP.%2BK.%26aulast%3Dvan%2BVoorhis%26aufirst%3DW.%2BC.%26atitle%3DResistance%2520to%2520a%2520protein%2520farnesyltransferase%2520inhibitor%2520in%2520Plasmodium%2520falciparum%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D13554%26epage%3D13559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Eastman, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hucke, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verlinde, C. L. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hast, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beese, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rathod, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Voorhis, W. C.</span><span> </span><span class="NLM_article-title">Resistance mutations at the lipid substrate binding site of <i>Plasmodium falciparum</i> protein farnesyltransferase</span> <span class="citation_source-journal">Mol. Biochem. Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">66</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm800113p&amp;key=10.1016%2Fj.molbiopara.2006.11.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm800113p&amp;key=17208314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm800113p&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslGmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2007&pages=66-71&author=R.+T.+Eastmanauthor=J.+Whiteauthor=O.+Huckeauthor=K.+Yokoyamaauthor=C.+L.+M.+J.+Verlindeauthor=M.+A.+Hastauthor=L.+S.+Beeseauthor=M.+H.+Gelbauthor=P.+K.+Rathodauthor=W.+C.+van+Voorhis&title=Resistance+mutations+at+the+lipid+substrate+binding+site+of+Plasmodium+falciparum+protein+farnesyltransferase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Resistance mutations at the lipid substrate binding site of Plasmodium falciparum protein farnesyltransferase</span></div><div class="casAuthors">Eastman, Richard T.; White, John; Hucke, Oliver; Yokoyama, Kohei; Verlinde, Christophe L. M. J.; Hast, Michael A.; Beese, Lorena S.; Gelb, Michael H.; Rathod, Pradipsinh K.; Van Voorhis, Wesley C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">66-71</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The post-translational farnesylation of proteins serves to anchor a subset of intracellular proteins to membranes in eukaryotic organisms and also promotes protein-protein interactions.  This enzymic reaction is carried out by protein farnesyltransferase (PFT), which catalyzes the transfer of a 15-carbon isoprenoid lipid unit, a farnesyl group, from farnesyl pyrophosphate to the C-termini of proteins contg. a CaaX motif.  Inhibition of PFT is lethal to the pathogenic protozoa Plasmodium falciparum.  Previously, we have shown that parasites resistant to a tetrahydroquinoline (THQ)-based PFT inhibitor BMS-388891 have mutations leading to amino acid substitutions in PFT that map to the peptide substrate binding domain.  We now report the selection of parasites resistant to another THQ PFT inhibitor BMS-339941.  In whole cell assays sensitivity to BMS-339941 was reduced by 33-fold in a resistant clone, and biochem. anal. demonstrated a corresponding 33-fold increase in the BMS-339941 Ki for the mutant PFT enzyme.  More detailed kinetic anal. revealed that the mutant enzyme required higher concn. of peptide and farnesyl pyrophosphate substrates for optimum catalysis.  Unlike previously characterized parasites resistant to BMS-388891, the resistant parasites have a mutation which is predicted to be in a distinct location of the enzymic pocket, near the farnesyl pyrophosphate binding pocket.  This is the first description of a mutation from any species affecting the farnesyl pyrophosphate binding pocket with reduced efficacy of PFT inhibitors.  These data provide further support that PFT is the target of THQ inhibitors in P. falciparum and suggest that PFT inhibitors should be combined with other antimalarial agents to minimize the development of resistant parasites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZJatvEO8FqrVg90H21EOLACvtfcHk0lg-UkpjZRkxQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslGmug%253D%253D&md5=76798da41ee790bc45527f8ca891259e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.molbiopara.2006.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molbiopara.2006.11.012%26sid%3Dliteratum%253Aachs%26aulast%3DEastman%26aufirst%3DR.%2BT.%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DHucke%26aufirst%3DO.%26aulast%3DYokoyama%26aufirst%3DK.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%2BM.%2BJ.%26aulast%3DHast%26aufirst%3DM.%2BA.%26aulast%3DBeese%26aufirst%3DL.%2BS.%26aulast%3DGelb%26aufirst%3DM.%2BH.%26aulast%3DRathod%26aufirst%3DP.%2BK.%26aulast%3Dvan%2BVoorhis%26aufirst%3DW.%2BC.%26atitle%3DResistance%2520mutations%2520at%2520the%2520lipid%2520substrate%2520binding%2520site%2520of%2520Plasmodium%2520falciparum%2520protein%2520farnesyltransferase%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D2007%26volume%3D152%26spage%3D66%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Ohkanda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockman, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croft, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendrick, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feagin, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaskovich, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, A. D.</span><span> </span><span class="NLM_article-title">Peptidomimetic inhibitors of protein farnesyltransferase show potent antimalarial activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">764</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=761-764&author=J.+Ohkandaauthor=J.+W.+Lockmanauthor=K.+Yokoyamaauthor=M.+H.+Gelbauthor=S.+L.+Croftauthor=H.+Kendrickauthor=M.+I.+Harrellauthor=J.+E.+Feaginauthor=M.+A.+Blaskovichauthor=S.+M.+Sebtiauthor=A.+D.+Hamilton&title=Peptidomimetic+inhibitors+of+protein+farnesyltransferase+show+potent+antimalarial+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhkanda%26aufirst%3DJ.%26aulast%3DLockman%26aufirst%3DJ.%2BW.%26aulast%3DYokoyama%26aufirst%3DK.%26aulast%3DGelb%26aufirst%3DM.%2BH.%26aulast%3DCroft%26aufirst%3DS.%2BL.%26aulast%3DKendrick%26aufirst%3DH.%26aulast%3DHarrell%26aufirst%3DM.%2BI.%26aulast%3DFeagin%26aufirst%3DJ.%2BE.%26aulast%3DBlaskovich%26aufirst%3DM.%2BA.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26atitle%3DPeptidomimetic%2520inhibitors%2520of%2520protein%2520farnesyltransferase%2520show%2520potent%2520antimalarial%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D761%26epage%3D764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Ohkanda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knowles, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaskovich, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, A. D.</span><span> </span><span class="NLM_article-title">Inhibitors of protein farnesyltransferase as novel anticancer agents</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">303</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm800113p&amp;key=10.2174%2F1568026023394281" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm800113p&amp;key=11944822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm800113p&amp;key=1%3ACAS%3A528%3ADC%252BD38XislGmur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=303-323&author=J.+Ohkandaauthor=D.+B.+Knowlesauthor=M.+A.+Blaskovichauthor=S.+M.+Sebtiauthor=A.+D.+Hamilton&title=Inhibitors+of+protein+farnesyltransferase+as+novel+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of protein farnesyltransferase as novel anticancer agents</span></div><div class="casAuthors">Ohkanda, Junko; Knowles, David B.; Blaskovich, Michelle A.; Sebti, Said M.; Hamilton, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Hilversum, Netherlands)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">303-323</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This paper describes recent progress in the design, synthesis and biol. evaluation of inhibitors for the enzyme protein farnesyltransferase (PFTase).  This enzyme plays a crit. role in the post-translational modification of a range of different intracellular proteins.  In particular, PFTase attaches a farnesyl group to the GTPase Ras whose oncogenically mutated form is found in over 30% of human cancers.  As a result PFTase inhibitors have been developed as potential cancer therapeutic drugs either by rational design based on the structure of the CAAX carboxyl terminus of Ras or random screening of chem. libraries or natural products.  Some of these inhibitors show remarkable inhibition potency against PFTase at subnanomolar concns. and >1000-fold selectivity compared to the related enzyme geranylgeranyltransferase-I.  Certain of these compds. are highly effective at blocking the growth of human tumors in animal models and are now undergoing clin. trials.  However, several issues in the research remain unsolved, including the mechanism by which PFTase inhibitors suppress tumor growth.  Although it has been established that PFTase inhibitors block prenylation of Ras in vitro, the results in whole cells and animal studies suggest the possibility that proteins other than Ras are affected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFHtU6WofbYLVg90H21EOLACvtfcHk0lg-UkpjZRkxQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XislGmur0%253D&md5=807019e8fbd4049d9f47e6ab10405cdd</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F1568026023394281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026023394281%26sid%3Dliteratum%253Aachs%26aulast%3DOhkanda%26aufirst%3DJ.%26aulast%3DKnowles%26aufirst%3DD.%2BB.%26aulast%3DBlaskovich%26aufirst%3DM.%2BA.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26atitle%3DInhibitors%2520of%2520protein%2520farnesyltransferase%2520as%2520novel%2520anticancer%2520agents%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2002%26volume%3D2%26spage%3D303%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Carrico, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkanda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendrick, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaskovich, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucher, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Voorhis, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrabarti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croft, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, A. D.</span><span> </span><span class="NLM_article-title">In vitro and in vivo antimalarial activity of peptidomimetic protein farnesyltransferase inhibitors with improved membrane permeability</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">6517</span><span class="NLM_x">–</span> <span class="NLM_lpage">6526</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=6517-6526&author=D.+Carricoauthor=J.+Ohkandaauthor=H.+Kendrickauthor=K.+Yokoyamaauthor=M.+A.+Blaskovichauthor=C.+J.+Bucherauthor=F.+S.+Bucknerauthor=W.+C.+van+Voorhisauthor=D.+Chakrabartiauthor=S.+L.+Croftauthor=M.+H.+Gelbauthor=S.+M.+Sebtiauthor=A.+D.+Hamilton&title=In+vitro+and+in+vivo+antimalarial+activity+of+peptidomimetic+protein+farnesyltransferase+inhibitors+with+improved+membrane+permeability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarrico%26aufirst%3DD.%26aulast%3DOhkanda%26aufirst%3DJ.%26aulast%3DKendrick%26aufirst%3DH.%26aulast%3DYokoyama%26aufirst%3DK.%26aulast%3DBlaskovich%26aufirst%3DM.%2BA.%26aulast%3DBucher%26aufirst%3DC.%2BJ.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3Dvan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DChakrabarti%26aufirst%3DD.%26aulast%3DCroft%26aufirst%3DS.%2BL.%26aulast%3DGelb%26aufirst%3DM.%2BH.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520antimalarial%2520activity%2520of%2520peptidomimetic%2520protein%2520farnesyltransferase%2520inhibitors%2520with%2520improved%2520membrane%2520permeability%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D6517%26epage%3D6526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">van Voorhis, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivas, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bendale, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nallan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horney, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smart, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ankala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hucke, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verlinde, C. L. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrabarti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, M. H.</span><span> </span><span class="NLM_article-title">Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of <i>Plasmodium falciparum</i> protein farnesyltransferase</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3659</span><span class="NLM_x">–</span> <span class="NLM_lpage">3671</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2007&pages=3659-3671&author=W.+C.+van+Voorhisauthor=K.+L.+Rivasauthor=P.+Bendaleauthor=L.+Nallanauthor=C.+Horneyauthor=L.+K.+Barrettauthor=K.+D.+Bauerauthor=B.+P.+Smartauthor=S.+Ankalaauthor=O.+Huckeauthor=C.+L.+M.+J.+Verlindeauthor=D.+Chakrabartiauthor=C.+Stricklandauthor=K.+Yokoyamaauthor=F.+S.+Bucknerauthor=A.+D.+Hamiltonauthor=D.+K.+Williamsauthor=L.+J.+Lombardoauthor=D.+Floydauthor=M.+H.+Gelb&title=Efficacy%2C+pharmacokinetics%2C+and+metabolism+of+tetrahydroquinoline+inhibitors+of+Plasmodium+falciparum+protein+farnesyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DRivas%26aufirst%3DK.%2BL.%26aulast%3DBendale%26aufirst%3DP.%26aulast%3DNallan%26aufirst%3DL.%26aulast%3DHorney%26aufirst%3DC.%26aulast%3DBarrett%26aufirst%3DL.%2BK.%26aulast%3DBauer%26aufirst%3DK.%2BD.%26aulast%3DSmart%26aufirst%3DB.%2BP.%26aulast%3DAnkala%26aufirst%3DS.%26aulast%3DHucke%26aufirst%3DO.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%2BM.%2BJ.%26aulast%3DChakrabarti%26aufirst%3DD.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DYokoyama%26aufirst%3DK.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26aulast%3DWilliams%26aufirst%3DD.%2BK.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DFloyd%26aufirst%3DD.%26aulast%3DGelb%26aufirst%3DM.%2BH.%26atitle%3DEfficacy%252C%2520pharmacokinetics%252C%2520and%2520metabolism%2520of%2520tetrahydroquinoline%2520inhibitors%2520of%2520Plasmodium%2520falciparum%2520protein%2520farnesyltransferase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2007%26volume%3D51%26spage%3D3659%26epage%3D3671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><a href="http://www.plasmodb.org" class="extLink">www.plasmodb.org</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=www.plasmodb.org."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Glenn, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hucke, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verlinde, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornéy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pendyala, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrabarti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Voorhis, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, A. D.</span><span> </span><span class="NLM_article-title">Structurally simple farnesyltransferase inhibitors arrest the growth of malaria parasites</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">4903</span><span class="NLM_x">–</span> <span class="NLM_lpage">4906</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=4903-4906&author=M.+P.+Glennauthor=S.-Y.+Changauthor=O.+Huckeauthor=C.+L.+Verlindeauthor=K.+Rivasauthor=C.+Horn%C3%A9yauthor=K.+Yokoyamaauthor=F.+S.+Bucknerauthor=P.+R.+Pendyalaauthor=D.+Chakrabartiauthor=M.+Gelbauthor=W.+C.+van+Voorhisauthor=S.+M.+Sebtiauthor=A.+D.+Hamilton&title=Structurally+simple+farnesyltransferase+inhibitors+arrest+the+growth+of+malaria+parasites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlenn%26aufirst%3DM.%2BP.%26aulast%3DChang%26aufirst%3DS.-Y.%26aulast%3DHucke%26aufirst%3DO.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%26aulast%3DRivas%26aufirst%3DK.%26aulast%3DHorn%25C3%25A9y%26aufirst%3DC.%26aulast%3DYokoyama%26aufirst%3DK.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DPendyala%26aufirst%3DP.%2BR.%26aulast%3DChakrabarti%26aufirst%3DD.%26aulast%3DGelb%26aufirst%3DM.%26aulast%3Dvan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26atitle%3DStructurally%2520simple%2520farnesyltransferase%2520inhibitors%2520arrest%2520the%2520growth%2520of%2520malaria%2520parasites%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2005%26volume%3D44%26spage%3D4903%26epage%3D4906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Glenn, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornéy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pusateri, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pendyala, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrabarti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Voorhis, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, A. D.</span><span> </span><span class="NLM_article-title">Structurally simple, potent <i>Plasmodium</i> selective farnesyltransferase inhibitors that arrest the growth of malaria parasites</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5710</span><span class="NLM_x">–</span> <span class="NLM_lpage">5727</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060081v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5710-5727&author=M.+P.+Glennauthor=S.-Y.+Changauthor=C.+Horn%C3%A9yauthor=K.+Rivasauthor=K.+Yokoyamaauthor=E.+E.+Pusateriauthor=S.+Fletcherauthor=C.+G.+Cummingsauthor=F.+S.+Bucknerauthor=P.+R.+Pendyalaauthor=D.+Chakrabartiauthor=S.+M.+Sebtiauthor=M.+Gelbauthor=W.+C.+van+Voorhisauthor=A.+D.+Hamilton&title=Structurally+simple%2C+potent+Plasmodium+selective+farnesyltransferase+inhibitors+that+arrest+the+growth+of+malaria+parasites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm060081v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060081v%26sid%3Dliteratum%253Aachs%26aulast%3DGlenn%26aufirst%3DM.%2BP.%26aulast%3DChang%26aufirst%3DS.-Y.%26aulast%3DHorn%25C3%25A9y%26aufirst%3DC.%26aulast%3DRivas%26aufirst%3DK.%26aulast%3DYokoyama%26aufirst%3DK.%26aulast%3DPusateri%26aufirst%3DE.%2BE.%26aulast%3DFletcher%26aufirst%3DS.%26aulast%3DCummings%26aufirst%3DC.%2BG.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DPendyala%26aufirst%3DP.%2BR.%26aulast%3DChakrabarti%26aufirst%3DD.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DGelb%26aufirst%3DM.%26aulast%3Dvan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26atitle%3DStructurally%2520simple%252C%2520potent%2520Plasmodium%2520selective%2520farnesyltransferase%2520inhibitors%2520that%2520arrest%2520the%2520growth%2520of%2520malaria%2520parasites%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5710%26epage%3D5727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span> </span><span class="NLM_article-title">Development and validation of a genetic algorithm for flexible docking</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm800113p&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm800113p&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm800113p&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+validation+of+a+genetic+algorithm+for+flexible+docking"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0lh-dY6FHZbjgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520genetic%2520algorithm%2520for%2520flexible%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Reissig, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, R.</span><span> </span><span class="NLM_article-title">Donor−acceptor-substituted cyclopropane derivatives and their application in organic synthesis</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">1151</span><span class="NLM_x">–</span> <span class="NLM_lpage">1196</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr010016n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2003&pages=1151-1196&author=H.+U.+Reissigauthor=R.+Zimmer&title=Donor%E2%88%92acceptor-substituted+cyclopropane+derivatives+and+their+application+in+organic+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fcr010016n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr010016n%26sid%3Dliteratum%253Aachs%26aulast%3DReissig%26aufirst%3DH.%2BU.%26aulast%3DZimmer%26aufirst%3DR.%26atitle%3DDonor%25E2%2588%2592acceptor-substituted%2520cyclopropane%2520derivatives%2520and%2520their%2520application%2520in%2520organic%2520synthesis%26jtitle%3DChem.%2520Rev.%26date%3D2003%26volume%3D103%26spage%3D1151%26epage%3D1196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span> <span class="citation_source-book">InsightII</span>; <span class="NLM_publisher-name">Accelrys Inc.</span>: <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2000</span><span class="NLM_x">; </span><a href="http://www.accelrys.com" class="extLink">http://www.accelrys.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=InsightII%3B+Accelrys+Inc.%3A+San+Diego%2C+CA%2C+2000%3B+http%3A%2F%2Fwww.accelrys.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DInsightII%26pub%3DAccelrys%2520Inc%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><div class="note"><p class="first last">Unpublished results.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><div class="note"><p class="first last">Thorpe−Ingold effect, or the “gem-dialkyl effect”: replacement of a C−CH<sub>2</sub>−C group with a C−CR<sub>2</sub>−C group causes a compression of the C−C−C bond angle at the now-quarternary carbon.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Thorpe%E2%88%92Ingold+effect%2C+or+the+%E2%80%9Cgem-dialkyl+effect%E2%80%9D%3A+replacement+of+a+C%E2%88%92CH2%E2%88%92C+group+with+a+C%E2%88%92CR2%E2%88%92C+group+causes+a+compression+of+the+C%E2%88%92C%E2%88%92C+bond+angle+at+the+now-quarternary+carbon."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Long, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kral, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellinga, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beese, L. S.</span><span> </span><span class="NLM_article-title">The crystal structure of human proteinfarnesyltransferase reveals the basis for inhibition by CaaX tetrapeptides and their mimetics</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">12948</span><span class="NLM_x">–</span> <span class="NLM_lpage">12953</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=12948-12953&author=S.+B.+Longauthor=P.+J.+Hancockauthor=A.+M.+Kralauthor=H.+W.+Hellingaauthor=L.+S.+Beese&title=The+crystal+structure+of+human+proteinfarnesyltransferase+reveals+the+basis+for+inhibition+by+CaaX+tetrapeptides+and+their+mimetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DS.%2BB.%26aulast%3DHancock%26aufirst%3DP.%2BJ.%26aulast%3DKral%26aufirst%3DA.%2BM.%26aulast%3DHellinga%26aufirst%3DH.%2BW.%26aulast%3DBeese%26aufirst%3DL.%2BS.%26atitle%3DThe%2520crystal%2520structure%2520of%2520human%2520proteinfarnesyltransferase%2520reveals%2520the%2520basis%2520for%2520inhibition%2520by%2520CaaX%2520tetrapeptides%2520and%2520their%2520mimetics%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2001%26volume%3D98%26spage%3D12948%26epage%3D12953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Seto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guengerich, F. P.</span><span> </span><span class="NLM_article-title">Partitioning between N-dealkylation and N-oxygenation in the oxidation of <i>N</i>,<i>N</i>-dialkylarylamines catalyzed by cytochrome P450 2B1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">9986</span><span class="NLM_x">–</span> <span class="NLM_lpage">9997</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm800113p&amp;key=8486725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm800113p&amp;key=1%3ACAS%3A528%3ADyaK3sXkvV2rsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1993&pages=9986-9997&author=Y.+Setoauthor=F.+P.+Guengerich&title=Partitioning+between+N-dealkylation+and+N-oxygenation+in+the+oxidation+of+N%2CN-dialkylarylamines+catalyzed+by+cytochrome+P450+2B1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Partitioning between N-dealkylation and N-oxygenation in the oxidation of N,N-dialkylarylamines catalyzed by cytochrome P450 2B1</span></div><div class="casAuthors">Seto, Yasuo; Guengerich, F. Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">9986-97</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Aminium radicals have been proposed as intermediates in amine N-dealkylations and N-oxygenations catalyzed by cytochrome P 450 (P 450) and some other enzymes.  P450s can form some N-oxides and hydroxylamines but these are not favored whenever N-dealkylation is possible.  However, if a paradigm involving 1-electron oxidn. is valid, then some finite level of partitioning of aminium radicals between N-oxygenation and N-dealkylation might be expected in all cases.  Methods were developed for the selective and sensitive measurement of N,N-dialkylaniline N-oxides using high performance liq. chromatog., radiochromatog., and TiCl3 redn.  These N-oxides were relatively stable in the presence of P 450 2B1.  In the presence of NADPH and NADPH-P 450 reductase some redn. of N,N-dialkylamines occurred, along with N-dealkylation (to monoalkylanilines); there was also slow N-dealkylation in the absence of NADPH, which is interpreted in terms of homolytic scission of the N-O bond; N,N-dialkylanilines were not formed nor did the N-oxides support other oxygenation reactions.  P 450 2B1 (with its reductase and NADPH) formed N-oxides at low rates from several N,N-dialkylaniline derivs., including N,N-dimethylaniline, N,N-diethylaniline, N-ethyl-N-methylaniline, 4-methyl-N,N-dimethylaniline, 4-cyano-N,N-dimethyl-2-aminofluorene.  The ratio of N-dealkylation:N-oxygenation varied from 1020 to 6 in this series.  These results are consistent with the view that aminium radicals are a branch point in N-oxygenation and N-dealkylation reactions catalyzed by metalloproteins, although some alternate explanations cannot be ruled out.  While N-dealkylation is the dominant process in all of the P 450-catalyzed amine oxidns., there should be a finite partition ratio between these reactions depending upon the particular enzyme and substrate.  The N-oxygenation reaction is probably more complex than a direct radical recombination event and is postulated to involve one or more intermediates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOH4rkAiDn7LVg90H21EOLACvtfcHk0lh-dY6FHZbjgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkvV2rsL0%253D&md5=2de50390efebd1e86e602dd084164a03</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeto%26aufirst%3DY.%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26atitle%3DPartitioning%2520between%2520N-dealkylation%2520and%2520N-oxygenation%2520in%2520the%2520oxidation%2520of%2520N%252CN-dialkylarylamines%2520catalyzed%2520by%2520cytochrome%2520P450%25202B1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1993%26volume%3D268%26spage%3D9986%26epage%3D9997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span> <span class="citation_source-book">Molecular Operating Environment</span>, version <span class="NLM_edition">2007.11</span>; <span class="NLM_publisher-name">Chemical Computing Group</span>: <span class="NLM_publisher-loc">Montreal, Quebec, Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Molecular+Operating+Environment%2C+version+2007.11%3B+Chemical+Computing+Group%3A+Montreal%2C+Quebec%2C+Canada%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMolecular%2520Operating%2520Environment%26pub%3DChemical%2520Computing%2520Group%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Sukumar, N.; Breneman, C. M.</span><span> </span><span class="NLM_article-title">QTAIM in Drug Discovery and Protein Modeling</span>. In  <span class="citation_source-book">The Quantum Theory of Atoms in Molecules: From Solid State to DNA and Drug Design</span>; <span class="NLM_contrib-group">Matta, C. F.; Boyd, R. J.</span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH</span>: Weinheim, Germany,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=N.+Sukumar&author=C.+M.+Brenemanauthor=C.+F.+Matta&author=R.+J.+Boyd&title=The+Quantum+Theory+of+Atoms+in+Molecules%3A+From+Solid+State+to+DNA+and+Drug+Design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSukumar%26aufirst%3DN.%26atitle%3DQTAIM%2520in%2520Drug%2520Discovery%2520and%2520Protein%2520Modeling%26btitle%3DThe%2520Quantum%2520Theory%2520of%2520Atoms%2520in%2520Molecules%253A%2520From%2520Solid%2520State%2520to%2520DNA%2520and%2520Drug%2520Design%26aulast%3DMatta%26aufirst%3DC.%2BF.%26pub%3DWiley-VCH%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Embrechts, M. J.</span> <span class="citation_source-book">KernelPLS(Analyze)</span>, version <span class="NLM_edition">6.36</span>; <span class="NLM_publisher-name">Rensselaer Polytechnic Institute</span>: <span class="NLM_publisher-loc">Troy, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=M.+J.+Embrechts&title=KernelPLS%28Analyze%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DEmbrechts%26aufirst%3DM.%2BJ.%26btitle%3DKernelPLS%2528Analyze%2529%26pub%3DRensselaer%2520Polytechnic%2520Institute%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Trager, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, J. B.</span><span> </span><span class="NLM_article-title">Human malaria parasites in continuous culture</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">193</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="NLM_x">–</span> <span class="NLM_lpage">675</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm800113p&amp;key=10.1126%2Fscience.781840" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm800113p&amp;key=781840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm800113p&amp;key=1%3ACAS%3A280%3ADyaE283ks1Wqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=1976&pages=673-675&author=W.+Tragerauthor=J.+B.+Jensen&title=Human+malaria+parasites+in+continuous+culture"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Human malaria parasites in continuous culture</span></div><div class="casAuthors">Trager W; Jensen J B</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">4254</span>),
    <span class="NLM_cas:pages">673-5</span>
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Plasmodium falciparum can now be maintained in continuous culture in human erythrocytes incubated at 38 degrees C in RPMI 1640 medium with human serum under an atmosphere with 7 percent carbon dioxide and low oxygen (1 or 5 percent).  The original parasite material, derived from an infected Aotus trivirgatus monkey, was diluted more than 100 million times by the addition of human erythrocytes at 3- or 4-day intervals.  The parasites continued to reproduce in their normal asexual cycle of approximately 48 hours but were no longer highly synchronous.  The have remained infective to Aotus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQPnKdQ--_afmyYR5VtavbzfW6udTcc2eYoxb34LSjUSrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE283ks1Wqug%253D%253D&md5=a7f43c2255b75d9841c36338433c78b8</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1126%2Fscience.781840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.781840%26sid%3Dliteratum%253Aachs%26aulast%3DTrager%26aufirst%3DW.%26aulast%3DJensen%26aufirst%3DJ.%2BB.%26atitle%3DHuman%2520malaria%2520parasites%2520in%2520continuous%2520culture%26jtitle%3DScience%26date%3D1976%26volume%3D193%26spage%3D673%26epage%3D675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10a','cit10b'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14a','cit14b'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 28 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong  Jiang</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiao  Chen</span>, <span class="hlFld-ContribAuthor ">Pornpun  Aramsangtienchai</span>, <span class="hlFld-ContribAuthor ">Zhen  Tong</span>, and <span class="hlFld-ContribAuthor ">Hening  Lin</span>  . </span><span class="cited-content_cbyCitation_article-title">Protein Lipidation: Occurrence, Mechanisms, Biological Functions, and Enabling Technologies. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2018,</strong> <em>118 </em>
                                    (3)
                                     , 919-988. <a href="https://doi.org/10.1021/acs.chemrev.6b00750" title="DOI URL">https://doi.org/10.1021/acs.chemrev.6b00750</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.6b00750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.6b00750%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DProtein%252BLipidation%25253A%252BOccurrence%25252C%252BMechanisms%25252C%252BBiological%252BFunctions%25252C%252Band%252BEnabling%252BTechnologies%26aulast%3DJiang%26aufirst%3DHong%26date%3D2018%26date%3D2018%26date%3D2016%26date%3D05112016%26date%3D02012018%26date%3D14022018%26volume%3D118%26issue%3D3%26spage%3D919%26epage%3D988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charuta C.  Palsuledesai</span>, <span class="hlFld-ContribAuthor ">Joshua D.  Ochocki</span>, <span class="hlFld-ContribAuthor ">Michelle M.  Kuhns</span>, <span class="hlFld-ContribAuthor ">Yen-Chih  Wang</span>, <span class="hlFld-ContribAuthor ">Janel K.  Warmka</span>, <span class="hlFld-ContribAuthor ">Dustin S.  Chernick</span>, <span class="hlFld-ContribAuthor ">Elizabeth V.  Wattenberg</span>, <span class="hlFld-ContribAuthor ">Ling  Li</span>, <span class="hlFld-ContribAuthor ">Edgar A.  Arriaga</span>, and <span class="hlFld-ContribAuthor ">Mark D.  Distefano</span>  . </span><span class="cited-content_cbyCitation_article-title">Metabolic Labeling with an Alkyne-modified Isoprenoid Analog Facilitates Imaging and Quantification of the Prenylome in Cells. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2016,</strong> <em>11 </em>
                                    (10)
                                     , 2820-2828. <a href="https://doi.org/10.1021/acschembio.6b00421" title="DOI URL">https://doi.org/10.1021/acschembio.6b00421</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.6b00421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.6b00421%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DMetabolic%252BLabeling%252Bwith%252Ban%252BAlkyne-modified%252BIsoprenoid%252BAnalog%252BFacilitates%252BImaging%252Band%252BQuantification%252Bof%252Bthe%252BPrenylome%252Bin%252BCells%26aulast%3DPalsuledesai%26aufirst%3DCharuta%2BC.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D16052016%26date%3D15082016%26date%3D31082016%26date%3D21102016%26date%3D15082016%26volume%3D11%26issue%3D10%26spage%3D2820%26epage%3D2828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charuta C.  Palsuledesai</span> and <span class="hlFld-ContribAuthor ">Mark D.  Distefano</span>  . </span><span class="cited-content_cbyCitation_article-title">Protein Prenylation: Enzymes, Therapeutics, and Biotechnology Applications. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2015,</strong> <em>10 </em>
                                    (1)
                                     , 51-62. <a href="https://doi.org/10.1021/cb500791f" title="DOI URL">https://doi.org/10.1021/cb500791f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb500791f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb500791f%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DProtein%252BPrenylation%25253A%252BEnzymes%25252C%252BTherapeutics%25252C%252Band%252BBiotechnology%252BApplications%26aulast%3DPalsuledesai%26aufirst%3DCharuta%2BC.%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D01102014%26date%3D17112014%26date%3D08122014%26date%3D16012015%26date%3D17112014%26volume%3D10%26issue%3D1%26spage%3D51%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta A. S.  Perez</span>, <span class="hlFld-ContribAuthor ">Sérgio F.  Sousa</span>, <span class="hlFld-ContribAuthor ">Eduardo F. T.  Oliveira</span>, <span class="hlFld-ContribAuthor ">Pedro A.  Fernandes</span>, and <span class="hlFld-ContribAuthor ">Maria J.  Ramos</span>  . </span><span class="cited-content_cbyCitation_article-title">Detection of Farnesyltransferase Interface Hot Spots through Computational Alanine Scanning Mutagenesis. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry B</span><span> <strong>2011,</strong> <em>115 </em>
                                    (51)
                                     , 15339-15354. <a href="https://doi.org/10.1021/jp205481y" title="DOI URL">https://doi.org/10.1021/jp205481y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jp205481y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjp205481y%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520B%26atitle%3DDetection%252Bof%252BFarnesyltransferase%252BInterface%252BHot%252BSpots%252Bthrough%252BComputational%252BAlanine%252BScanning%252BMutagenesis%26aulast%3DPerez%26aufirst%3DMarta%2BA.%2BS.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D11062011%26date%3D07112011%26date%3D02122011%26date%3D29122011%26date%3D07112011%26volume%3D115%26issue%3D51%26spage%3D15339%26epage%3D15354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven  Fletcher</span>, <span class="hlFld-ContribAuthor ">Erin Pusateri  Keaney</span>, <span class="hlFld-ContribAuthor ">Christopher G.  Cummings</span>, <span class="hlFld-ContribAuthor ">Michelle A.  Blaskovich</span>, <span class="hlFld-ContribAuthor ">Michael A.  Hast</span>, <span class="hlFld-ContribAuthor ">Matthew P.  Glenn</span>, <span class="hlFld-ContribAuthor ">Sung-Youn  Chang</span>, <span class="hlFld-ContribAuthor ">Cynthia J.  Bucher</span>, <span class="hlFld-ContribAuthor ">Ryan J.  Floyd</span>, <span class="hlFld-ContribAuthor ">William P.  Katt</span>, <span class="hlFld-ContribAuthor ">Michael H.  Gelb</span>, <span class="hlFld-ContribAuthor ">Wesley C.  Van Voorhis</span>, <span class="hlFld-ContribAuthor ">Lorena S.  Beese</span>, <span class="hlFld-ContribAuthor ">Said M.  Sebti</span>, and <span class="hlFld-ContribAuthor ">Andrew D.  Hamilton</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design and Synthesis of Potent, Ethylenediamine-Based, Mammalian Farnesyltransferase Inhibitors as Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (19)
                                     , 6867-6888. <a href="https://doi.org/10.1021/jm1001748" title="DOI URL">https://doi.org/10.1021/jm1001748</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm1001748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm1001748%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Band%252BSynthesis%252Bof%252BPotent%25252C%252BEthylenediamine-Based%25252C%252BMammalian%252BFarnesyltransferase%252BInhibitors%252Bas%252BAnticancer%252BAgents%26aulast%3DFletcher%26aufirst%3DSteven%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D09022010%26date%3D07092010%26date%3D14102010%26volume%3D53%26issue%3D19%26spage%3D6867%26epage%3D6888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian A. M. R.  van Slagmaat</span>, <span class="hlFld-ContribAuthor ">Teresa  Faber</span>, <span class="hlFld-ContribAuthor ">Khi Chhay  Chou</span>, <span class="hlFld-ContribAuthor ">Alfonso J.  Schwalb Freire</span>, <span class="hlFld-ContribAuthor ">Darya  Hadavi</span>, <span class="hlFld-ContribAuthor ">Peiliang  Han</span>, <span class="hlFld-ContribAuthor ">Peter J. L. M.  Quaedflieg</span>, <span class="hlFld-ContribAuthor ">Gerard K. M.  Verzijl</span>, <span class="hlFld-ContribAuthor ">Paul L.  Alsters</span>, <span class="hlFld-ContribAuthor ">Stefaan M. A.  De Wildeman</span>. </span><span class="cited-content_cbyCitation_article-title">Chemoselective formation of cyclo-aliphatic and cyclo-olefinic 1,3-diols
              via
              pressure hydrogenation of potentially biobased platform molecules using Knölker-type catalysts. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2021,</strong> <em>50 </em>
                                    (29)
                                     , 10102-10112. <a href="https://doi.org/10.1039/D1DT01252E" title="DOI URL">https://doi.org/10.1039/D1DT01252E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1DT01252E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1DT01252E%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DChemoselective%252Bformation%252Bof%252Bcyclo-aliphatic%252Band%252Bcyclo-olefinic%252B1%25252C3-diols%252Bvia%252Bpressure%252Bhydrogenation%252Bof%252Bpotentially%252Bbiobased%252Bplatform%252Bmolecules%252Busing%252BKn%2525C3%2525B6lker-type%252Bcatalysts%26aulast%3Dvan%2BSlagmaat%26aufirst%3DChristian%2BA.%2BM.%2BR.%26date%3D2021%26date%3D2021%26volume%3D50%26issue%3D29%26spage%3D10102%26epage%3D10112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashwaq  Bahkali</span>, <span class="hlFld-ContribAuthor ">Jacob Xin  Wei</span>, <span class="hlFld-ContribAuthor ">Yuanjian  Deng</span>. </span><span class="cited-content_cbyCitation_article-title">Structural comparison of ethylenediamine platinum(II) complexes containing thiourea and its di- and tetramethyl substituted derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Coordination Chemistry</span><span> <strong>2021,</strong> <em>74 </em>
                                    (12)
                                     , 1992-2003. <a href="https://doi.org/10.1080/00958972.2021.1923015" title="DOI URL">https://doi.org/10.1080/00958972.2021.1923015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00958972.2021.1923015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00958972.2021.1923015%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Coordination%2520Chemistry%26atitle%3DStructural%252Bcomparison%252Bof%252Bethylenediamine%252Bplatinum%252528II%252529%252Bcomplexes%252Bcontaining%252Bthiourea%252Band%252Bits%252Bdi-%252Band%252Btetramethyl%252Bsubstituted%252Bderivatives%26aulast%3DBahkali%26aufirst%3DAshwaq%26date%3D2021%26date%3D2021%26volume%3D74%26issue%3D12%26spage%3D1992%26epage%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashwaq  Bahkali</span>, <span class="hlFld-ContribAuthor ">Jacob  Wei</span>, <span class="hlFld-ContribAuthor ">Yuanjian  Deng</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and characterization of ethylenediamine platinum(II) complexes containing thiourea derivatives. X-ray crystal structures of [Pt(en)(2-imidazolidinethione)2](NO3)2 and [Pt(en)(1-phenyl-2-thiourea)2](NO3)2. </span><span class="cited-content_cbyCitation_journal-name">Inorganica Chimica Acta</span><span> <strong>2021,</strong> <em>520 </em>, 120302. <a href="https://doi.org/10.1016/j.ica.2021.120302" title="DOI URL">https://doi.org/10.1016/j.ica.2021.120302</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ica.2021.120302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ica.2021.120302%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganica%2520Chimica%2520Acta%26atitle%3DSynthesis%252Band%252Bcharacterization%252Bof%252Bethylenediamine%252Bplatinum%252528II%252529%252Bcomplexes%252Bcontaining%252Bthiourea%252Bderivatives.%252BX-ray%252Bcrystal%252Bstructures%252Bof%252B%25255BPt%252528en%252529%2525282-imidazolidinethione%2525292%25255D%252528NO3%2525292%252Band%252B%25255BPt%252528en%252529%2525281-phenyl-2-thiourea%2525292%25255D%252528NO3%2525292%26aulast%3DBahkali%26aufirst%3DAshwaq%26date%3D2021%26volume%3D520%26spage%3D120302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Graham L.  Patrick</span>. </span><span class="cited-content_cbyCitation_article-title">Transferases and their inhibition. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 433-458. <a href="https://doi.org/10.1016/B978-0-08-101210-9.00012-3" title="DOI URL">https://doi.org/10.1016/B978-0-08-101210-9.00012-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-101210-9.00012-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-101210-9.00012-3%26sid%3Dliteratum%253Aachs%26atitle%3DTransferases%252Band%252Btheir%252Binhibition%26aulast%3DPatrick%26aufirst%3DGraham%2BL.%26date%3D2020%26spage%3D433%26epage%3D458%26pub%3DElsevier%26atitle%3DAntimalarial%252BAgents%26date%3D2020%26volume%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mai  Tsubamoto</span>, <span class="hlFld-ContribAuthor ">Toan Khanh  Le</span>, <span class="hlFld-ContribAuthor ">Minghua  Li</span>, <span class="hlFld-ContribAuthor ">Taku  Watanabe</span>, <span class="hlFld-ContribAuthor ">Chiemi  Matsumi</span>, <span class="hlFld-ContribAuthor ">Prakash  Parvatkar</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Fujii</span>, <span class="hlFld-ContribAuthor ">Nobuo  Kato</span>, <span class="hlFld-ContribAuthor ">Jiazhi  Sun</span>, <span class="hlFld-ContribAuthor ">Junko  Ohkanda</span>. </span><span class="cited-content_cbyCitation_article-title">A Guanidyl‐Based Bivalent Peptidomimetic Inhibits K‐Ras Prenylation and Association with c‐Raf. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2019,</strong> <em>25 </em>
                                    (59)
                                     , 13531-13536. <a href="https://doi.org/10.1002/chem.201903129" title="DOI URL">https://doi.org/10.1002/chem.201903129</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201903129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201903129%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DA%252BGuanidyl%2525E2%252580%252590Based%252BBivalent%252BPeptidomimetic%252BInhibits%252BK%2525E2%252580%252590Ras%252BPrenylation%252Band%252BAssociation%252Bwith%252Bc%2525E2%252580%252590Raf%26aulast%3DTsubamoto%26aufirst%3DMai%26date%3D2019%26date%3D2019%26volume%3D25%26issue%3D59%26spage%3D13531%26epage%3D13536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna Caroline  Aguiar</span>, <span class="hlFld-ContribAuthor ">Lorena R.F.  de Sousa</span>, <span class="hlFld-ContribAuthor ">Celia R.S.  Garcia</span>, <span class="hlFld-ContribAuthor ">Glaucius  Oliva</span>, <span class="hlFld-ContribAuthor ">Rafael V.C.  Guido</span>. </span><span class="cited-content_cbyCitation_article-title">New Molecular Targets and Strategies for Antimalarial Discovery. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2019,</strong> <em>26 </em>
                                    (23)
                                     , 4380-4402. <a href="https://doi.org/10.2174/0929867324666170830103003" title="DOI URL">https://doi.org/10.2174/0929867324666170830103003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867324666170830103003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867324666170830103003%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DNew%252BMolecular%252BTargets%252Band%252BStrategies%252Bfor%252BAntimalarial%252BDiscovery%26aulast%3DAguiar%26aufirst%3DAnna%2BCaroline%26date%3D2019%26volume%3D26%26issue%3D23%26spage%3D4380%26epage%3D4402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. N.  Grozav</span>, <span class="hlFld-ContribAuthor ">V. A.  Chornous</span>, <span class="hlFld-ContribAuthor ">V. I.  Dorokhov</span>, <span class="hlFld-ContribAuthor ">M. V.  Vovk</span>. </span><span class="cited-content_cbyCitation_article-title">Polyfunctional imidazoles: XIV. 4-sulfonyl-5-formyl-1H-imidazoles. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>53 </em>
                                    (10)
                                     , 1548-1555. <a href="https://doi.org/10.1134/S1070428017100104" title="DOI URL">https://doi.org/10.1134/S1070428017100104</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428017100104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428017100104%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPolyfunctional%252Bimidazoles%25253A%252BXIV.%252B4-sulfonyl-5-formyl-1H-imidazoles%26aulast%3DGrozav%26aufirst%3DA.%2BN.%26date%3D2017%26date%3D2017%26volume%3D53%26issue%3D10%26spage%3D1548%26epage%3D1555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kuldeep K.  Roy</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the active sites of malarial proteases for antimalarial drug discovery: approaches, progress and challenges. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Antimicrobial Agents</span><span> <strong>2017,</strong> <em>50 </em>
                                    (3)
                                     , 287-302. <a href="https://doi.org/10.1016/j.ijantimicag.2017.04.006" title="DOI URL">https://doi.org/10.1016/j.ijantimicag.2017.04.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijantimicag.2017.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijantimicag.2017.04.006%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Antimicrobial%2520Agents%26atitle%3DTargeting%252Bthe%252Bactive%252Bsites%252Bof%252Bmalarial%252Bproteases%252Bfor%252Bantimalarial%252Bdrug%252Bdiscovery%25253A%252Bapproaches%25252C%252Bprogress%252Band%252Bchallenges%26aulast%3DRoy%26aufirst%3DKuldeep%2BK.%26date%3D2017%26volume%3D50%26issue%3D3%26spage%3D287%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Damien  Bosc</span>, <span class="hlFld-ContribAuthor ">Elisabeth  Mouray</span>, <span class="hlFld-ContribAuthor ">Sandrine  Cojean</span>, <span class="hlFld-ContribAuthor ">Caio Haddad  Franco</span>, <span class="hlFld-ContribAuthor ">Philippe M.  Loiseau</span>, <span class="hlFld-ContribAuthor ">Lucio H.  Freitas-Junior</span>, <span class="hlFld-ContribAuthor ">Carolina Borsoi  Moraes</span>, <span class="hlFld-ContribAuthor ">Philippe  Grellier</span>, <span class="hlFld-ContribAuthor ">Joëlle  Dubois</span>. </span><span class="cited-content_cbyCitation_article-title">Highly improved antiparasitic activity after introduction of an N-benzylimidazole moiety on protein farnesyltransferase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>109 </em>, 173-186. <a href="https://doi.org/10.1016/j.ejmech.2015.12.045" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.12.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.12.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.12.045%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHighly%252Bimproved%252Bantiparasitic%252Bactivity%252Bafter%252Bintroduction%252Bof%252Ban%252BN-benzylimidazole%252Bmoiety%252Bon%252Bprotein%252Bfarnesyltransferase%252Binhibitors%26aulast%3DBosc%26aufirst%3DDamien%26date%3D2016%26volume%3D109%26spage%3D173%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liuqing  Yang</span>, <span class="hlFld-ContribAuthor ">Wei  Liu</span>, <span class="hlFld-ContribAuthor ">Hanbing  Mei</span>, <span class="hlFld-ContribAuthor ">Yuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaojuan  Yu</span>, <span class="hlFld-ContribAuthor ">Yufang  Xu</span>, <span class="hlFld-ContribAuthor ">Honglin  Li</span>, <span class="hlFld-ContribAuthor ">Jin  Huang</span>, <span class="hlFld-ContribAuthor ">Zhenjiang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of pentanedioic acid derivatives as farnesyltransferase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2015,</strong> <em>6 </em>
                                    (4)
                                     , 671-676. <a href="https://doi.org/10.1039/C4MD00498A" title="DOI URL">https://doi.org/10.1039/C4MD00498A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4MD00498A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4MD00498A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bpentanedioic%252Bacid%252Bderivatives%252Bas%252Bfarnesyltransferase%252Binhibitors%26aulast%3DYang%26aufirst%3DLiuqing%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D4%26spage%3D671%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tabish  Qidwai</span>, <span class="hlFld-ContribAuthor ">Farrukh  Jamal</span>, <span class="hlFld-ContribAuthor ">Mohd Y.  Khan</span>, <span class="hlFld-ContribAuthor ">Bechan  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring Drug Targets in Isoprenoid Biosynthetic Pathway for
              Plasmodium falciparum. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry Research International</span><span> <strong>2014,</strong> <em>2014 </em>, 1-12. <a href="https://doi.org/10.1155/2014/657189" title="DOI URL">https://doi.org/10.1155/2014/657189</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2014/657189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2014%2F657189%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%2520Research%2520International%26atitle%3DExploring%252BDrug%252BTargets%252Bin%252BIsoprenoid%252BBiosynthetic%252BPathway%252Bfor%252BPlasmodium%252Bfalciparum%26aulast%3DQidwai%26aufirst%3DTabish%26date%3D2014%26volume%3D2014%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maryanna E.  Lanning</span>, <span class="hlFld-ContribAuthor ">Steven  Fletcher</span>. </span><span class="cited-content_cbyCitation_article-title">Azodicarbonyl dimorpholide (ADDM): an effective, versatile, and water-soluble Mitsunobu reagent. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2013,</strong> <em>54 </em>
                                    (35)
                                     , 4624-4628. <a href="https://doi.org/10.1016/j.tetlet.2013.06.049" title="DOI URL">https://doi.org/10.1016/j.tetlet.2013.06.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2013.06.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2013.06.049%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DAzodicarbonyl%252Bdimorpholide%252B%252528ADDM%252529%25253A%252Ban%252Beffective%25252C%252Bversatile%25252C%252Band%252Bwater-soluble%252BMitsunobu%252Breagent%26aulast%3DLanning%26aufirst%3DMaryanna%2BE.%26date%3D2013%26volume%3D54%26issue%3D35%26spage%3D4624%26epage%3D4628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joshua D.  Ochocki</span>, <span class="hlFld-ContribAuthor ">Mark D.  Distefano</span>. </span><span class="cited-content_cbyCitation_article-title">Prenyltransferase inhibitors: treating human ailments from cancer to parasitic infections. </span><span class="cited-content_cbyCitation_journal-name">Med. Chem. Commun.</span><span> <strong>2013,</strong> <em>4 </em>
                                    (3)
                                     , 476-492. <a href="https://doi.org/10.1039/C2MD20299A" title="DOI URL">https://doi.org/10.1039/C2MD20299A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C2MD20299A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC2MD20299A%26sid%3Dliteratum%253Aachs%26jtitle%3DMed.%2520Chem.%2520Commun.%26atitle%3DPrenyltransferase%252Binhibitors%25253A%252Btreating%252Bhuman%252Bailments%252Bfrom%252Bcancer%252Bto%252Bparasitic%252Binfections%26aulast%3DOchocki%26aufirst%3DJoshua%2BD.%26date%3D2013%26date%3D2013%26volume%3D4%26issue%3D3%26spage%3D476%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaojuan  Yu</span>, <span class="hlFld-ContribAuthor ">Xue  Zhao</span>, <span class="hlFld-ContribAuthor ">Lili  Zhu</span>, <span class="hlFld-ContribAuthor ">Chuanxin  Zou</span>, <span class="hlFld-ContribAuthor ">Xiaofeng  Liu</span>, <span class="hlFld-ContribAuthor ">Zhenjiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Jin  Huang</span>, <span class="hlFld-ContribAuthor ">Honglin  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel inhibitors for human farnesyltransferase (hFTase) via structure-based virtual screening. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2013,</strong> <em>4 </em>
                                    (6)
                                     , 962. <a href="https://doi.org/10.1039/c3md00058c" title="DOI URL">https://doi.org/10.1039/c3md00058c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3md00058c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3md00058c%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDiscovery%252Bof%252Bnovel%252Binhibitors%252Bfor%252Bhuman%252Bfarnesyltransferase%252B%252528hFTase%252529%252Bvia%252Bstructure-based%252Bvirtual%252Bscreening%26aulast%3DYu%26aufirst%3DXiaojuan%26date%3D2013%26volume%3D4%26issue%3D6%26spage%3D962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Esther  Jortzik</span>, <span class="hlFld-ContribAuthor ">Lihui  Wang</span>, <span class="hlFld-ContribAuthor ">Katja  Becker</span>. </span><span class="cited-content_cbyCitation_article-title">Thiol-Based Posttranslational Modifications in Parasites. </span><span class="cited-content_cbyCitation_journal-name">Antioxidants & Redox Signaling</span><span> <strong>2012,</strong> <em>17 </em>
                                    (4)
                                     , 657-673. <a href="https://doi.org/10.1089/ars.2011.4266" title="DOI URL">https://doi.org/10.1089/ars.2011.4266</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/ars.2011.4266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fars.2011.4266%26sid%3Dliteratum%253Aachs%26jtitle%3DAntioxidants%2520%2526%2520Redox%2520Signaling%26atitle%3DThiol-Based%252BPosttranslational%252BModifications%252Bin%252BParasites%26aulast%3DJortzik%26aufirst%3DEsther%26date%3D2012%26volume%3D17%26issue%3D4%26spage%3D657%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sérgio Filipe  Sousa</span>, <span class="hlFld-ContribAuthor ">Pedro Alexandrino  Fernandes</span>, <span class="hlFld-ContribAuthor ">Maria João  Ramos</span>. </span><span class="cited-content_cbyCitation_article-title">Computational enzymatic catalysis – clarifying enzymatic mechanisms with the help of computers. </span><span class="cited-content_cbyCitation_journal-name">Physical Chemistry Chemical Physics</span><span> <strong>2012,</strong> <em>14 </em>
                                    (36)
                                     , 12431. <a href="https://doi.org/10.1039/c2cp41180f" title="DOI URL">https://doi.org/10.1039/c2cp41180f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c2cp41180f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc2cp41180f%26sid%3Dliteratum%253Aachs%26jtitle%3DPhysical%2520Chemistry%2520Chemical%2520Physics%26atitle%3DComputational%252Benzymatic%252Bcatalysis%252B%2525E2%252580%252593%252Bclarifying%252Benzymatic%252Bmechanisms%252Bwith%252Bthe%252Bhelp%252Bof%252Bcomputers%26aulast%3DSousa%26aufirst%3DS%25C3%25A9rgio%2BFilipe%26date%3D2012%26volume%3D14%26issue%3D36%26spage%3D12431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuqin  Qiao</span>, <span class="hlFld-ContribAuthor ">Jinbo  Gao</span>, <span class="hlFld-ContribAuthor ">Yongge  Qiu</span>, <span class="hlFld-ContribAuthor ">Long  Wu</span>, <span class="hlFld-ContribAuthor ">Fei  Guo</span>, <span class="hlFld-ContribAuthor ">Kenneth  Kam-Wing Lo</span>, <span class="hlFld-ContribAuthor ">Ding  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and characterization of piperazinedione-based dual protein inhibitors for both farnesyltransferase and geranylgeranyltransferase-I. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>46 </em>
                                    (6)
                                     , 2264-2273. <a href="https://doi.org/10.1016/j.ejmech.2011.03.007" title="DOI URL">https://doi.org/10.1016/j.ejmech.2011.03.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2011.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2011.03.007%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bcharacterization%252Bof%252Bpiperazinedione-based%252Bdual%252Bprotein%252Binhibitors%252Bfor%252Bboth%252Bfarnesyltransferase%252Band%252Bgeranylgeranyltransferase-I%26aulast%3DQiao%26aufirst%3DYuqin%26date%3D2011%26volume%3D46%26issue%3D6%26spage%3D2264%26epage%3D2273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeremy N.  Burrows</span>, <span class="hlFld-ContribAuthor ">David  Waterson</span>. </span><span class="cited-content_cbyCitation_article-title">Discovering New Medicines to Control and Eradicate Malaria. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 125-180. <a href="https://doi.org/10.1007/7355_2011_14" title="DOI URL">https://doi.org/10.1007/7355_2011_14</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2011_14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2011_14%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovering%252BNew%252BMedicines%252Bto%252BControl%252Band%252BEradicate%252BMalaria%26aulast%3DBurrows%26aufirst%3DJeremy%2BN.%26date%3D2011%26date%3D2011%26spage%3D125%26epage%3D180%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DThird%252BWorld%252BDiseases%26aulast%3DElliott%26aufirst%3DRichard%26date%3D2011%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Corissa L.  Lamphear</span>, <span class="hlFld-ContribAuthor ">Elaina A.  Zverina</span>, <span class="hlFld-ContribAuthor ">James L.  Hougland</span>, <span class="hlFld-ContribAuthor ">Carol A.  Fierke</span>. </span><span class="cited-content_cbyCitation_article-title">Global Identification of Protein Prenyltransferase Substrates. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 207-234. <a href="https://doi.org/10.1016/B978-0-12-381339-8.00012-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-381339-8.00012-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-381339-8.00012-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-381339-8.00012-3%26sid%3Dliteratum%253Aachs%26atitle%3DGlobal%252BIdentification%252Bof%252BProtein%252BPrenyltransferase%252BSubstrates%26aulast%3DLamphear%26aufirst%3DCorissa%2BL.%26date%3D2011%26spage%3D207%26epage%3D234%26pub%3DElsevier%26atitle%3DProtein%252BPrenylation%252BPART%252BA%26date%3D2011%26volume%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Norbert  Berndt</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Hamilton</span>, <span class="hlFld-ContribAuthor ">Saïd M.  Sebti</span>. </span><span class="cited-content_cbyCitation_article-title">Geranylgeranyltransferase-1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 129-163. <a href="https://doi.org/10.1016/B978-0-12-415922-8.00006-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-415922-8.00006-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-415922-8.00006-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-415922-8.00006-9%26sid%3Dliteratum%253Aachs%26atitle%3DGeranylgeranyltransferase-1%252BInhibitors%26aulast%3DBerndt%26aufirst%3DNorbert%26date%3D2011%26spage%3D129%26epage%3D163%26pub%3DElsevier%26atitle%3DProtein%252BPrenylation%252BPart%252BB%26date%3D2011%26volume%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gregory J.  Crowther</span>, <span class="hlFld-ContribAuthor ">Alberto J.  Napuli</span>, <span class="hlFld-ContribAuthor ">James H.  Gilligan</span>, <span class="hlFld-ContribAuthor ">Kerstin  Gagaring</span>, <span class="hlFld-ContribAuthor ">Rachel  Borboa</span>, <span class="hlFld-ContribAuthor ">Carolyn  Francek</span>, <span class="hlFld-ContribAuthor ">Zhong  Chen</span>, <span class="hlFld-ContribAuthor ">Eleanor F.  Dagostino</span>, <span class="hlFld-ContribAuthor ">Justin B.  Stockmyer</span>, <span class="hlFld-ContribAuthor ">Yu  Wang</span>, <span class="hlFld-ContribAuthor ">Philip P.  Rodenbough</span>, <span class="hlFld-ContribAuthor ">Lisa J.  Castaneda</span>, <span class="hlFld-ContribAuthor ">David J.  Leibly</span>, <span class="hlFld-ContribAuthor ">Janhavi  Bhandari</span>, <span class="hlFld-ContribAuthor ">Michael H.  Gelb</span>, <span class="hlFld-ContribAuthor ">Achim  Brinker</span>, <span class="hlFld-ContribAuthor ">Ingo H.  Engels</span>, <span class="hlFld-ContribAuthor ">Jennifer  Taylor</span>, <span class="hlFld-ContribAuthor ">Arnab K.  Chatterjee</span>, <span class="hlFld-ContribAuthor ">Pascal  Fantauzzi</span>, <span class="hlFld-ContribAuthor ">Richard J.  Glynne</span>, <span class="hlFld-ContribAuthor ">Wesley C.  Van Voorhis</span>, <span class="hlFld-ContribAuthor ">Kelli L.  Kuhen</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of inhibitors for putative malaria drug targets among novel antimalarial compounds. </span><span class="cited-content_cbyCitation_journal-name">Molecular and Biochemical Parasitology</span><span> <strong>2011,</strong> <em>175 </em>
                                    (1)
                                     , 21-29. <a href="https://doi.org/10.1016/j.molbiopara.2010.08.005" title="DOI URL">https://doi.org/10.1016/j.molbiopara.2010.08.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molbiopara.2010.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molbiopara.2010.08.005%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520and%2520Biochemical%2520Parasitology%26atitle%3DIdentification%252Bof%252Binhibitors%252Bfor%252Bputative%252Bmalaria%252Bdrug%252Btargets%252Bamong%252Bnovel%252Bantimalarial%252Bcompounds%26aulast%3DCrowther%26aufirst%3DGregory%2BJ.%26date%3D2011%26volume%3D175%26issue%3D1%26spage%3D21%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kunal  Roy</span>, <span class="hlFld-ContribAuthor ">Probir Kumar  Ojha</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in quantitative structure–activity relationship models of antimalarials. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2010,</strong> <em>5 </em>
                                    (8)
                                     , 751-778. <a href="https://doi.org/10.1517/17460441.2010.497812" title="DOI URL">https://doi.org/10.1517/17460441.2010.497812</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2010.497812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2010.497812%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DAdvances%252Bin%252Bquantitative%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Bmodels%252Bof%252Bantimalarials%26aulast%3DRoy%26aufirst%3DKunal%26date%3D2010%26date%3D2010%26volume%3D5%26issue%3D8%26spage%3D751%26epage%3D778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Duk-Won  Doug Chung</span>, <span class="hlFld-ContribAuthor ">Nadia  Ponts</span>, <span class="hlFld-ContribAuthor ">Serena  Cervantes</span>, <span class="hlFld-ContribAuthor ">Karine G.  Le Roch</span>. </span><span class="cited-content_cbyCitation_article-title">Post-translational modifications in Plasmodium: More than you think!. </span><span class="cited-content_cbyCitation_journal-name">Molecular and Biochemical Parasitology</span><span> <strong>2009,</strong> <em>168 </em>
                                    (2)
                                     , 123-134. <a href="https://doi.org/10.1016/j.molbiopara.2009.08.001" title="DOI URL">https://doi.org/10.1016/j.molbiopara.2009.08.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molbiopara.2009.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molbiopara.2009.08.001%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520and%2520Biochemical%2520Parasitology%26atitle%3DPost-translational%252Bmodifications%252Bin%252BPlasmodium%25253A%252BMore%252Bthan%252Byou%252Bthink%252521%26aulast%3DDoug%2BChung%26aufirst%3DDuk-Won%26date%3D2009%26volume%3D168%26issue%3D2%26spage%3D123%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0001.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. The various scaffolds used in this study as alternatives to the ethylenediamine scaffold in <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Low energy docked conformations (GOLD<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a>) of inhibitors loosely constrained to the predicted binding mode of <b>1a</b>.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> Docked inhibitors are colored by atom type and are overlaid by the predicted docking pose of <b>1a</b> in yellow. Farnesylpyrophosphate (FPP) is shown in red. Hydrophobic surface residues are colored red, hydrophilic residues and structural waters are blue, and the Zn<sup>2+</sup> ion is pink: (A) <b>1a</b> docked alone; (B) (±)-<b>6a</b> overlaid with <b>1a</b>; (C) (±)-<b>9a</b> overlaid with <b>1a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0019.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. 2-Aminoethanamide- (<i>n</i> = 1) and 3-aminopropanamide- (<i>n</i> = 2) based inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0004.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) DHP, cat. PPTS, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C → rt, 16 h, 85%; (b) H<sub>2</sub>, 10% Pd/C, MeOH, rt, 1 h, 82%; (c) <i>p</i>-fluorobenzonitrile, DIPEA, DMSO, 120 °C, 24 h, 87%; (d) (1) NaH, DMF, 0 °C, 30 min; (2) <b>15</b>, 0 °C → rt, 3 h, 81% (or 97% brsm); (e) <i>p</i>-TsOH·H<sub>2</sub>O, MeOH, rt, 1 h, 88%; (f) <b>19a</b>−<b>e</b>, DIAD, PPh<sub>3</sub>, THF, rt, 1 h, 61−98%.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0005.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) RNH<sub>2</sub>, DIPEA, CH<sub>3</sub>CN, 0 °C → rt, 16 h, 81−93%.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0006.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Boc<sub>2</sub>O, cat. DMAP, THF, rt, 16 h, 99%; (b) H<sub>2</sub>, 10% Pd/C, EtOH, rt, 16 h, 100%; (c) <i>N</i>-(2-pyrimidinyl)-4-hydroxymethylpiperidine, PPh<sub>3</sub>, DIAD, THF, rt, 16 h; (d) TFA/CH<sub>2</sub>Cl<sub>2</sub>, 1:1, rt, 3 h, 92% (two steps).</p></p></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0007.jpeg" id="rightTab-gs4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <i>p</i>-fluorobenzonitrile, DIPEA, DMSO, 180 °C, 48 h, 40%; (b) TBDPSCl, Im, DMF, 45 °C, 18 h, 90%; (c) (1) NaH, DMF, 0 °C, 30 min; (2) <b>15</b>, 0 °C → rt, 3 h, 53% (or 82% brsm); (d) TBAF, THF, 0 °C → rt, 2 h, 95%; (e) <b>19a</b>−<b>e</b>, DIAD, PPh<sub>3</sub>, THF, 45 °C, 18 h, 50−68%.</p></p></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0008.jpeg" id="rightTab-gs5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (1) 3-Methyl-3<i>H</i>-imidazole-4-carbaldehyde, AcOH, 4 Å molecular sieves, MeOH, rt, 1 h; (2) NaCNBH<sub>3</sub>, rt, 16 h, 63%; (b) benzyloxyacetyl chloride (or 3-benzyloxypropanoyl chloride), pyridine, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h, 87−94%; (c) Zn(CN)<sub>2</sub>, 10 mol % Pd(PPh<sub>3</sub>)<sub>4</sub>, cat. Zn(OAc)<sub>2</sub>, cat. Zn dust, DMF, 120 °C, 2 h, 85−89%; (d) H<sub>2</sub>, 10% Pd/C, 0.5% conc HCl (v/v), EtOH, rt, 90 min, 84−94%; (e) <b>19a</b> or <b>19d</b>, PPh<sub>3</sub>, DIAD, THF, rt, 1 h, 52% for <b>4a</b>, or 20% for <b>4d</b>; or <b>21</b>, PPh<sub>3</sub>, DIAD, THF, rt, 1 h, 56% for <b>34</b>; (f) TFA/CH<sub>2</sub>Cl<sub>2</sub>, 1:1, rt, 3 h, 97%; (g) RBr, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, 16−36 h, 50−96%.</p></p></figure><figure data-id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0009.jpeg" id="rightTab-gs6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <i>p</i>-Fluorobenzonitrile, DIPEA, DMSO, 120 °C, 24 h, 87%; (b) (1) NaH, DMF, 0 °C, 30 min; (2) <b>15</b>, 0 °C → rt, 3 h, 56% (or 89% brsm); (c) H<sub>2</sub>, 10% Pd/C, 0.5% conc HCl, EtOH, rt, 1 h, 87%; (d) PPh<sub>3</sub>, DIAD, DPPA, THF, 0 °C → rt, 16 h; (e) (1) PPh<sub>3</sub>, THF, rt, 1 h; (2) H<sub>2</sub>O, 65 °C, 7 h, 56% (combined yield for steps d and e); (f) <b>18</b>, DIPEA, CH<sub>3</sub>CN, 0 °C → rt, 16 h, 75%; (g) RBr (or RI), Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, 16 h to 7 days, 22−81%.</p></p></figure><figure data-id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0010.jpeg" id="rightTab-gs7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <i>p</i>-Nitrobenzoic acid, PPh<sub>3</sub>, DIAD, THF, rt, 16 h; (b) LiOH·H<sub>2</sub>O, THF/MeOH/H<sub>2</sub>O, 3:1:1, rt, 3 h, 39% (two steps); (c) <b>21</b>, PPh<sub>3</sub>, DIAD, THF, 45 °C, 16 h; (d) TFA/CH<sub>2</sub>Cl<sub>2</sub>, 1:1, rt, 3 h, 63% (two steps); (e) RBr, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, 16 h to 7 days, 75−85%.</p></p></figure><figure data-id="sch8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0011.jpeg" id="rightTab-gs8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) TBDPSCl, Im, THF, 45 °C, 16 h, 99%; (b) Grubbs’s first generation catalyst, CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 days, 63%; (c) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C → rt, 16 h, 43% (<b>49</b>), 41% (<b>50</b>); (d) LiAlH<sub>4</sub>, THF, 0 °C, 2 h, 93% ((±)-<b>51</b>) or 84% ((±)-<b>56</b>); (e) BnBr, NaH, DMF, 0 °C → rt, 16 h, 98%; (f) TBAF, THF, 0 °C → rt, 3 h, 97%; (g) PPh<sub>3</sub>, DIAD, DPPA, THF, rt, 16 h, 88% (from (±)-<b>52</b>) or 92% (from (±)-<b>57</b>); (h) (1) PPh<sub>3</sub>, THF, rt, 1 h; (2) H<sub>2</sub>O, 65 °C, 7 h, 94% ((±)-<b>53</b>) or 97% ((±)-<b>58</b>); (i) <i>p</i>-fluorobenzonitrile, DIPEA, DMSO, 120 °C, 2 d, 48 h, 99% (from (±)-<b>53</b>) or 94% (from (±)-<b>58</b>); (j) (1) NaH, DMF, 0 °C, 30 min; (2) <b>15</b>, 0 °C → rt, 3 h, 52% ((±)-<b>54</b>) or 47% ((±)-<b>59</b>); (k) H<sub>2</sub>, 10% Pd/C, 0.5% conc HCl (v/v), EtOH, rt, 1 h, 83% ((±)-<b>55</b>) or 85% ((±)-<b>60</b>); (l) <b>19a</b>−<b>e</b>, PPh<sub>3</sub>, DIAD, THF, rt, 16 h, 32−79%; (m) (1) NaH, THF, 0 °C, 1 h; (2) BnBr, TBAI, 0 °C → rt, 16 h, 95%.</p></p></figure><figure data-id="sch9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0012.jpeg" id="rightTab-gs9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <i>p</i>-fluorobenzonitrile, DIPEA, DMSO, 120 °C, 48 h, 77% (for (±)-<b>62</b>) or 89% (from (±)-<b>65</b>); (b) <b>18</b>, DIPEA, CH<sub>3</sub>CN, rt, 16 h, 76% (for (±)-<b>63</b>) or 86% (for (±)-<b>66</b>); (c) RBr, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, 16 h to 3 days, 82−99%; (d) (1) NaH, DMF, 0 °C, 30 min; (2) <b>15</b>, 0 °C → rt, 12 h, 61−69% (92−95% brsm); (e) TFA/CH<sub>2</sub>Cl<sub>2</sub>, 1:1, rt, 30 min, 100%.</p></p></figure><figure data-id="fig4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0028.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. QSAR model in which descriptors were calculated on the basis of docked poses of ligands constrained to our hypothesized binding mode: (blue diamond) training set, <i>r</i><sup>2</sup> = 0.86; (pink square) test set, <i>q</i><sup>2</sup> = 0.81.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/medium/jm-2008-00113p_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0029.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. QSAR model in which descriptors were calculated on the basis of ligands that had been energy-minimized: (blue diamond) training set, <i>r</i><sup>2</sup> = 0.86; (pink square) test set, <i>q</i><sup>2</sup> = 0.37.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-17/jm800113p/production/images/large/jm-2008-00113p_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800113p&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i91">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33510" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33510" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 38 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Sachs, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malaney, P.</span><span> </span><span class="NLM_article-title">The economic and social burden of malaria</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">415</span><span class="NLM_x">, </span> <span class="NLM_fpage">680</span><span class="NLM_x">–</span> <span class="NLM_lpage">685</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm800113p&amp;key=10.1038%2F415680a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm800113p&amp;key=11832956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm800113p&amp;key=1%3ACAS%3A528%3ADC%252BD38XhsVCjtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=415&publication_year=2002&pages=680-685&author=J.+Sachsauthor=P.+Malaney&title=The+economic+and+social+burden+of+malaria"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The economic and social burden of malaria</span></div><div class="casAuthors">Sachs, Jeffrey; Malaney, Pia</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">415</span>
        (<span class="NLM_cas:issue">6872</span>),
    <span class="NLM_cas:pages">680-685</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Where malaria prospers most, human societies have prospered least.  The global distribution of per-capita gross domestic product shows a striking correlation between malaria and poverty, and malaria-endemic countries also have lower rates of economic growth.  There are multiple channels by which malaria impedes development, including effects on fertility, population growth, saving and investment, worker productivity, absenteeism, premature mortality and medical costs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJw0oyArOfc7Vg90H21EOLACvtfcHk0liPuAhDCSf8UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhsVCjtrY%253D&md5=0c755731170660d29535bc48425b494e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2F415680a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F415680a%26sid%3Dliteratum%253Aachs%26aulast%3DSachs%26aufirst%3DJ.%26aulast%3DMalaney%26aufirst%3DP.%26atitle%3DThe%2520economic%2520and%2520social%2520burden%2520of%2520malaria%26jtitle%3DNature%26date%3D2002%26volume%3D415%26spage%3D680%26epage%3D685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><a href="http://www.mmv.org" class="extLink">www.mmv.org</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=www.mmv.org."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Snow, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trape, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K.</span><span> </span><span class="NLM_article-title">The past, present and future of childhood malaria mortality in Africa</span> <span class="citation_source-journal">Trends Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">593</span><span class="NLM_x">–</span> <span class="NLM_lpage">597</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm800113p&amp;key=10.1016%2FS1471-4922%2801%2902031-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm800113p&amp;key=11756044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm800113p&amp;key=1%3ACAS%3A280%3ADC%252BD38%252Fjs1OmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2001&pages=593-597&author=R.+W.+Snowauthor=J.+F.+Trapeauthor=K.+Marsh&title=The+past%2C+present+and+future+of+childhood+malaria+mortality+in+Africa"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The past, present and future of childhood malaria mortality in Africa</span></div><div class="casAuthors">Snow R W; Trape J F; Marsh K</div><div class="citationInfo"><span class="NLM_cas:title">Trends in parasitology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">593-7</span>
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    </div><div class="casAbstract">During the past few years, there has been a historic series of declarations of renewed commitment to malaria control in Africa.  Whether the burden of malaria is increasing in Africa is a moot point.  This article attempts to re-construct the evidence for the trends in childhood mortality as a result of Plasmodium falciparum infection over the last century in Africa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS4Qd7nIUDExhjv2lLSLOxFfW6udTcc2eYKqVP-BhcegLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38%252Fjs1OmtA%253D%253D&md5=dafa1e94d9454a0acc3057b88e5f9efb</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS1471-4922%2801%2902031-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1471-4922%252801%252902031-1%26sid%3Dliteratum%253Aachs%26aulast%3DSnow%26aufirst%3DR.%2BW.%26aulast%3DTrape%26aufirst%3DJ.%2BF.%26aulast%3DMarsh%26aufirst%3DK.%26atitle%3DThe%2520past%252C%2520present%2520and%2520future%2520of%2520childhood%2520malaria%2520mortality%2520in%2520Africa%26jtitle%3DTrends%2520Parasitol.%26date%3D2001%26volume%3D17%26spage%3D593%26epage%3D597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Olliaro, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloland, P. B.</span><span> </span><span class="NLM_article-title">Clinical and public health implications of antimalarial drug resistance</span> <span class="citation_source-journal">Antimalar. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm800113p&amp;key=10.1385%2F1-59259-111-6%3A65" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=65-83&author=P.+L.+Olliaroauthor=P.+B.+Bloland&title=Clinical+and+public+health+implications+of+antimalarial+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1385%2F1-59259-111-6%3A65&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252F1-59259-111-6%253A65%26sid%3Dliteratum%253Aachs%26aulast%3DOlliaro%26aufirst%3DP.%2BL.%26aulast%3DBloland%26aufirst%3DP.%2BB.%26atitle%3DClinical%2520and%2520public%2520health%2520implications%2520of%2520antimalarial%2520drug%2520resistance%26jtitle%3DAntimalar.%2520Chemother.%26date%3D2001%26spage%3D65%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Wiesner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jomaa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlitzer, M.</span><span> </span><span class="NLM_article-title">New antimalarial drugs</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5274</span><span class="NLM_x">–</span> <span class="NLM_lpage">5293</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=5274-5293&author=J.+Wiesnerauthor=R.+Ortmannauthor=H.+Jomaaauthor=M.+Schlitzer&title=New+antimalarial+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWiesner%26aufirst%3DJ.%26aulast%3DOrtmann%26aufirst%3DR.%26aulast%3DJomaa%26aufirst%3DH.%26aulast%3DSchlitzer%26aufirst%3DM.%26atitle%3DNew%2520antimalarial%2520drugs%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D5274%26epage%3D5293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">May, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, C. G.</span><span> </span><span class="NLM_article-title">Chemoresistance in falciparum malaria</span> <span class="citation_source-journal">Trends Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">432</span><span class="NLM_x">–</span> <span class="NLM_lpage">435</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm800113p&amp;key=10.1016%2Fj.pt.2003.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm800113p&amp;key=14519577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm800113p&amp;key=1%3ACAS%3A528%3ADC%252BD3sXns1Kmtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2003&pages=432-435&author=J.+Mayauthor=C.+G.+Meyer&title=Chemoresistance+in+falciparum+malaria"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoresistance in falciparum malaria</span></div><div class="casAuthors">May, Jurgen; Meyer, Christian G.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Parasitology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">432-435</span>CODEN:
                <span class="NLM_cas:coden">TPRACT</span>;
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Tropical countries increasingly face the burden of drug resistance in Plasmodium falciparum infections.  Malaria-related mortality of African children rises in contrast to the decline of the overall mortality of children under five years of age in sub-Saharan Africa within the past four decades.  The disaster can largely be attributed to antimalarial drug resistance in most malaria-endemic countries.  The principles and mechanisms of chemoresistance in Plasmodium falciparum infections, in addn. to the development and evaluation of new drugs and drug combinations, are major concerns of current malaria research and control strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWU6fqwkUYzrVg90H21EOLACvtfcHk0lh89lJ7Lswp7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXns1Kmtbc%253D&md5=489d889d4b6005107d52853be32b5187</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2003.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2003.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DJ.%26aulast%3DMeyer%26aufirst%3DC.%2BG.%26atitle%3DChemoresistance%2520in%2520falciparum%2520malaria%26jtitle%3DTrends%2520Parasitol.%26date%3D2003%26volume%3D19%26spage%3D432%26epage%3D435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Ridley, R. G.</span><span> </span><span class="NLM_article-title">Medical need, scientific opportunity and the drive for antimalarial drugs</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">415</span><span class="NLM_x">, </span> <span class="NLM_fpage">686</span><span class="NLM_x">–</span> <span class="NLM_lpage">693</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm800113p&amp;key=10.1038%2F415686a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm800113p&amp;key=11832957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm800113p&amp;key=1%3ACAS%3A528%3ADC%252BD38XhsVCjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=415&publication_year=2002&pages=686-693&author=R.+G.+Ridley&title=Medical+need%2C+scientific+opportunity+and+the+drive+for+antimalarial+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Medical need, scientific opportunity and the drive for antimalarial drugs</span></div><div class="casAuthors">Ridley, Robert G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">415</span>
        (<span class="NLM_cas:issue">6872</span>),
    <span class="NLM_cas:pages">686-693</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Continued and sustainable improvements in antimalarial medicines through focused research and development are essential for the world's future ability to treat and control malaria.  Unfortunately, malaria is a disease of poverty, and despite a wealth of scientific knowledge there is insufficient market incentive to generate the competitive, business-driven industrial antimalarial drug research and development that is normally needed to deliver new products.  Mechanisms of partnering with industry have been established to overcome this obstacle and to open up and build on scientific opportunities for improved chemotherapy in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5CP8Iq1Vig7Vg90H21EOLACvtfcHk0lh89lJ7Lswp7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhsVCjtrc%253D&md5=49bc148f43f8cd433d585b2e28e5a739</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F415686a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F415686a%26sid%3Dliteratum%253Aachs%26aulast%3DRidley%26aufirst%3DR.%2BG.%26atitle%3DMedical%2520need%252C%2520scientific%2520opportunity%2520and%2520the%2520drive%2520for%2520antimalarial%2520drugs%26jtitle%3DNature%26date%3D2002%26volume%3D415%26spage%3D686%26epage%3D693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Greenwood, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutabingwa, T.</span><span> </span><span class="NLM_article-title">Malaria in 2002</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">415</span><span class="NLM_x">, </span> <span class="NLM_fpage">670</span><span class="NLM_x">–</span> <span class="NLM_lpage">672</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=415&publication_year=2002&pages=670-672&author=B.+Greenwoodauthor=T.+Mutabingwa&title=Malaria+in+2002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGreenwood%26aufirst%3DB.%26aulast%3DMutabingwa%26aufirst%3DT.%26atitle%3DMalaria%2520in%25202002%26jtitle%3DNature%26date%3D2002%26volume%3D415%26spage%3D670%26epage%3D672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Chakrabarti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azam, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DelVecchio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, Y.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, C. M.</span><span> </span><span class="NLM_article-title">Protein prenyl transferase activities of <i>Plasmodium falciparum</i></span> <span class="citation_source-journal">Mol. Biochem. Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm800113p&amp;key=10.1016%2FS0166-6851%2898%2900065-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm800113p&amp;key=9747968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm800113p&amp;key=1%3ACAS%3A528%3ADyaK1cXkvFOlu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1998&pages=175-184&author=D.+Chakrabartiauthor=T.+Azamauthor=C.+DelVecchioauthor=L.+Qiuauthor=Y.-I.+Parkauthor=C.+M.+Allen&title=Protein+prenyl+transferase+activities+of+Plasmodium+falciparum"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Protein prenyl transferase activities of Plasmodium falciparum</span></div><div class="casAuthors">Chakrabarti, Debopam; Azam, Tania; DelVecchio, Cherie; Qiu, Libo; Park, Yong-il; Allen, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Biochemical Parasitology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">175-184</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Prenylated proteins have been shown to function in important cellular regulatory processes, including signal transduction.  The enzymes involved in protein prenylation, farnesyl transferase and geranylgeranyl transferase, have been recent targets for development of cancer chemotherapeutics.  We have initiated a systematic study of protein prenyl transferases of the malaria parasite, Plasmodium falciparum, to det. whether these enzymes can be developed as targets for antimalarial chemotherapy.  We report here the identification of protein farnesyl transferase and protein geranylgeranyl transferase-I in the malaria parasite, P. falciparum.  The farnesyl transferase has been partially purified from the cytosolic fraction through ammonium sulfate pptn. and Mono-Q chromatog.  Farnesyl and geranylgeranyl transferase-I activities are present at all stages of P. falciparum intraerythrocytic development with max. specific activity in the ring stage.  Geranylgeranyl transferase-I specific activity is two times that of farnesyl transferase in the ring stage.  Peptidomimetics and prenyl analogs of protein farnesyl transferase substrates were tested as in vitro inhibitors of partially purified P. falciparum prenyl transferase and of malaria parasite growth.  The peptidomimetics were significantly more potent inhibitors than lipid substrate analogs of both the activity of Mono-Q purified enzyme and parasite growth in intraerythrocytic cultures.  Exposure of the parasite to the peptidomimetic L-745,631 also showed significant inhibition of morphol. development beyond the trophozoite stage.  These studies suggest the potential of designing or identifying differential inhibitors of P. falciparum and mammalian prenyl transferases as an approach to novel malaria therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNLhRGJJLEGLVg90H21EOLACvtfcHk0lh89lJ7Lswp7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvFOlu7o%253D&md5=a68f47f1f5b51cc77c6fb85eb997ccb3</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0166-6851%2898%2900065-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-6851%252898%252900065-6%26sid%3Dliteratum%253Aachs%26aulast%3DChakrabarti%26aufirst%3DD.%26aulast%3DAzam%26aufirst%3DT.%26aulast%3DDelVecchio%26aufirst%3DC.%26aulast%3DQiu%26aufirst%3DL.%26aulast%3DPark%26aufirst%3DY.-I.%26aulast%3DAllen%26aufirst%3DC.%2BM.%26atitle%3DProtein%2520prenyl%2520transferase%2520activities%2520of%2520Plasmodium%2520falciparum%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D1998%26volume%3D94%26spage%3D175%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nallan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bendale, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornéy, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pendyala, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windsor, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrabarti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Voorhis, W. C.</span><span> </span><span class="NLM_article-title">Protein farnesyltransferase inhibitors exhibit potent antimalarial activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3704</span><span class="NLM_x">–</span> <span class="NLM_lpage">3713</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0491039" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3704-3713&author=L.+Nallanauthor=K.+D.+Bauerauthor=P.+Bendaleauthor=K.+Rivasauthor=K.+Yokoyamaauthor=C.+P.+Horn%C3%A9yauthor=P.+R.+Pendyalaauthor=D.+Floydauthor=L.+J.+Lombardoauthor=D.+F.+Williamsauthor=A.+Hamiltonauthor=S.+Sebtiauthor=W.+T.+Windsorauthor=P.+C.+Weberauthor=F.+S.+Bucknerauthor=D.+Chakrabartiauthor=M.+H.+Gelbauthor=W.+C.+van+Voorhis&title=Protein+farnesyltransferase+inhibitors+exhibit+potent+antimalarial+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1021%2Fjm0491039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0491039%26sid%3Dliteratum%253Aachs%26aulast%3DNallan%26aufirst%3DL.%26aulast%3DBauer%26aufirst%3DK.%2BD.%26aulast%3DBendale%26aufirst%3DP.%26aulast%3DRivas%26aufirst%3DK.%26aulast%3DYokoyama%26aufirst%3DK.%26aulast%3DHorn%25C3%25A9y%26aufirst%3DC.%2BP.%26aulast%3DPendyala%26aufirst%3DP.%2BR.%26aulast%3DFloyd%26aufirst%3DD.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DWilliams%26aufirst%3DD.%2BF.%26aulast%3DHamilton%26aufirst%3DA.%26aulast%3DSebti%26aufirst%3DS.%26aulast%3DWindsor%26aufirst%3DW.%2BT.%26aulast%3DWeber%26aufirst%3DP.%2BC.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DChakrabarti%26aufirst%3DD.%26aulast%3DGelb%26aufirst%3DM.%2BH.%26aulast%3Dvan%2BVoorhis%26aufirst%3DW.%2BC.%26atitle%3DProtein%2520farnesyltransferase%2520inhibitors%2520exhibit%2520potent%2520antimalarial%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3704%26epage%3D3713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bendale, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olepu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suryadevara, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulbule, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nallan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smart, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ankala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pendyala, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrabarti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verlinde, C. L. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Voorhis, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gel</span><span class="NLM_x">; </span><span class="NLM_contrib-group">M. H</span><span> </span><span class="NLM_article-title">Second generation tetrahydroquinoline-based protein farnesyltransferase inhibitors as antimalarials</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4585</span><span class="NLM_x">–</span> <span class="NLM_lpage">4605</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0703340" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4585-4605&author=P.+Bendaleauthor=S.+Olepuauthor=P.+K.+Suryadevaraauthor=V.+Bulbuleauthor=K.+Rivasauthor=L.+Nallanauthor=B.+Smartauthor=K.+Yokoyamaauthor=S.+Ankalaauthor=P.+R.+Pendyalaauthor=D.+Floydauthor=L.+J.+Lombardoauthor=D.+K.+Williamsauthor=F.+S.+Bucknerauthor=D.+Chakrabartiauthor=C.+L.+M.+J.+Verlindeauthor=W.+C.+van+Voorhisauthor=+Gelauthor=+M.+H&title=Second+generation+tetrahydroquinoline-based+protein+farnesyltransferase+inhibitors+as+antimalarials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1021%2Fjm0703340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0703340%26sid%3Dliteratum%253Aachs%26aulast%3DBendale%26aufirst%3DP.%26aulast%3DOlepu%26aufirst%3DS.%26aulast%3DSuryadevara%26aufirst%3DP.%2BK.%26aulast%3DBulbule%26aufirst%3DV.%26aulast%3DRivas%26aufirst%3DK.%26aulast%3DNallan%26aufirst%3DL.%26aulast%3DSmart%26aufirst%3DB.%26aulast%3DYokoyama%26aufirst%3DK.%26aulast%3DAnkala%26aufirst%3DS.%26aulast%3DPendyala%26aufirst%3DP.%2BR.%26aulast%3DFloyd%26aufirst%3DD.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DWilliams%26aufirst%3DD.%2BK.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DChakrabarti%26aufirst%3DD.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%2BM.%2BJ.%26aulast%3Dvan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DGel%26aulast%3DM.%2BH%26atitle%3DSecond%2520generation%2520tetrahydroquinoline-based%2520protein%2520farnesyltransferase%2520inhibitors%2520as%2520antimalarials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4585%26epage%3D4605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Clough, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, R. J. M.</span><span> </span><span class="NLM_article-title">Antibiotics and plasmodial plastid organelle</span> <span class="citation_source-journal">Antimalar. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm800113p&amp;key=10.1385%2F1-59259-111-6%3A265" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=265-286&author=N.+Cloughauthor=R.+J.+M.+Wilson&title=Antibiotics+and+plasmodial+plastid+organelle"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1385%2F1-59259-111-6%3A265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252F1-59259-111-6%253A265%26sid%3Dliteratum%253Aachs%26aulast%3DClough%26aufirst%3DN.%26aulast%3DWilson%26aufirst%3DR.%2BJ.%2BM.%26atitle%3DAntibiotics%2520and%2520plasmodial%2520plastid%2520organelle%26jtitle%3DAntimalar.%2520Chemother.%26date%3D2001%26spage%3D265%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Loyevsky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordeuk, V. R.</span><span> </span><span class="NLM_article-title">Iron chelators</span> <span class="citation_source-journal">Antimalar. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm800113p&amp;key=10.1385%2F1-59259-111-6%3A307" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=307-324&author=M.+Loyevskyauthor=V.+R.+Gordeuk&title=Iron+chelators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1385%2F1-59259-111-6%3A307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252F1-59259-111-6%253A307%26sid%3Dliteratum%253Aachs%26aulast%3DLoyevsky%26aufirst%3DM.%26aulast%3DGordeuk%26aufirst%3DV.%2BR.%26atitle%3DIron%2520chelators%26jtitle%3DAntimalar.%2520Chemother.%26date%3D2001%26spage%3D307%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Gelb, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Voorhis, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panethymitaki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. F.</span><span> </span><span class="NLM_article-title">Protein farnesyl and <i>N</i>-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics</span> <span class="citation_source-journal">Mol. Biochem. Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm800113p&amp;key=10.1016%2FS0166-6851%2802%2900282-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm800113p&amp;key=12615314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm800113p&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhs1Kktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2003&pages=155-163&author=M.+H.+Gelbauthor=W.+C.+van+Voorhisauthor=F.+S.+Bucknerauthor=K.+Yokoyamaauthor=R.+Eastmanauthor=E.+P.+Carpenterauthor=C.+Panethymitakiauthor=K.+A.+Brownauthor=D.+F.+Smith&title=Protein+farnesyl+and+N-myristoyl+transferases%3A+piggy-back+medicinal+chemistry+targets+for+the+development+of+antitrypanosomatid+and+antimalarial+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Protein farnesyl and N-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics</span></div><div class="casAuthors">Gelb, Michael H.; Van Voorhis, Wesley C.; Buckner, Frederick S.; Yokoyama, Kohei; Eastman, Richard; Carpenter, Elisabeth P.; Panethymitaki, Chrysoula; Brown, Katherine A.; Smith, Deborah F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-163</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  To accelerate progress in the development of therapeutics for protozoan parasitic diseases, we are studying enzymes active in co- and post-translational protein modification that are already the focus of drug development in other eukaryotic systems.  Inhibitors of the protein farnesyltransferases (PFT) are well-established antitumor agents of low cytotoxicity and known pharmokinetic properties, while inhibitors of N-myristoyl transferase show both selectivity and specificity in the treatment of fungal infections.  Here, we summarize the current evidence that supports the targeting of these ubiquitous eukaryotic enzymes for drug development against trypanosomatid infections and malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotJTH0pFykdLVg90H21EOLACvtfcHk0ljvfqEkhFuUgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhs1Kktro%253D&md5=a3bed65fea78e6b5ca32b3663cea627a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0166-6851%2802%2900282-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-6851%252802%252900282-7%26sid%3Dliteratum%253Aachs%26aulast%3DGelb%26aufirst%3DM.%2BH.%26aulast%3Dvan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DYokoyama%26aufirst%3DK.%26aulast%3DEastman%26aufirst%3DR.%26aulast%3DCarpenter%26aufirst%3DE.%2BP.%26aulast%3DPanethymitaki%26aufirst%3DC.%26aulast%3DBrown%26aufirst%3DK.%2BA.%26aulast%3DSmith%26aufirst%3DD.%2BF.%26atitle%3DProtein%2520farnesyl%2520and%2520N-myristoyl%2520transferases%253A%2520piggy-back%2520medicinal%2520chemistry%2520targets%2520for%2520the%2520development%2520of%2520antitrypanosomatid%2520and%2520antimalarial%2520therapeutics%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D2003%26volume%3D126%26spage%3D155%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wiesner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kettler, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzin, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jomaa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlitzer, M.</span><span> </span><span class="NLM_article-title">Farnesyltransferase inhibitors inhibit the growth of malaria parasites in vitro and in vivo</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=251-254&author=J.+Wiesnerauthor=K.+Kettlerauthor=J.+Sakowskiauthor=R.+Ortmannauthor=A.+M.+Katzinauthor=E.+A.+Kimuraauthor=K.+Silberauthor=G.+Klebeauthor=H.+Jomaaauthor=M.+Schlitzer&title=Farnesyltransferase+inhibitors+inhibit+the+growth+of+malaria+parasites+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWiesner%26aufirst%3DJ.%26aulast%3DKettler%26aufirst%3DK.%26aulast%3DSakowski%26aufirst%3DJ.%26aulast%3DOrtmann%26aufirst%3DR.%26aulast%3DKatzin%26aufirst%3DA.%2BM.%26aulast%3DKimura%26aufirst%3DE.%2BA.%26aulast%3DSilber%26aufirst%3DK.%26aulast%3DKlebe%26aufirst%3DG.%26aulast%3DJomaa%26aufirst%3DH.%26aulast%3DSchlitzer%26aufirst%3DM.%26atitle%3DFarnesyltransferase%2520inhibitors%2520inhibit%2520the%2520growth%2520of%2520malaria%2520parasites%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2004%26volume%3D43%26spage%3D251%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schlitzer, M.</span><span> </span><span class="NLM_article-title">Structure based design of benzophenone-based non-thiol farnesyltransferase inhibitors</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1713</span><span class="NLM_x">–</span> <span class="NLM_lpage">1722</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Fjm800113p&amp;key=10.2174%2F1381612023394061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Fjm800113p&amp;key=12171543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Fjm800113p&amp;key=1%3ACAS%3A528%3ADC%252BD38XlslKhtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=1713-1722&author=M.+Schlitzer&title=Structure+based+design+of+benzophenone-based+non-thiol+farnesyltransferase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Structure based design of benzophenone-based non-thiol farnesyltransferase inhibitors</span></div><div class="casAuthors">Schlitzer, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1713-1722</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  Farnesyltransferase catalyzes the transfer of a farnesyl residue from farnesylpyrophosphate to the thiol of a cysteine side chain of proteins which carry at the C-terminus the so called CAAX-sequence.  Although the exact cellular events affected by farnesyltransferase inhibition remain to be detd., farnesyltransferase has become a major target in the development of potential anti-cancer drugs.  Numerous farnesyltransferase inhibitors have been described from which the majority are CAAX-peptidomimetics possessing a free thiol group which coordinates the enzyme-bound zinc ion.  The development of farnesyltransferase inhibitors is clearly directed towards the so-called non-thiol farnesyltransferase inhibitors because of adverse drug effects connected to free thiols.  This review mainly deals with the efforts of the authors group towards the design of non-thiol-farnesyltransferase inhibitors.  Our first step on the way to non-thiol farnesyltransferase inhibitors was the development of an CAAX-peptidomimetic based on a pharmacophore model.  On the basis of this benzophenone core, bisubstrate analogs were developed as one class of non-thiol farnesyltransferase inhibitors.  In most non-thiol farnesyltransferase inhibitors known in literature nitrogen contg. heterocycles are used as cysteine replacements supposedly coordinating the enzyme bound zinc.  However, we and others have shown that nitrogen heterocycles can be replaced by aryl residues lacking the ability to coordinate metal atoms, an observation which let to the postulation of two hitherto unknown aryl binding sites.  Using flexible docking of model compds. and GRID anal. we were able to locate these postulated aryl binding sites.  Subsequently, we used one of this aryl binding sites for the structure based design of highly active non-thiol farnesyltransferase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowWax3Ap70g7Vg90H21EOLACvtfcHk0li-b1ydVktSkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlslKhtrs%253D&md5=48165f5372f0478027c34284631014c4</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.2174%2F1381612023394061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612023394061%26sid%3Dliteratum%253Aachs%26aulast%3DSchlitzer%26aufirst%3DM.%26atitle%3DStructure%2520based%2520design%2520of%2520benzophenone-based%2520non-thiol%2520farnesyltransferase%2520inhibitors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2002%26volume%3D8%26spage%3D1713%26epage%3D1722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, A. D.</span><span> </span><span class="NLM_article-title">Farnesyltransferase and geranylgeranyltransferase-I inhibitors and cancer therapy: lessons from mechanism and bench-to-bedside translational studies</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6584</span><span class="NLM_x">–</span> <span class="NLM_lpage">6593</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=6584-6593&author=S.+M.+Sebtiauthor=A.+D.+Hamilton&title=Farnesyltransferase+and+geranylgeranyltransferase-I+inhibitors+and+cancer+therapy%3A+lessons+from+mechanism+and+bench-to-bedside+translational+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26atitle%3DFarnesyltransferase%2520and%2520geranylgeranyltransferase-I%2520inhibitors%2520and%2520cancer%2520therapy%253A%2520lessons%2520from%2520mechanism%2520and%2520bench-to-bedside%2520translational%2520studies%26jtitle%3DOncogene%26date%3D2000%26volume%3D19%26spage%3D6584%26epage%3D6593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Bell, I. M.</span><span> </span><span class="NLM_article-title">Inhibitors of farnesyltransferase: a rational approach to cancer chemotherapy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1870</span><span class="NLM_x">–</span> <span class="NLM_lpage">1878</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1870-1878&author=I.+M.+Bell&title=Inhibitors+of+farnesyltransferase%3A+a+rational+approach+to+cancer+chemotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DI.%2BM.%26atitle%3DInhibitors%2520of%2520farnesyltransferase%253A%2520a%2520rational%2520approach%2520to%2520cancer%2520chemotherapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1870%26epage%3D1878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Strickland, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windsor, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bond, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beese, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P. C.</span><span> </span><span class="NLM_article-title">Crystal structure of farnesyl protein transferase complexed with a CaaX peptide and farnesyl diphosphate analog</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">16601</span><span class="NLM_x">–</span> <span class="NLM_lpage">16611</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi981197z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=16601-16611&author=C.+L.+Stricklandauthor=W.+T.+Windsorauthor=R.+Sytoauthor=L.+Wangauthor=R.+Bondauthor=Z.+Wuauthor=J.+Schwartzauthor=H.+V.+Leauthor=L.+S.+Beeseauthor=P.+C.+Weber&title=Crystal+structure+of+farnesyl+protein+transferase+complexed+with+a+CaaX+peptide+and+farnesyl+diphosphate+analog"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fbi981197z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi981197z%26sid%3Dliteratum%253Aachs%26aulast%3DStrickland%26aufirst%3DC.%2BL.%26aulast%3DWindsor%26aufirst%3DW.%2BT.%26aulast%3DSyto%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBond%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DSchwartz%26aufirst%3DJ.%26aulast%3DLe%26aufirst%3DH.%2BV.%26aulast%3DBeese%26aufirst%3DL.%2BS.%26aulast%3DWeber%26aufirst%3DP.%2BC.%26atitle%3DCrystal%2520structure%2520of%2520farnesyl%2520protein%2520transferase%2520complexed%2520with%2520a%2520CaaX%2520peptide%2520and%2520farnesyl%2520diphosphate%2520analog%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26spage%3D16601%26epage%3D16611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Chakrabarti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Silva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquette, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, C. M.</span><span> </span><span class="NLM_article-title">Protein farnesyltransferase and protein prenylation in <i>Plasmodium falciparum</i></span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">42066</span><span class="NLM_x">–</span> <span class="NLM_lpage">42073</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=42066-42073&author=D.+Chakrabartiauthor=T.+Da+Silvaauthor=J.+Bargerauthor=S.+Paquetteauthor=H.+Patelauthor=S.+Pattersonauthor=C.+M.+Allen&title=Protein+farnesyltransferase+and+protein+prenylation+in+Plasmodium+falciparum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChakrabarti%26aufirst%3DD.%26aulast%3DDa%2BSilva%26aufirst%3DT.%26aulast%3DBarger%26aufirst%3DJ.%26aulast%3DPaquette%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DH.%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DAllen%26aufirst%3DC.%2BM.%26atitle%3DProtein%2520farnesyltransferase%2520and%2520protein%2520prenylation%2520in%2520Plasmodium%2520falciparum%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D42066%26epage%3D42073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Eastman, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hucke, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nallan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrabarti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verlinde, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rathod, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Voorhis, W. C.</span><span> </span><span class="NLM_article-title">Resistance to a protein farnesyltransferase inhibitor in <i>Plasmodium falciparum</i></span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">13554</span><span class="NLM_x">–</span> <span class="NLM_lpage">13559</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=13554-13559&author=R.+T.+Eastmanauthor=J.+Whiteauthor=O.+Huckeauthor=K.+Bauerauthor=K.+Yokoyamaauthor=L.+Nallanauthor=D.+Chakrabartiauthor=C.+L.+Verlindeauthor=M.+H.+Gelbauthor=P.+K.+Rathodauthor=W.+C.+van+Voorhis&title=Resistance+to+a+protein+farnesyltransferase+inhibitor+in+Plasmodium+falciparum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEastman%26aufirst%3DR.%2BT.%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DHucke%26aufirst%3DO.%26aulast%3DBauer%26aufirst%3DK.%26aulast%3DYokoyama%26aufirst%3DK.%26aulast%3DNallan%26aufirst%3DL.%26aulast%3DChakrabarti%26aufirst%3DD.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%26aulast%3DGelb%26aufirst%3DM.%2BH.%26aulast%3DRathod%26aufirst%3DP.%2BK.%26aulast%3Dvan%2BVoorhis%26aufirst%3DW.%2BC.%26atitle%3DResistance%2520to%2520a%2520protein%2520farnesyltransferase%2520inhibitor%2520in%2520Plasmodium%2520falciparum%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D13554%26epage%3D13559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Eastman, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hucke, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verlinde, C. L. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hast, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beese, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rathod, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Voorhis, W. C.</span><span> </span><span class="NLM_article-title">Resistance mutations at the lipid substrate binding site of <i>Plasmodium falciparum</i> protein farnesyltransferase</span> <span class="citation_source-journal">Mol. Biochem. Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">66</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm800113p&amp;key=10.1016%2Fj.molbiopara.2006.11.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm800113p&amp;key=17208314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm800113p&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslGmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2007&pages=66-71&author=R.+T.+Eastmanauthor=J.+Whiteauthor=O.+Huckeauthor=K.+Yokoyamaauthor=C.+L.+M.+J.+Verlindeauthor=M.+A.+Hastauthor=L.+S.+Beeseauthor=M.+H.+Gelbauthor=P.+K.+Rathodauthor=W.+C.+van+Voorhis&title=Resistance+mutations+at+the+lipid+substrate+binding+site+of+Plasmodium+falciparum+protein+farnesyltransferase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Resistance mutations at the lipid substrate binding site of Plasmodium falciparum protein farnesyltransferase</span></div><div class="casAuthors">Eastman, Richard T.; White, John; Hucke, Oliver; Yokoyama, Kohei; Verlinde, Christophe L. M. J.; Hast, Michael A.; Beese, Lorena S.; Gelb, Michael H.; Rathod, Pradipsinh K.; Van Voorhis, Wesley C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">66-71</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The post-translational farnesylation of proteins serves to anchor a subset of intracellular proteins to membranes in eukaryotic organisms and also promotes protein-protein interactions.  This enzymic reaction is carried out by protein farnesyltransferase (PFT), which catalyzes the transfer of a 15-carbon isoprenoid lipid unit, a farnesyl group, from farnesyl pyrophosphate to the C-termini of proteins contg. a CaaX motif.  Inhibition of PFT is lethal to the pathogenic protozoa Plasmodium falciparum.  Previously, we have shown that parasites resistant to a tetrahydroquinoline (THQ)-based PFT inhibitor BMS-388891 have mutations leading to amino acid substitutions in PFT that map to the peptide substrate binding domain.  We now report the selection of parasites resistant to another THQ PFT inhibitor BMS-339941.  In whole cell assays sensitivity to BMS-339941 was reduced by 33-fold in a resistant clone, and biochem. anal. demonstrated a corresponding 33-fold increase in the BMS-339941 Ki for the mutant PFT enzyme.  More detailed kinetic anal. revealed that the mutant enzyme required higher concn. of peptide and farnesyl pyrophosphate substrates for optimum catalysis.  Unlike previously characterized parasites resistant to BMS-388891, the resistant parasites have a mutation which is predicted to be in a distinct location of the enzymic pocket, near the farnesyl pyrophosphate binding pocket.  This is the first description of a mutation from any species affecting the farnesyl pyrophosphate binding pocket with reduced efficacy of PFT inhibitors.  These data provide further support that PFT is the target of THQ inhibitors in P. falciparum and suggest that PFT inhibitors should be combined with other antimalarial agents to minimize the development of resistant parasites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZJatvEO8FqrVg90H21EOLACvtfcHk0liMiZp3MEvdOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslGmug%253D%253D&md5=76798da41ee790bc45527f8ca891259e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.molbiopara.2006.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molbiopara.2006.11.012%26sid%3Dliteratum%253Aachs%26aulast%3DEastman%26aufirst%3DR.%2BT.%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DHucke%26aufirst%3DO.%26aulast%3DYokoyama%26aufirst%3DK.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%2BM.%2BJ.%26aulast%3DHast%26aufirst%3DM.%2BA.%26aulast%3DBeese%26aufirst%3DL.%2BS.%26aulast%3DGelb%26aufirst%3DM.%2BH.%26aulast%3DRathod%26aufirst%3DP.%2BK.%26aulast%3Dvan%2BVoorhis%26aufirst%3DW.%2BC.%26atitle%3DResistance%2520mutations%2520at%2520the%2520lipid%2520substrate%2520binding%2520site%2520of%2520Plasmodium%2520falciparum%2520protein%2520farnesyltransferase%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D2007%26volume%3D152%26spage%3D66%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Ohkanda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockman, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croft, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendrick, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrell, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feagin, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaskovich, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, A. D.</span><span> </span><span class="NLM_article-title">Peptidomimetic inhibitors of protein farnesyltransferase show potent antimalarial activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">764</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=761-764&author=J.+Ohkandaauthor=J.+W.+Lockmanauthor=K.+Yokoyamaauthor=M.+H.+Gelbauthor=S.+L.+Croftauthor=H.+Kendrickauthor=M.+I.+Harrellauthor=J.+E.+Feaginauthor=M.+A.+Blaskovichauthor=S.+M.+Sebtiauthor=A.+D.+Hamilton&title=Peptidomimetic+inhibitors+of+protein+farnesyltransferase+show+potent+antimalarial+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhkanda%26aufirst%3DJ.%26aulast%3DLockman%26aufirst%3DJ.%2BW.%26aulast%3DYokoyama%26aufirst%3DK.%26aulast%3DGelb%26aufirst%3DM.%2BH.%26aulast%3DCroft%26aufirst%3DS.%2BL.%26aulast%3DKendrick%26aufirst%3DH.%26aulast%3DHarrell%26aufirst%3DM.%2BI.%26aulast%3DFeagin%26aufirst%3DJ.%2BE.%26aulast%3DBlaskovich%26aufirst%3DM.%2BA.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26atitle%3DPeptidomimetic%2520inhibitors%2520of%2520protein%2520farnesyltransferase%2520show%2520potent%2520antimalarial%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D761%26epage%3D764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Ohkanda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knowles, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaskovich, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, A. D.</span><span> </span><span class="NLM_article-title">Inhibitors of protein farnesyltransferase as novel anticancer agents</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">303</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm800113p&amp;key=10.2174%2F1568026023394281" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm800113p&amp;key=11944822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm800113p&amp;key=1%3ACAS%3A528%3ADC%252BD38XislGmur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=303-323&author=J.+Ohkandaauthor=D.+B.+Knowlesauthor=M.+A.+Blaskovichauthor=S.+M.+Sebtiauthor=A.+D.+Hamilton&title=Inhibitors+of+protein+farnesyltransferase+as+novel+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of protein farnesyltransferase as novel anticancer agents</span></div><div class="casAuthors">Ohkanda, Junko; Knowles, David B.; Blaskovich, Michelle A.; Sebti, Said M.; Hamilton, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Hilversum, Netherlands)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">303-323</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This paper describes recent progress in the design, synthesis and biol. evaluation of inhibitors for the enzyme protein farnesyltransferase (PFTase).  This enzyme plays a crit. role in the post-translational modification of a range of different intracellular proteins.  In particular, PFTase attaches a farnesyl group to the GTPase Ras whose oncogenically mutated form is found in over 30% of human cancers.  As a result PFTase inhibitors have been developed as potential cancer therapeutic drugs either by rational design based on the structure of the CAAX carboxyl terminus of Ras or random screening of chem. libraries or natural products.  Some of these inhibitors show remarkable inhibition potency against PFTase at subnanomolar concns. and >1000-fold selectivity compared to the related enzyme geranylgeranyltransferase-I.  Certain of these compds. are highly effective at blocking the growth of human tumors in animal models and are now undergoing clin. trials.  However, several issues in the research remain unsolved, including the mechanism by which PFTase inhibitors suppress tumor growth.  Although it has been established that PFTase inhibitors block prenylation of Ras in vitro, the results in whole cells and animal studies suggest the possibility that proteins other than Ras are affected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFHtU6WofbYLVg90H21EOLACvtfcHk0liMiZp3MEvdOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XislGmur0%253D&md5=807019e8fbd4049d9f47e6ab10405cdd</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F1568026023394281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026023394281%26sid%3Dliteratum%253Aachs%26aulast%3DOhkanda%26aufirst%3DJ.%26aulast%3DKnowles%26aufirst%3DD.%2BB.%26aulast%3DBlaskovich%26aufirst%3DM.%2BA.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26atitle%3DInhibitors%2520of%2520protein%2520farnesyltransferase%2520as%2520novel%2520anticancer%2520agents%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2002%26volume%3D2%26spage%3D303%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Carrico, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkanda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendrick, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaskovich, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucher, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Voorhis, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrabarti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croft, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, A. D.</span><span> </span><span class="NLM_article-title">In vitro and in vivo antimalarial activity of peptidomimetic protein farnesyltransferase inhibitors with improved membrane permeability</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">6517</span><span class="NLM_x">–</span> <span class="NLM_lpage">6526</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=6517-6526&author=D.+Carricoauthor=J.+Ohkandaauthor=H.+Kendrickauthor=K.+Yokoyamaauthor=M.+A.+Blaskovichauthor=C.+J.+Bucherauthor=F.+S.+Bucknerauthor=W.+C.+van+Voorhisauthor=D.+Chakrabartiauthor=S.+L.+Croftauthor=M.+H.+Gelbauthor=S.+M.+Sebtiauthor=A.+D.+Hamilton&title=In+vitro+and+in+vivo+antimalarial+activity+of+peptidomimetic+protein+farnesyltransferase+inhibitors+with+improved+membrane+permeability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarrico%26aufirst%3DD.%26aulast%3DOhkanda%26aufirst%3DJ.%26aulast%3DKendrick%26aufirst%3DH.%26aulast%3DYokoyama%26aufirst%3DK.%26aulast%3DBlaskovich%26aufirst%3DM.%2BA.%26aulast%3DBucher%26aufirst%3DC.%2BJ.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3Dvan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DChakrabarti%26aufirst%3DD.%26aulast%3DCroft%26aufirst%3DS.%2BL.%26aulast%3DGelb%26aufirst%3DM.%2BH.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520antimalarial%2520activity%2520of%2520peptidomimetic%2520protein%2520farnesyltransferase%2520inhibitors%2520with%2520improved%2520membrane%2520permeability%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D6517%26epage%3D6526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">van Voorhis, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivas, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bendale, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nallan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horney, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smart, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ankala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hucke, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verlinde, C. L. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrabarti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, M. H.</span><span> </span><span class="NLM_article-title">Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of <i>Plasmodium falciparum</i> protein farnesyltransferase</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3659</span><span class="NLM_x">–</span> <span class="NLM_lpage">3671</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2007&pages=3659-3671&author=W.+C.+van+Voorhisauthor=K.+L.+Rivasauthor=P.+Bendaleauthor=L.+Nallanauthor=C.+Horneyauthor=L.+K.+Barrettauthor=K.+D.+Bauerauthor=B.+P.+Smartauthor=S.+Ankalaauthor=O.+Huckeauthor=C.+L.+M.+J.+Verlindeauthor=D.+Chakrabartiauthor=C.+Stricklandauthor=K.+Yokoyamaauthor=F.+S.+Bucknerauthor=A.+D.+Hamiltonauthor=D.+K.+Williamsauthor=L.+J.+Lombardoauthor=D.+Floydauthor=M.+H.+Gelb&title=Efficacy%2C+pharmacokinetics%2C+and+metabolism+of+tetrahydroquinoline+inhibitors+of+Plasmodium+falciparum+protein+farnesyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DRivas%26aufirst%3DK.%2BL.%26aulast%3DBendale%26aufirst%3DP.%26aulast%3DNallan%26aufirst%3DL.%26aulast%3DHorney%26aufirst%3DC.%26aulast%3DBarrett%26aufirst%3DL.%2BK.%26aulast%3DBauer%26aufirst%3DK.%2BD.%26aulast%3DSmart%26aufirst%3DB.%2BP.%26aulast%3DAnkala%26aufirst%3DS.%26aulast%3DHucke%26aufirst%3DO.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%2BM.%2BJ.%26aulast%3DChakrabarti%26aufirst%3DD.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DYokoyama%26aufirst%3DK.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26aulast%3DWilliams%26aufirst%3DD.%2BK.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DFloyd%26aufirst%3DD.%26aulast%3DGelb%26aufirst%3DM.%2BH.%26atitle%3DEfficacy%252C%2520pharmacokinetics%252C%2520and%2520metabolism%2520of%2520tetrahydroquinoline%2520inhibitors%2520of%2520Plasmodium%2520falciparum%2520protein%2520farnesyltransferase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2007%26volume%3D51%26spage%3D3659%26epage%3D3671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><a href="http://www.plasmodb.org" class="extLink">www.plasmodb.org</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=www.plasmodb.org."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Glenn, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hucke, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verlinde, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornéy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pendyala, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrabarti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Voorhis, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, A. D.</span><span> </span><span class="NLM_article-title">Structurally simple farnesyltransferase inhibitors arrest the growth of malaria parasites</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">4903</span><span class="NLM_x">–</span> <span class="NLM_lpage">4906</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=4903-4906&author=M.+P.+Glennauthor=S.-Y.+Changauthor=O.+Huckeauthor=C.+L.+Verlindeauthor=K.+Rivasauthor=C.+Horn%C3%A9yauthor=K.+Yokoyamaauthor=F.+S.+Bucknerauthor=P.+R.+Pendyalaauthor=D.+Chakrabartiauthor=M.+Gelbauthor=W.+C.+van+Voorhisauthor=S.+M.+Sebtiauthor=A.+D.+Hamilton&title=Structurally+simple+farnesyltransferase+inhibitors+arrest+the+growth+of+malaria+parasites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlenn%26aufirst%3DM.%2BP.%26aulast%3DChang%26aufirst%3DS.-Y.%26aulast%3DHucke%26aufirst%3DO.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%26aulast%3DRivas%26aufirst%3DK.%26aulast%3DHorn%25C3%25A9y%26aufirst%3DC.%26aulast%3DYokoyama%26aufirst%3DK.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DPendyala%26aufirst%3DP.%2BR.%26aulast%3DChakrabarti%26aufirst%3DD.%26aulast%3DGelb%26aufirst%3DM.%26aulast%3Dvan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26atitle%3DStructurally%2520simple%2520farnesyltransferase%2520inhibitors%2520arrest%2520the%2520growth%2520of%2520malaria%2520parasites%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2005%26volume%3D44%26spage%3D4903%26epage%3D4906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Glenn, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornéy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pusateri, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pendyala, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrabarti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Voorhis, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, A. D.</span><span> </span><span class="NLM_article-title">Structurally simple, potent <i>Plasmodium</i> selective farnesyltransferase inhibitors that arrest the growth of malaria parasites</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5710</span><span class="NLM_x">–</span> <span class="NLM_lpage">5727</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060081v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5710-5727&author=M.+P.+Glennauthor=S.-Y.+Changauthor=C.+Horn%C3%A9yauthor=K.+Rivasauthor=K.+Yokoyamaauthor=E.+E.+Pusateriauthor=S.+Fletcherauthor=C.+G.+Cummingsauthor=F.+S.+Bucknerauthor=P.+R.+Pendyalaauthor=D.+Chakrabartiauthor=S.+M.+Sebtiauthor=M.+Gelbauthor=W.+C.+van+Voorhisauthor=A.+D.+Hamilton&title=Structurally+simple%2C+potent+Plasmodium+selective+farnesyltransferase+inhibitors+that+arrest+the+growth+of+malaria+parasites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm060081v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060081v%26sid%3Dliteratum%253Aachs%26aulast%3DGlenn%26aufirst%3DM.%2BP.%26aulast%3DChang%26aufirst%3DS.-Y.%26aulast%3DHorn%25C3%25A9y%26aufirst%3DC.%26aulast%3DRivas%26aufirst%3DK.%26aulast%3DYokoyama%26aufirst%3DK.%26aulast%3DPusateri%26aufirst%3DE.%2BE.%26aulast%3DFletcher%26aufirst%3DS.%26aulast%3DCummings%26aufirst%3DC.%2BG.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DPendyala%26aufirst%3DP.%2BR.%26aulast%3DChakrabarti%26aufirst%3DD.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DGelb%26aufirst%3DM.%26aulast%3Dvan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26atitle%3DStructurally%2520simple%252C%2520potent%2520Plasmodium%2520selective%2520farnesyltransferase%2520inhibitors%2520that%2520arrest%2520the%2520growth%2520of%2520malaria%2520parasites%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5710%26epage%3D5727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span> </span><span class="NLM_article-title">Development and validation of a genetic algorithm for flexible docking</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm800113p&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm800113p&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm800113p&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+validation+of+a+genetic+algorithm+for+flexible+docking"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0lipqsCU05llsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520genetic%2520algorithm%2520for%2520flexible%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Reissig, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, R.</span><span> </span><span class="NLM_article-title">Donor−acceptor-substituted cyclopropane derivatives and their application in organic synthesis</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">1151</span><span class="NLM_x">–</span> <span class="NLM_lpage">1196</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr010016n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2003&pages=1151-1196&author=H.+U.+Reissigauthor=R.+Zimmer&title=Donor%E2%88%92acceptor-substituted+cyclopropane+derivatives+and+their+application+in+organic+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fcr010016n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr010016n%26sid%3Dliteratum%253Aachs%26aulast%3DReissig%26aufirst%3DH.%2BU.%26aulast%3DZimmer%26aufirst%3DR.%26atitle%3DDonor%25E2%2588%2592acceptor-substituted%2520cyclopropane%2520derivatives%2520and%2520their%2520application%2520in%2520organic%2520synthesis%26jtitle%3DChem.%2520Rev.%26date%3D2003%26volume%3D103%26spage%3D1151%26epage%3D1196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span> <span class="citation_source-book">InsightII</span>; <span class="NLM_publisher-name">Accelrys Inc.</span>: <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2000</span><span class="NLM_x">; </span><a href="http://www.accelrys.com" class="extLink">http://www.accelrys.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=InsightII%3B+Accelrys+Inc.%3A+San+Diego%2C+CA%2C+2000%3B+http%3A%2F%2Fwww.accelrys.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DInsightII%26pub%3DAccelrys%2520Inc%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><div class="note"><p class="first last">Unpublished results.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><div class="note"><p class="first last">Thorpe−Ingold effect, or the “gem-dialkyl effect”: replacement of a C−CH<sub>2</sub>−C group with a C−CR<sub>2</sub>−C group causes a compression of the C−C−C bond angle at the now-quarternary carbon.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Thorpe%E2%88%92Ingold+effect%2C+or+the+%E2%80%9Cgem-dialkyl+effect%E2%80%9D%3A+replacement+of+a+C%E2%88%92CH2%E2%88%92C+group+with+a+C%E2%88%92CR2%E2%88%92C+group+causes+a+compression+of+the+C%E2%88%92C%E2%88%92C+bond+angle+at+the+now-quarternary+carbon."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Long, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kral, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellinga, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beese, L. S.</span><span> </span><span class="NLM_article-title">The crystal structure of human proteinfarnesyltransferase reveals the basis for inhibition by CaaX tetrapeptides and their mimetics</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">12948</span><span class="NLM_x">–</span> <span class="NLM_lpage">12953</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=12948-12953&author=S.+B.+Longauthor=P.+J.+Hancockauthor=A.+M.+Kralauthor=H.+W.+Hellingaauthor=L.+S.+Beese&title=The+crystal+structure+of+human+proteinfarnesyltransferase+reveals+the+basis+for+inhibition+by+CaaX+tetrapeptides+and+their+mimetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DS.%2BB.%26aulast%3DHancock%26aufirst%3DP.%2BJ.%26aulast%3DKral%26aufirst%3DA.%2BM.%26aulast%3DHellinga%26aufirst%3DH.%2BW.%26aulast%3DBeese%26aufirst%3DL.%2BS.%26atitle%3DThe%2520crystal%2520structure%2520of%2520human%2520proteinfarnesyltransferase%2520reveals%2520the%2520basis%2520for%2520inhibition%2520by%2520CaaX%2520tetrapeptides%2520and%2520their%2520mimetics%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2001%26volume%3D98%26spage%3D12948%26epage%3D12953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Seto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guengerich, F. P.</span><span> </span><span class="NLM_article-title">Partitioning between N-dealkylation and N-oxygenation in the oxidation of <i>N</i>,<i>N</i>-dialkylarylamines catalyzed by cytochrome P450 2B1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">9986</span><span class="NLM_x">–</span> <span class="NLM_lpage">9997</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm800113p&amp;key=8486725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm800113p&amp;key=1%3ACAS%3A528%3ADyaK3sXkvV2rsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1993&pages=9986-9997&author=Y.+Setoauthor=F.+P.+Guengerich&title=Partitioning+between+N-dealkylation+and+N-oxygenation+in+the+oxidation+of+N%2CN-dialkylarylamines+catalyzed+by+cytochrome+P450+2B1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Partitioning between N-dealkylation and N-oxygenation in the oxidation of N,N-dialkylarylamines catalyzed by cytochrome P450 2B1</span></div><div class="casAuthors">Seto, Yasuo; Guengerich, F. Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">9986-97</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Aminium radicals have been proposed as intermediates in amine N-dealkylations and N-oxygenations catalyzed by cytochrome P 450 (P 450) and some other enzymes.  P450s can form some N-oxides and hydroxylamines but these are not favored whenever N-dealkylation is possible.  However, if a paradigm involving 1-electron oxidn. is valid, then some finite level of partitioning of aminium radicals between N-oxygenation and N-dealkylation might be expected in all cases.  Methods were developed for the selective and sensitive measurement of N,N-dialkylaniline N-oxides using high performance liq. chromatog., radiochromatog., and TiCl3 redn.  These N-oxides were relatively stable in the presence of P 450 2B1.  In the presence of NADPH and NADPH-P 450 reductase some redn. of N,N-dialkylamines occurred, along with N-dealkylation (to monoalkylanilines); there was also slow N-dealkylation in the absence of NADPH, which is interpreted in terms of homolytic scission of the N-O bond; N,N-dialkylanilines were not formed nor did the N-oxides support other oxygenation reactions.  P 450 2B1 (with its reductase and NADPH) formed N-oxides at low rates from several N,N-dialkylaniline derivs., including N,N-dimethylaniline, N,N-diethylaniline, N-ethyl-N-methylaniline, 4-methyl-N,N-dimethylaniline, 4-cyano-N,N-dimethyl-2-aminofluorene.  The ratio of N-dealkylation:N-oxygenation varied from 1020 to 6 in this series.  These results are consistent with the view that aminium radicals are a branch point in N-oxygenation and N-dealkylation reactions catalyzed by metalloproteins, although some alternate explanations cannot be ruled out.  While N-dealkylation is the dominant process in all of the P 450-catalyzed amine oxidns., there should be a finite partition ratio between these reactions depending upon the particular enzyme and substrate.  The N-oxygenation reaction is probably more complex than a direct radical recombination event and is postulated to involve one or more intermediates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOH4rkAiDn7LVg90H21EOLACvtfcHk0lj9AIfTE1Kw8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkvV2rsL0%253D&md5=2de50390efebd1e86e602dd084164a03</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeto%26aufirst%3DY.%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26atitle%3DPartitioning%2520between%2520N-dealkylation%2520and%2520N-oxygenation%2520in%2520the%2520oxidation%2520of%2520N%252CN-dialkylarylamines%2520catalyzed%2520by%2520cytochrome%2520P450%25202B1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1993%26volume%3D268%26spage%3D9986%26epage%3D9997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span> <span class="citation_source-book">Molecular Operating Environment</span>, version <span class="NLM_edition">2007.11</span>; <span class="NLM_publisher-name">Chemical Computing Group</span>: <span class="NLM_publisher-loc">Montreal, Quebec, Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Molecular+Operating+Environment%2C+version+2007.11%3B+Chemical+Computing+Group%3A+Montreal%2C+Quebec%2C+Canada%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMolecular%2520Operating%2520Environment%26pub%3DChemical%2520Computing%2520Group%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Sukumar, N.; Breneman, C. M.</span><span> </span><span class="NLM_article-title">QTAIM in Drug Discovery and Protein Modeling</span>. In  <span class="citation_source-book">The Quantum Theory of Atoms in Molecules: From Solid State to DNA and Drug Design</span>; <span class="NLM_contrib-group">Matta, C. F.; Boyd, R. J.</span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH</span>: Weinheim, Germany,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=N.+Sukumar&author=C.+M.+Brenemanauthor=C.+F.+Matta&author=R.+J.+Boyd&title=The+Quantum+Theory+of+Atoms+in+Molecules%3A+From+Solid+State+to+DNA+and+Drug+Design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSukumar%26aufirst%3DN.%26atitle%3DQTAIM%2520in%2520Drug%2520Discovery%2520and%2520Protein%2520Modeling%26btitle%3DThe%2520Quantum%2520Theory%2520of%2520Atoms%2520in%2520Molecules%253A%2520From%2520Solid%2520State%2520to%2520DNA%2520and%2520Drug%2520Design%26aulast%3DMatta%26aufirst%3DC.%2BF.%26pub%3DWiley-VCH%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Embrechts, M. J.</span> <span class="citation_source-book">KernelPLS(Analyze)</span>, version <span class="NLM_edition">6.36</span>; <span class="NLM_publisher-name">Rensselaer Polytechnic Institute</span>: <span class="NLM_publisher-loc">Troy, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=M.+J.+Embrechts&title=KernelPLS%28Analyze%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DEmbrechts%26aufirst%3DM.%2BJ.%26btitle%3DKernelPLS%2528Analyze%2529%26pub%3DRensselaer%2520Polytechnic%2520Institute%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Trager, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, J. B.</span><span> </span><span class="NLM_article-title">Human malaria parasites in continuous culture</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">193</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="NLM_x">–</span> <span class="NLM_lpage">675</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm800113p&amp;key=10.1126%2Fscience.781840" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm800113p&amp;key=781840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm800113p&amp;key=1%3ACAS%3A280%3ADyaE283ks1Wqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=1976&pages=673-675&author=W.+Tragerauthor=J.+B.+Jensen&title=Human+malaria+parasites+in+continuous+culture"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Human malaria parasites in continuous culture</span></div><div class="casAuthors">Trager W; Jensen J B</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">4254</span>),
    <span class="NLM_cas:pages">673-5</span>
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Plasmodium falciparum can now be maintained in continuous culture in human erythrocytes incubated at 38 degrees C in RPMI 1640 medium with human serum under an atmosphere with 7 percent carbon dioxide and low oxygen (1 or 5 percent).  The original parasite material, derived from an infected Aotus trivirgatus monkey, was diluted more than 100 million times by the addition of human erythrocytes at 3- or 4-day intervals.  The parasites continued to reproduce in their normal asexual cycle of approximately 48 hours but were no longer highly synchronous.  The have remained infective to Aotus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQPnKdQ--_afmyYR5VtavbzfW6udTcc2eaPOKWfp9GoBrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE283ks1Wqug%253D%253D&md5=a7f43c2255b75d9841c36338433c78b8</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1126%2Fscience.781840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.781840%26sid%3Dliteratum%253Aachs%26aulast%3DTrager%26aufirst%3DW.%26aulast%3DJensen%26aufirst%3DJ.%2BB.%26atitle%3DHuman%2520malaria%2520parasites%2520in%2520continuous%2520culture%26jtitle%3DScience%26date%3D1976%26volume%3D193%26spage%3D673%26epage%3D675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i90"><a href="/doi/suppl/10.1021/jm800113p">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_01001"></div></div></div></div></div><hr /></hr><p class="last">GOLD low energy docked pictures of compounds <b>2a</b>−<b>5a</b>, <b>7a</b>, <b>8a</b>, <b>10a</b>, and <b>11a</b>, experimental procedures and full characterizations of compounds <b>14</b>−<b>64d</b>, and HPLC traces of two independent conditions for all target molecules (<b>2a</b>−<b>9e</b>, <b>10a</b>, <b>10d</b>, <b>11a</b>, <b>11d</b>). This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm800113p/suppl_file/jm800113p-file002.pdf">jm800113p-file002.pdf (3.72 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm800113p&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-17%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm800113p%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm800113p" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679998b0f9f13db2","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
